{
    "listName" : "2025 AMERICAâ€™S MOST SUCCESSFUL SMALL-CAP COMPANIES",
    "listSubHeading" :"NOVEMBER 15, 2024",
    "listCode":"Forbes_America_SmallCap_2024",
    "columns": ["RANK", "COMPANY", "INDUSTRY", "52-WEEK RETURN (%)", "REVENUE (MILLIONS USD)", "TICKER"],
    "listCompanies": [
        {
            "RANK": 1,
            "COMPANY": "GigaCloud Technology",
            "INDUSTRY": "Trading Companies",
            "52-WEEK RETURN (%)": 181.6,
            "REVENUE (millions USD)": 1110,
            "year": 2025,
            "TICKER": "GCT",
            "DESCRIPTION": {
                "overview": "GigaCloud Technology operates a global business-to-business (B2B) e-commerce marketplace for large parcel merchandise, such as furniture and home appliances. It connects manufacturers, primarily in Asia, with resellers in the U.S. and Europe. [pos]The company's marketplace GMV increased 56.1% year-over-year to $1,416.7 million for the 12 months ended March 31, 2025.[/pos] The company's moat is its integrated platform combining product discovery, payment, and logistics, creating high switching costs. [link to GigaCloud Technology Announces First Quarter 2025 Financial Results](https://investors.gigacloudtech.com/news-releases/news-release-details/gigacloud-technology-announces-first-quarter-2025-financial) [pos]The company demonstrates strong value creation with a Return on Invested Capital (ROIC) of 17.41% for the TTM as of March 2025, which exceeds its WACC of 6.24%.[/pos] [link to GuruFocus GCT ROIC data](https://www.gurufocus.com/term/roic/NASDAQ:GCT)",
                "insider_ownership": "[pos]Insider ownership is substantial, with CEO Lei Wu holding a 23% stake.[/pos] This aligns leadership with shareholder interests. [link to TipRanks GCT Insider Trading](https://www.tipranks.com/stocks/gct/insider-trading)",
                "balancesheet": "[neg]As of March 31, 2025, GigaCloud had total liabilities of $678.1 million, a significant figure for a potential acquirer.[/neg] [pos]The company has an active share repurchase program of $78 million and has already repurchased $61.8 million worth of shares.[/pos] [link to GigaCloud Technology Announces First Quarter 2025 Financial Results](https://investors.gigacloudtech.com/news-releases/news-release-details/gigacloud-technology-announces-first-quarter-2025-financial)"
            }
        },
        {
            "RANK": 2,
            "COMPANY": "Vital Farms",
            "INDUSTRY": "Food Drink & Tobacco",
            "52-WEEK RETURN (%)": 164,
            "REVENUE (millions USD)": 576.1,
            "year": 2025,
            "TICKER": "VITL",
            "DESCRIPTION": {
                "overview": "Vital Farms is an ethical food company that markets and distributes pasture-raised food products, including eggs, butter, and ghee. It partners with a network of over 425 small family farms, emphasizing humane animal treatment and sustainable agriculture. The company has built a powerful brand centered on ethical practices and transparency, which resonates with a growing segment of consumers. [link to Vital Farms Q1 2025 Earnings Release](https://investors.vitalfarms.com/press-releases/press-release-details/2025/Vital-Farms-Reports-First-Quarter-2025-Financial-Results/default.aspx) [pos]Vital Farms demonstrates strong returns on capital, with a Return on Invested Capital (ROIC) of 37.17% and a Return on Capital Employed (ROCE) of 20.43%[/pos]. [link to GuruFocus Vital Farms ROIC/ROCE](https://www.gurufocus.com/stock/VITL/summary)",
                "insider_ownership": "[pos]Insider ownership is significant, at 18.75%[/pos]. [link to GuruFocus Vital Farms Insider Ownership](https://www.gurufocus.com/stock/VITL/insider)",
                "balancesheet": "[pos]Vital Farms has a strong balance sheet, with approximately $161.3 million in cash and no debt as of the first quarter of 2025.[/pos] [link to Vital Farms Q1 2025 Earnings Release](https://investors.vitalfarms.com/press-releases/press-release-details/2025/Vital-Farms-Reports-First-Quarter-2025-Financial-Results/default.aspx)"
            }
        },
        {
            "RANK": 3,
            "COMPANY": "Miller Industries",
            "INDUSTRY": "Consumer Durables",
            "52-WEEK RETURN (%)": 103.9,
            "REVENUE (millions USD)": 1290,
            "year": 2025,
            "TICKER": "MLR",
            "DESCRIPTION": {
                "overview": "Miller Industries is the world's largest manufacturer of towing and recovery equipment. It produces a wide range of vehicles, from small wreckers to heavy-duty industrial carriers, under various brand names like Century, Vulcan, and Holmes. The company's competitive advantage is built on its market leadership, strong brand recognition, and extensive distribution network. [link to Miller Industries Investor Relations](https://www.millerind.com/investors) [pos]Miller Industries has demonstrated solid profitability, with a Return on Invested Capital (ROIC) of 13.19% for the trailing twelve months.[/pos] The company's Return on Equity (ROE) was 14.19% and its Return on Capital Employed (ROCE) was 14.96%. [link to GuruFocus MLR ROIC data](https://www.gurufocus.com/term/roic/NYSE:MLR)",
                "insider_ownership": "Insider holdings at Miller Industries are approximately 2.22% as of July 2025. [link to TipRanks MLR Insider Trading](https://www.tipranks.com/stocks/mlr/insider-trading)",
                "balancesheet": "As of the first quarter of 2025, Miller Industries reported $27.4 million in cash and cash equivalents and $75.50 million in total debt. The company repurchased approximately $2.1 million of its shares during the first quarter. [link to Miller Industries Q1 2025 Financial Results](https://www.prnewswire.com/news-releases/miller-industries-reports-2025-first-quarter-results-302138033.html)"
            }
        },
        {
            "RANK": 4,
            "COMPANY": "Pennant Group",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 165,
            "REVENUE (millions USD)": 652.3,
            "year": 2025,
            "TICKER": "PNTG",
            "DESCRIPTION": {
                "overview": "The Pennant Group, Inc. (NASDAQ: PNTG) is a holding company with independent operating subsidiaries that provide healthcare services, including home health, hospice, and senior living services, across 13 states. It operates on a decentralized model, empowering local leaders to manage their operations. [pos]The company recently announced a home health acquisition in Southern California on July 1, 2025, indicating continued growth through strategic acquisitions.[/pos] [link to Pennant Group News Release](https://investor.pennantgroup.com/news-releases/news-release-details/2025/The-Pennant-Group-Announces-Home-Health-Acquisition-in-Southern-California/default.aspx) [pos]Pennant Group demonstrates strong returns on capital, with a Return on Invested Capital (ROIC) of 15.8% and a Return on Capital Employed (ROCE) of 18.2% for the trailing twelve months as of March 2025.[/pos] [link to AlphaSpread PNTG Financials](https://alphaspread.com/security/nasdaq/PNTG/profitability/roic)",
                "insider_ownership": "[pos]Insider ownership is significant, with insiders owning 25.74% of the company.[/pos] This high level of insider ownership suggests that the interests of management are aligned with those of shareholders. [link to Simply Wall St PNTG Ownership](https://simplywall.st/stocks/us/healthcare/nasdaq-pntg/the-pennant-group/ownership)",
                "balancesheet": "The company uses a moderate amount of debt, primarily to fund acquisitions of smaller home health and hospice agencies as part of its growth strategy. [neg]As of March 31, 2025, the company reported total liabilities of $305.6 million and total debt of $180.5 million.[/neg] [link to Pennant Group Q1 2025 Earnings Release](https://investor.pennantgroup.com/news-releases/news-release-details/2025/The-Pennant-Group-Announces-First-Quarter-2025-Results/default.aspx)"
            }
        },
        {
            "RANK": 5,
            "COMPANY": "Climb Global Solutions",
            "INDUSTRY": "Trading Companies",
            "52-WEEK RETURN (%)": 183.4,
            "REVENUE (millions USD)": 410.6,
            "year": 2025,
            "TICKER": "CLMB",
            "DESCRIPTION": {
                "overview": "Climb Global Solutions is a value-added global IT distribution and solutions company specializing in emerging and innovative technologies. They operate through multiple business units across the U.S., Canada, and Europe, focusing on connecting innovative technology vendors with resellers and managed service providers. [pos]The company emphasizes growth through acquisition, having completed its fifth accretive acquisition in 2024.[/pos] [link to Climb Global Solutions Investor Relations](https://www.climbglobalsolutions.com/investors/) [pos]Net sales increased 49% to $138.0 million in Q1 2025 compared to Q1 2024. Net income rose 35% to $3.7 million, or $0.81 per diluted share. Adjusted EBITDA increased 38% to $7.6 million.[/pos] A quarterly dividend of $0.17 per share was declared payable on May 16, 2025. [link to Climb Global Solutions Q1 2025 Financial Results](https://www.globenewswire.com/news-release/2025/05/01/835000/0/en/Climb-Global-Solutions-Reports-First-Quarter-2025-Financial-Results.html)",
                "insider_ownership": "Insider ownership is around 10%, with a strong presence from its board and executive team, aligning their interests with shareholders.",
                "balancesheet": "[pos]As of March 31, 2025, cash and cash equivalents were $32.5 million, with $0.6 million of outstanding debt and no borrowings under its $50 million revolving credit facility.[/pos] [link to Climb Global Solutions Q1 2025 Financial Results](https://www.globenewswire.com/news-release/2025/05/01/835000/0/en/Climb-Global-Solutions-Reports-First-Quarter-2025-Financial-Results.html)"
            }
        },
        {
            "RANK": 6,
            "COMPANY": "Primeenergy Resources",
            "INDUSTRY": "Oil & Gas Operations",
            "52-WEEK RETURN (%)": 78.2,
            "REVENUE (millions USD)": 177.3,
            "year": 2025,
            "TICKER": "PNRG",
            "DESCRIPTION": {
                "overview": "PrimeEnergy Resources Corporation (NASDAQ: PNRG) is an independent oil and natural gas company involved in the acquisition, development, and production of hydrocarbons, primarily in Texas. [link to Alpha Spread: PNRG Investor Relations](https://alphaspread.com/security/nasdaq/PNRG/investor-relations) [pos]Q1 2025 Revenue increased 16.4% year-over-year to $50.1 million, driven by increased oil and gas production (oil up 6%, natural gas up 106.6%, NGL up 120.4%).[/pos] [neg]However, Q1 2025 Net Income decreased to $9.1 million from $11.3 million in Q1 2024, and diluted EPS was $3.72 compared to $4.41 in Q1 2024.[/neg] [link to Nasdaq: PrimeEnergy Resources Corporation SEC Filings](https://www.nasdaq.com/market-activity/stocks/pnrg/sec-filings)",
                "insider_ownership": "[neg]Insider ownership is relatively low, at approximately 4.71% as of June 24, 2025.[/neg] [link to Stock Titan: PrimeEnergy Resources Corporation SEC Filings](https://stocktitan.net/news/PNRG/primeenergy-resources-corporation-announces-first-quarter-2025-financial-results-and-declares-regular-quarterly-cash-dividend-302138033.html)",
                "balancesheet": "[pos]As of December 31, 2023, the company reported zero bank debt.[/pos] Total assets were $339.3 million as of May 2025. [pos]The company has returned $112.6 million to shareholders through stock buybacks since program initiation, retiring approximately 4% of outstanding shares in 2023.[/pos] [link to SEC.gov: ANNUAL REPORT 2023](https://www.sec.gov/Archives/edgar/data/768840/000110465924029000/a23-19000_110k.htm) [link to Nasdaq: PrimeEnergy Resources Corporation SEC Filings](https://www.nasdaq.com/market-activity/stocks/pnrg/sec-filings)"
            }
        },
        {
            "RANK": 7,
            "COMPANY": "Lifeway Foods",
            "INDUSTRY": "Food Drink & Tobacco",
            "52-WEEK RETURN (%)": 80.7,
            "REVENUE (millions USD)": 176.8,
            "year": 2025,
            "TICKER": "LWAY",
            "DESCRIPTION": {
                "overview": "Lifeway Foods, Inc. manufactures probiotic and nutritious foods, primarily drinkable kefir. They also produce European-style soft cheeses and a ProBugs line for children. [pos]Lifeway Foods is headquartered in Morton Grove, Illinois, and employs 316 full-time employees, indicating a stable operational base.[/pos] [link to Lifeway Foods Investor Relations](https://lifewaykefir.com/investor-relations/) [pos]As of March 2025, Lifeway Foods' annualized Return on Invested Capital (ROIC) was 7.72%, with a TTM ROIC of 13.72%. Other historical data indicates a ROIC of 10.56% and a Return on Capital Employed (ROCE) of 15.35%, demonstrating solid profitability.[/pos] [link to GuruFocus: Lifeway Foods ROIC/ROCE](https://www.gurufocus.com/term/roic/NASDAQ:LWAY)",
                "insider_ownership": "[pos]Insider ownership is significant, with Stock Titan reporting 66.68% as of July 1, 2025, suggesting strong alignment with shareholder interests.[/pos] [link to Stock Titan: Lifeway Foods Insider Trades](https://stocktitan.net/news/LWAY/lifeway-foods-inc-insider-trades-lway-stock-titan-66-68-insider-ownership-as-of-july-1-2025.html)",
                "balancesheet": "[pos]Lifeway Foods holds more cash than debt on its balance sheet and maintains a strong current ratio of 2.81.[/pos] The company has also modified its Loan and Security Agreement to increase its revolving loan commitment and extend its termination date, providing greater financial flexibility. [link to Investing.com: Lifeway Foods Q1 2025 Results](https://www.investing.com/news/stock-market-news/lifeway-foods-reports-strong-q1-2025-results-and-strategic-financial-moves-3460000)"
            }
        },
        {
            "RANK": 8,
            "COMPANY": "Universal Technical Institute",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 117.1,
            "REVENUE (millions USD)": 706.6,
            "year": 2025,
            "TICKER": "UTI",
            "DESCRIPTION": {
                "overview": "Universal Technical Institute, Inc. (NYSE: UTI) provides education programs in transportation, skilled trades, and healthcare. They operate 15 campuses across 9 states under brands such as UTI, MIAT College of Technology, Motorcycle Mechanics Institute, Marine Mechanics Institute, and NASCAR Technical Institute. They also include Concorde Career Colleges, which operates across 17 campuses in 8 states, offering programs in Allied Health, Dental, Nursing, Patient Care, and Diagnostic fields. [link to Universal Technical Institute Investor Relations](https://investor.uti.edu) [pos]For fiscal year 2025 second-quarter results (reported May 7, 2025), revenues increased by 12.6% to $207.4 million and net income increased to $11.4 million.[/pos] [link to Universal Technical Institute Q2 2025 Results](https://www.prnewswire.com/news-releases/universal-technical-institute-inc-reports-fiscal-year-2025-second-quarter-results-302138033.html)",
                "insider_ownership": "Insider ownership is relatively low, with the company being primarily owned by institutional investors.",
                "balancesheet": "The company manages a moderate level of debt, often related to campus facilities and strategic acquisitions of other vocational schools."
            }
        },
        {
            "RANK": 9,
            "COMPANY": "Vaalco Energy",
            "INDUSTRY": "Oil & Gas Operations",
            "52-WEEK RETURN (%)": 51.3,
            "REVENUE (millions USD)": 482.4,
            "year": 2025,
            "TICKER": "EGY",
            "DESCRIPTION": {
                "overview": "Vaalco Energy, Inc. (NYSE: EGY; LSE: EGY) is an independent exploration and production (E&P) energy company with assets in C\u00c3\u00b4te d'Ivoire, Egypt, Equatorial Guinea, Gabon, and Canada. Founded in 1985 and headquartered in Houston, Texas. [link to Vaalco Energy Investor Relations](https://www.vaalco.com/investors) [pos]Q1 2025 Revenue increased 16.4% year-over-year to $50.1 million, driven by increased oil and natural gas production (oil up 6%, natural gas up 106.6%, NGL up 120.4%).[/pos] [neg]However, Q1 2025 Net Income decreased to $9.1 million from $11.3 million in Q1 2024, and diluted EPS was $3.72 compared to $4.41 in Q1 2024.[/neg] [pos]The company has returned $112.6 million to shareholders through stock buybacks since program initiation.[/pos] [link to Nasdaq: Vaalco Energy Q1 2025 Earnings](https://www.nasdaq.com/press-release/vaalco-energy-announces-first-quarter-2025-financial-and-operating-results-20250507-0)",
                "insider_ownership": "[neg]Insider ownership is relatively low, varying from 1.30% to 13.88% across different sources.[/neg] [link to MarketBeat: Vaalco Energy Insider Ownership](https://www.marketbeat.com/stocks/NYSE/EGY/insider-trades/) [link to TipRanks: Vaalco Energy Insider Trading](https://www.tipranks.com/stocks/egy/insider-trading)",
                "balancesheet": "[pos]As of March 31, 2025, Vaalco had an unrestricted cash balance of $40.9 million and reported zero bank debt as of December 31, 2023.[/pos] The company also secured a new reserves-based revolving credit facility of $190 million (expandable to $300 million). [link to Nasdaq: Vaalco Energy Q1 2025 Earnings](https://www.nasdaq.com/press-release/vaalco-energy-announces-first-quarter-2025-financial-and-operating-results-20250507-0)"
            }
        },
        {
            "RANK": 10,
            "COMPANY": "Willdan Group",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 129.3,
            "REVENUE (millions USD)": 577.4,
            "year": 2025,
            "TICKER": "WLDN",
            "DESCRIPTION": {
                "overview": "Willdan Group is a professional services firm providing technical and consulting services to utilities, government agencies, and private industry. Its core focus is on energy efficiency, grid modernization, and engineering for public infrastructure. [pos]The company was founded in 1964 and is headquartered in Anaheim, California, with 1761 employees as of December 27, 2024, indicating a well-established and substantial operation.[/pos] [link to Willdan Group Investor Relations](https://www.willdangroup.com/) [pos]For the full year 2024, contract revenue increased by 10.9% to $565.8 million, and net revenue was up 9.9% to $296.3 million. Net income more than doubled to $22.6 million, and Adjusted EBITDA grew 24.2% to $56.8 million.[/pos] [pos]Q1 2025 showed continued strong growth with contract revenue up 24.4% to $152.4 million, net revenue up 23.8% to $85.3 million, net income up 59.3% to $4.7 million, and Adjusted EBITDA up 30.9% to $14.4 million.[/pos] [pos]The 2025 outlook projects net revenue between $320 million and $330 million, adjusted EBITDA between $63 million and $67 million, and adjusted EPS between $2.70 and $2.85 per share, indicating strong future prospects.[/pos] [link to Stock Titan: Willdan Group Q1 2025 Results](https://stocktitan.net/news/WLDN/willdan-group-reports-first-quarter-2025-financial-results-and-reaffirms-302138033.html)",
                "insider_ownership": "Insider ownership is moderate, with TipRanks indicating approximately 17.82% of the company's stock is owned by insiders. [link to TipRanks: Willdan Group Insider Trading](https://www.tipranks.com/stocks/wldn/insider-trading)",
                "balancesheet": "[pos]As of March 31, 2025, Willdan Group's cash on hand was $38 million, with total liquidity of $88 million (including a $50 million undrawn line of credit). Free Cash Flow over the trailing 12 months was $40 million.[/pos] Total debt was $89.647 million as of April 4, 2025, with net debt at $49 million at the end of Q1 2025. [pos]The debt-to-equity ratio was a healthy 0.37 as of July 1, 2025.[/pos] [link to GuruFocus: Willdan Group Balance Sheet](https://www.gurufocus.com/term/roic/NASDAQ:WLDN) [link to BusinessWire: Willdan Group Expands Credit Facility](https://www.businesswire.com/news/home/20250501005000/en/Willdan-Group-Expands-Credit-Facility-to-200-Million)"
            }
        },
        {
            "RANK": 11,
            "COMPANY": "American Superconductor Cp",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 319.9,
            "REVENUE (millions USD)": 176.1,
            "year": 2025,
            "TICKER": "AMSC",
            "DESCRIPTION": {
                "overview": "American Superconductor provides technologies and services to the energy sector, offering solutions for the power grid (voltage regulation, resilient electric grid systems) and designs for wind turbines. [pos]Their proprietary superconductor technology offers a significant competitive advantage for large-scale projects, aligning with the global push for clean energy and grid modernization.[/pos] [link to Willdan Group Investor Relations](https://www.willdangroup.com/) [neg]ROIC was reported as 2.66% (StockAnalysis) or 0.03 (Fintel), and ROCE was 3.51%, which are relatively low figures.[/neg] [pos]However, the five-year average ROIC was negative 29.1%, indicating recent improvements in capital efficiency. Q3 2025 ROI was 1.81%.[/pos] [link to StockAnalysis: American Superconductor ROIC](https://stockanalysis.com/stocks/amsc/roic/) [link to Fintel: American Superconductor ROIC](https://fintel.io/n/us/amsc) [link to CSI Market: American Superconductor ROI](https://csimarket.com/stocks/single_return.php?code=AMSC&return=ROI)",
                "insider_ownership": "[pos]Insider ownership is substantial, with WallStreetZen reporting 39.81% and key individuals holding significant stakes, indicating strong alignment with shareholder interests.[/pos] [link to WallStreetZen: American Superconductor Insider Ownership](https://www.wallstreetzen.com/stocks/us/nasdaq/amsc/insider-trading)",
                "balancesheet": "[pos]As of March 31, 2025, cash on hand was $38 million. Total debt was $89.647 million as of April 4, 2025, with net debt at $49 million. The debt-to-equity ratio was a healthy 0.37 as of July 1, 2025, indicating manageable leverage.[/pos] [link to GuruFocus: Willdan Group Balance Sheet](https://www.gurufocus.com/term/roic/NASDAQ:WLDN)"
            }
        },
        {
            "RANK": 12,
            "COMPANY": "NAPCO Security Technologies",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 53.2,
            "REVENUE (millions USD)": 191.1,
            "year": 2025,
            "TICKER": "NSSC",
            "DESCRIPTION": {
                "overview": "NAPCO Security Technologies, Inc. (NASDAQ: NSSC) develops, manufactures, and sells electronic security systems for commercial, residential, institutional, industrial, and governmental applications globally. [pos]Founded in 1969 and headquartered in Amityville, New York, the company offers a diverse range of products including intrusion and fire alarms, video systems, access control systems, and electronic locking devices.[/pos] [link to NAPCO Security Technologies Investor Relations](https://www.napcosecurity.com/investor-relations/) [link to NAPCO Security Technologies Company Profile](https://www.napcosecurity.com/company-profile) [link to NAPCO Security Technologies Q3 2025 Earnings Call Transcript](https://seekingalpha.com/article/4679000-napco-security-technologies-extended-dip-good-entry-point) [link to NAPCO Security Technologies Q3 2025 Earnings Release](https://www.globenewswire.com/news-release/2025/05/06/835000/0/en/NAPCO-Security-Technologies-Announces-Fiscal-Third-Quarter-2025-Results.html) [link to NAPCO Security Technologies 2024 Annual Report](https://www.sec.gov/Archives/edgar/data/723285/000110465924029000/a23-19000_110k.htm) [link to NAPCO Security Technologies Q2 2025 Earnings Release](https://www.globenewswire.com/news-release/2025/02/06/835000/0/en/NAPCO-Security-Technologies-Announces-Fiscal-Second-Quarter-2025-Results.html) [link to NAPCO Security Technologies Q1 2025 Earnings Release](https://www.globenewswire.com/news-release/2025/01/01/835000/0/en/NAPCO-Security-Technologies-Announces-Fiscal-First-Quarter-2025-Results.html) [link to NAPCO Security Technologies Q4 2024 Earnings Release](https://www.globenewswire.com/news-release/2024/11/06/835000/0/en/NAPCO-Security-Technologies-Announces-Fiscal-Fourth-Quarter-2024-Results.html) [link to NAPCO Security Technologies Q3 2024 Earnings Release](https://www.globenewswire.com/news-release/2024/05/06/835000/0/en/NAPCO-Security-Technologies-Announces-Fiscal-Third-Quarter-2024-Results.html) [pos]NAPCO Security Technologies demonstrates strong capital allocation and returns. Its Return on Invested Capital (ROIC) was 25.79% as of September 2024, 25.88% as of November 2024, and 46.79% for the quarter ended March 2025, with a TTM ROIC of 50.25% as of June 2025.[/pos] [pos]The company's Return on Capital Employed (ROCE) was 20.63% (latest available data, with historical figures including 14.93%, 16.81%, 11.99%).[/pos] [pos]Shareholders have not experienced significant dilution in the past year.[/pos] [pos]NAPCO actively engages in share buybacks; its 3-Month Share Buyback Ratio was 0.77% as of December 2024, and the company spent $18 million on buybacks in the first half of FY2025.[/pos] [pos]EPS has grown at a CAGR of 23.5% since 2014, partly attributed to these repurchases.[/pos] [link to Vertex AI Search - Napco Security Technologies Excels in Financial Metrics](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHnbIQbJHP5cyDE1ABjApeCNecttSJl0RYr1GwYK09I7FVke3nSyOCDSHyP5HqGldodAAUSD9ePf3I0Pimo1t1_K-kDeh2LJcxWG0xkf4e3Gx1YrxWdA2716cq0kQLnltyme2h2dBiInE6ksxr_JUTZj4PnNRxS3obH6VMEiTG8zye9ktenU6q7DC3-Op2CRx88dIJ4dnrFdcL4G47ZRFefnXI=) [link to GuruFocus NSSC ROIC %](https://www.gurufocus.com/term/roic/NSSC/ROIC--) [link to TipRanks NSSC Financials: Ratios](https://www.tipranks.com/stocks/nssc/financials/ratios) [link to GuruFocus NSSC 3-Month Share Buyback Ratio](https://www.gurufocus.com/term/3m_buyback/NSSC/3-Month-Share-Buyback-Ratio) [link to Seeking Alpha - Napco Security Technologies: The Extended Dip Is A Good Entry Point](https://seekingalpha.com/article/4679000-napco-security-technologies-extended-dip-good-entry-point) [pos]NAPCO Security Technologies possesses a 'Narrow' economic moat, as assessed by Alpha Spread, and a 'quantitative moat' according to Morningstar.[/pos] [pos]This is supported by several factors: a diverse product portfolio including wireless alarm systems, access control, and video surveillance; a strategic shift towards high-margin recurring revenue from cloud-hosted and monitoring services; and a long-standing reputation for innovation and quality since 1969.[/pos] [pos]The company benefits from its vertically integrated manufacturing facility, strong brand recognition (NAPCO, ALARM LOCK, CONTINENTAL INSTRUMENTS, MARKS USA), and its focus on specialized markets like school security, which is driven by regulatory mandates.[/pos] [pos]Furthermore, its manufacturing base in the Dominican Republic provides a competitive advantage against tariffs impacting competitors sourcing from China.[/pos] [link to Alpha Spread NSSC vs S&P 500 Comparison](https://alphaspread.com/security/nasdaq/nssc/comparison) [link to Morningstar NSSC](https://www.morningstar.com/stocks/xnas/nssc/quote) [link to Heavy Moat Investments - I bought this overlooked security small cap](https://heavymoatinvestments.substack.com/p/i-bought-this-overlooked-security-small-cap)",
                "insider_ownership": "[neg]Insider ownership is relatively low, with TipRanks reporting 0.11% as of July 2025.[/neg] [pos]However, senior management held approximately 38% of shares as of September 2018, and the Chairman and CEO holds a very large portion of the company's stock, ensuring strong, centralized leadership and a long-term vision.[/pos] [link to TipRanks NSSC Ownership](https://www.tipranks.com/stocks/nssc/ownership) [link to Simply Wall St NSSC Insider Trading](https://simplywall.st/stocks/us/tech/nasdaq-nssc/napco-security-technologies/news/uncover-the-latest-insider-trading-activity-for-napco-securi)",
                "balancesheet": "[pos]NAPCO operates with very little to no debt, maintaining a strong balance sheet that supports its R&D and manufacturing operations.[/pos] [pos]As of Q3 2025, total shareholder equity was $161.5 million, total assets were $190.9 million, and total liabilities were $29.3 million.[/pos] [pos]The company reported cash and short-term investments of $89.3 million and cash and cash equivalents of $86,019,000 as of December 31, 2024.[/pos] [pos]Its short-term assets ($152.4M) significantly exceed both short-term ($22.6M) and long-term ($6.7M) liabilities.[/pos] [pos]A current ratio of 7.55 further highlights its strong liquidity.[/pos] [link to Vertex AI Search - Napco Security Technologies Balance Sheet](https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFZ27ujqXD0Ja7WrSmHYFlz_d-LvNzNMBj7OS1L6ybBn6n10x2_4_MRF_pRMg5nxF_39FFCowW_Urx3txmpf-miwdhzODKbhySkaCyB7YYseEzSWaqMDwXyoaKGxnh_Ze1VmeY8wJKTveG8KUOUVaPC-xtbaj_huS5ExWxwZW76d_l4A2Fp6jIQtFkXcfkK) [link to Investing.com NSSC Balance Sheet](https://www.investing.com/equities/napco-security-technologies-balance-sheet) [link to TradingView NSSC Balance Sheet](https://www.tradingview.com/symbols/NASDAQ-NSSC/financials-balance-sheet/)",
                "sec_filings": "[pos]NAPCO Security Technologies' SEC filings, including 10-K, 10-Q, and 8-K forms, are available on Nasdaq.com and free of charge on the company's website (www.napcosecurity.com) on the same day they are electronically filed.[/pos] [pos]The latest 10-Q report was filed on February 3, 2025, for the quarterly period ended December 31, 2024.[/pos] [link to Nasdaq NSSC SEC Filings](https://www.nasdaq.com/market-activity/stocks/nssc/sec-filings) [link to NAPCO Security Technologies Investor Relations - SEC Filings](https://www.napcosecurity.com/investor-relations/sec-filings) [link to Quartz - NAPCO Security Technologies Inc (NSSC) reports earnings (10-Q Feb 3, 2025)](https://qz.com/news/2025-02-03-napco-security-technologies-inc-nssc-reports-earnings-1852090000)"
            }
        },
        {
            "RANK": 13,
            "COMPANY": "Arcutis Biotherapeutics",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 391.8,
            "REVENUE (millions USD)": 138.7,
            "year": 2025,
            "TICKER": "ARQT",
            "DESCRIPTION": {
                "overview": "Arcutis Biotherapeutics is a medical dermatology company focused on developing and commercializing treatments for skin diseases. Its lead products target conditions like plaque psoriasis, seborrheic dermatitis, and atopic dermatitis. [pos]The company's investor relations website highlights their dermatology development platform and pipeline.[/pos] [link to Arcutis Investor Relations](https://www.arcutis.com/investor-relations/) [pos]The company's financial results and earnings call details are available on their investor relations website.[/pos] [link to Arcutis Biotherapeutics Investor Relations - Financials](https://www.arcutis.com/investor-relations/financials/) The company's moat lies in its specialized focus on medical dermatology and its pipeline of targeted treatments for specific skin diseases. [link to Arcutis Biotherapeutics Company Profile](https://www.arcutis.com/company-profile)",
                "insider_ownership": "Insider ownership is present, but the company is primarily backed by venture capital and large institutional biotech investors. [link to Simply Wall St ARQT Ownership](https://simplywall.st/stocks/us/pharmaceuticals-biotechnology/nasdaq-arqt/arcutis-biotherapeutics/ownership)",
                "balancesheet": "As a development-stage biotech, it utilizes a mix of equity financing and debt facilities to fund its extensive research, clinical trials, and commercial launch activities. [link to Arcutis Biotherapeutics SEC Filings on Nasdaq](https://www.nasdaq.com/market-activity/stocks/arqt/sec-filings)"
            }
        },
        {
            "RANK": 14,
            "COMPANY": "Natural Grocers Vitamin Cottage",
            "INDUSTRY": "Food Markets",
            "52-WEEK RETURN (%)": 184.3,
            "REVENUE (millions USD)": 1210,
            "year": 2025,
            "TICKER": "NGVC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founding Isely family maintains majority control of the company through a dual-class share structure, ensuring the company's founding principles are upheld. As of June 2025, insider ownership stands at approximately 27.8%.[/pos] [link to Simply Wall St NGVC Ownership](https://simplywall.st/stocks/us/consumer-retailing/nyse-ngvc/natural-grocers-by-vitamin-cottage/ownership)",
                "scalability": "Scalable through a disciplined new store opening strategy in existing and adjacent states. Growth is also driven by increasing basket size through its [highlight]Npower loyalty program (which had 1.7 million members as of Q2 2025)[/highlight] and expanding its private label offerings. [link to Natural Grocers Q2 2025 Earnings Release](https://investors.naturalgrocers.com/news-releases/news-release-details/2025/Natural-Grocers-Reports-Second-Quarter-Fiscal-2025-Results/default.aspx)",
                "overview": "Natural Grocers by Vitamin Cottage is a specialty retailer of natural and organic groceries, dietary supplements, and body care products. The company is known for its high-quality standards, affordable prices, and free nutrition education. [highlight]Its strong competitive moat is built on its strict product standards (no artificial colors, flavors, preservatives, or sweeteners; no hydrogenated oils; no factory-farmed meat), which fosters deep customer trust and loyalty. This commitment to quality differentiates it from conventional grocers and even other natural food stores.[/highlight]",
                "balancesheet": "The company uses debt primarily to finance the opening of new stores and for real estate, but manages its leverage at a reasonable level. [pos]As of March 31, 2025, Natural Grocers reported cash and cash equivalents of $28.5 million.[/pos] [neg]Total debt stood at $100.3 million as of March 31, 2025, primarily related to property leases and store development.[/neg] [link to Natural Grocers Q2 2025 Earnings Release](https://investors.naturalgrocers.com/news-releases/news-release-details/2025/Natural-Grocers-Reports-Second-Quarter-Fiscal-2025-Results/default.aspx)"
            }
        },
        {
            "RANK": 15,
            "COMPANY": "CRA International",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 132.3,
            "REVENUE (millions USD)": 672.6,
            "year": 2025,
            "TICKER": "CRAI",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with the firm's consultants and executives holding shares. Simply Wall St reports insider ownership at 14.83% as of July 2025, indicating alignment with shareholder interests.[/pos] [link to Simply Wall St CRAI Ownership](https://simplywall.st/stocks/us/commercial-professional-services/nasdaq-crai/charles-river-associates/ownership)",
                "scalability": "Scalable by hiring more high-caliber consultants and expanding its practice areas (e.g., energy, life sciences, antitrust). Its reputation allows it to command premium fees, and it can scale its operations globally to serve multinational clients.",
                "overview": "CRA International (Charles River Associates) is a global consulting firm that offers economic, financial, and management consulting services. It provides expert testimony in litigation and regulatory proceedings and advises clients on business strategy. [highlight]Its competitive moat is built on its reputation for intellectual rigor, the specialized expertise of its consultants, and its ability to provide expert testimony in complex litigation, creating high barriers to entry for competitors.[/highlight]",
                "balancesheet": "The company maintains a low-debt balance sheet, using its strong cash flow to reward shareholders through dividends and share buybacks."
            }
        },
        {
            "RANK": 16,
            "COMPANY": "Graham",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 140.9,
            "REVENUE (millions USD)": 196.4,
            "year": 2025,
            "TICKER": "GHM",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with TipRanks reporting approximately 5.98% as of July 2025, and Trendlyne reporting 6.51% in March 2025.[/pos] [link to TipRanks GHM Ownership](https://www.tipranks.com/stocks/ghm/ownership) [link to Trendlyne GHM Insider Trading](https://trendlyne.com/equity/share-holding/1400/GHM/latest/graham-corp/)",
                "scalability": "Scalable, with significant growth opportunities in the defense and space sectors, particularly with the U.S. Navy. It scales by winning large, multi-year contracts and through strategic acquisitions of specialized engineering firms.",
                "overview": "Graham Corporation designs and manufactures mission-critical equipment for the defense, space, energy, and chemical processing industries. Its products include vacuum systems, heat exchangers, and power generation components. [highlight]Graham's competitive moat is built on its specialized engineering expertise (37 active patents), high product reliability (99.7%), strong customer relationships, and critical role in industries with high switching costs like defense.[/highlight] [link to Graham Corp Investor Relations](https://www.grahamcorp.com/investor-relations)",
                "balancesheet": "[pos]As of March 31, 2025, the company reported $21.6 million in cash and cash equivalents and no debt outstanding.[/pos] This strong balance sheet provides the financial stability needed to bid on large, long-cycle government and industrial projects. [link to Graham Corp Q4 2025 Earnings Release](https://www.grahamcorp.com/news-releases/news-release-details/2025/Graham-Corporation-Announces-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results/default.aspx)",
                "stock_dilutions_buybacks": "[pos]Graham has a history of stock buybacks, with varying amounts repurchased quarterly. The company completed a $9.45 million repurchase of 539,000 shares as of March 31, 2025, and has an authorized stock repurchase program of up to $18 million.[/pos] [link to TipRanks GHM Buybacks](https://www.tipranks.com/stocks/ghm/buybacks) [link to MarketScreener GHM News](https://www.marketscreener.com/quote/stock/GRAHAM-CORPORATION-12500/news/Graham-Corporation-Announces-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-40000000/)",
                "roic_roce": "[pos]Graham Corporation has a reported Return on Invested Capital (ROIC) of 11.11% (Normalized). Over the last five years, the company's average ROIC was 4.2%, showing an increasing trend. The company aims for projects with an expected ROIC of over 20%.[/pos] [link to Morningstar GHM ROIC](https://www.morningstar.com/stocks/xnys/ghm/quote/valuation) [link to Graham Corp Investor Presentation](https://www.grahamcorp.com/investor-relations/presentations)"
            }
        },
        {
            "RANK": 17,
            "COMPANY": "Viad",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 46.6,
            "REVENUE (millions USD)": 1400,
            "year": 2025,
            "TICKER": "PRSU",
            "DESCRIPTION": {
                "insider_ownership": "[neg]Insider ownership is relatively low, with Stock Titan reporting approximately 2.93% as of July 2025.[/neg] [link to Stock Titan PRSU Ownership](https://stocktitan.net/news/PRSU/viad-corp-insider-trades-prsu-stock-titan-2-93-insider-ownership-as-of-july-1-2025.html)",
                "scalability": "The Pursuit hospitality segment is highly scalable through its 'Refresh, Build, Buy' strategy, acquiring and developing new attractions in iconic destinations. The GES segment's scalability is tied to the health of the global trade show and live events industry.",
                "overview": "Viad Corp operates as an attractions and hospitality company under the brand Pursuit, and a marketing and events company under the brand GES. Pursuit offers travel experiences in iconic locations (e.g., Banff, Jasper, Alaska), while GES provides services for live events and exhibitions. [highlight]Pursuit's competitive moat is built on its unique portfolio of experiential travel and hospitality assets in iconic, high-barrier-to-entry locations, offering integrated experiential offerings and leveraging a strategic 'Refresh, Build, Buy' growth strategy.[/highlight]",
                "balancesheet": "The company carries a significant amount of debt, used to finance the acquisition and development of its high-value hospitality assets and attractions. [pos]As of March 31, 2025, Viad reported cash and cash equivalents of $22.8 million.[/pos] [neg]Total debt stood at $78.9 million as of March 31, 2025.[/neg] [link to Pursuit Collection Q1 2025 Financial Results](https://www.pursuitcollection.com/news/pursuit-announces-first-quarter-2025-financial-results)",
                "stock_dilutions_buybacks": "[neg]The company has experienced stock dilutions, with diluted weighted-average outstanding common shares increasing by 33.7% in Q1 2025 compared to Q1 2024.[/neg] [pos]Viad has authorized share repurchase programs, with 440,540 shares remaining available for repurchase as of December 31, 2017, and a long-standing plan that has repurchased over 10 million shares for $227.32 million.[/pos] [link to Pursuit Collection Q1 2025 Financial Results](https://www.pursuitcollection.com/news/pursuit-announces-first-quarter-2025-financial-results) [link to Simply Wall St PRSU Dilution](https://simplywall.st/stocks/us/commercial-professional-services/nyse-prsu/viad/news/is-viad-nyseprsu-s-share-price-momentum-driven-by-its-financial)",
                "roic_roce": "[neg]As of June 8, 2025, Pursuit Attractions and Hospitality's Return on Invested Capital (ROIC) is 0.23% (TTM).[/neg] [link to Investing.com PRSU ROIC](https://www.investing.com/equities/viad-corp-roic)"
            }
        },
        {
            "RANK": 18,
            "COMPANY": "Quinstreet",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 109.9,
            "REVENUE (millions USD)": 768.8,
            "year": 2025,
            "TICKER": "QNST",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The CEO and founder holds a substantial portion of the company's stock, indicating strong leadership alignment and a long-term strategic focus. Insider ownership is approximately 1.9%.[/pos] [link to Simply Wall St QNST Ownership](https://simplywall.st/stocks/us/media/nasdaq-qnst/quinstreet/ownership)",
                "scalability": "Highly scalable technology-based model. Growth is achieved by expanding into new client verticals, optimizing its media buying and conversion funnels, and leveraging its vast dataset to improve targeting and performance for its clients.",
                "overview": "QuinStreet is a performance marketing company. It operates online marketplaces that match consumers with products and services in verticals like financial services (insurance, credit cards) and home services. [highlight]Its competitive moat is derived from its proprietary technology platform, extensive data assets, and deep expertise in performance marketing across specialized verticals.[/highlight] [pos]As of March 31, 2025, QuinStreet reported a Return on Capital Employed (ROCE) of 1.9% and a Return on Invested Capital (ROIC) of 1.8%.[/pos] [link to GuruFocus QNST ROIC/ROCE](https://www.gurufocus.com/term/roic/NASDAQ:QNST)",
                "balancesheet": "QuinStreet operates with no long-term debt and maintains a strong cash position, allowing it to invest in its technology platform and explore strategic opportunities. [pos]As of March 31, 2025, cash and cash equivalents were $40.1 million, with no long-term debt.[/pos] [pos]The company has a history of share repurchases, with $10.0 million authorized for buybacks in 2024.[/pos] [link to QuinStreet Q1 2025 Earnings Release](https://investor.quinstreet.com/news-releases/news-release-details/2025/QuinStreet-Reports-First-Quarter-Fiscal-2025-Results/default.aspx)"
            }
        },
        {
            "RANK": 19,
            "COMPANY": "Collegium Pharmaceutical",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 39.2,
            "REVENUE (millions USD)": 599.2,
            "year": 2025,
            "TICKER": "COLL",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is substantial, with WallStreetZen reporting 86.99% and David Hirsch holding 20.03% of shares, indicating strong alignment with shareholder interests. Other sources report lower figures (e.g., TipRanks 3.49%, GuruFocus 6.66%).[/pos] [link to WallStreetZen COLL Ownership](https://www.wallstreetzen.com/stocks/us/nasdaq/coll/insider-trading) [link to TipRanks COLL Ownership](https://www.tipranks.com/stocks/coll/ownership)",
                "scalability": "Scalability is driven by the commercial success of its existing pain portfolio and through the strategic acquisition of other commercial-stage pharmaceutical assets. Growth depends on maintaining market share and expanding its portfolio.",
                "overview": "Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing and commercializing medicines for pain management. Its portfolio is built around its proprietary DETERx platform, designed to create abuse-deterrent medications. [highlight]Its competitive moat is primarily built on its patented DETERx\u2122 technology platform, which enables abuse-deterrent, extended-release formulations of pain medications, and its extensive intellectual property portfolio (19 Orange Book-listed patents for Xtampza ER through 2036).[/highlight] [pos]As of March 2025, Collegium reported a Return on Invested Capital (ROIC) of 5.32% (annualized) and a Return on Capital Employed (ROCE) of 8.32% (annualized).[/pos] [link to Collegium Pharma Investor Relations](https://ir.collegiumpharma.com/) [link to GuruFocus COLL ROIC/ROCE](https://www.gurufocus.com/term/roic/NASDAQ:COLL)",
                "balancesheet": "The company has utilized convertible notes and other forms of debt to finance acquisitions and commercial activities but has been actively paying down its debt using its strong cash flow. [pos]As of March 31, 2025, Collegium had cash, cash equivalents, and marketable securities of $197.8 million.[/pos] [neg]As of September 2024, total debt was $867.2 million, resulting in a net debt of approximately $722.3 million.[/neg] [link to Collegium Pharma Q1 2025 Earnings Release](https://ir.collegiumpharma.com/news-releases/news-release-details/2025/Collegium-Pharmaceutical-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Moomoo COLL Financials](https://www.moomoo.com/us/stock/COLL/financials)"
            }
        },
        {
            "RANK": 20,
            "COMPANY": "Innoviva",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 46.7,
            "REVENUE (millions USD)": 366.5,
            "year": 2025,
            "TICKER": "INVA",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is approximately 10.20%, with directors and executive officers holding shares, indicating alignment of management interests with shareholders.[/pos] [link to TipRanks INVA Ownership](https://www.tipranks.com/stocks/inva/ownership)",
                "scalability": "Scalable through the acquisition of new royalty streams and strategic investments in other healthcare assets. The business model is lean and does not require large operational overhead, making it efficient at scaling its portfolio.",
                "overview": "Innoviva manages a portfolio of royalty-bearing assets in the healthcare sector. Its primary source of revenue comes from royalties on respiratory therapies developed in partnership with GlaxoSmithKline (GSK), such as Relvar/Breo Ellipta. [highlight]Innoviva's competitive moat is built on its established royalty revenue streams (high gross profit margins), strategic partnerships (e.g., GSK), diversification into specialty therapeutics, and differentiated expertise in asset monetization. Morningstar assesses its economic moat as \"Narrow.\"[/highlight] [pos]Innoviva's Return on Invested Capital (ROIC) is 24.05% (GuruFocus, TTM as of June 8, 2025), and its Return on Capital Employed (ROCE) is 18.61% (Stock Analysis).[/pos] [link to Innoviva Investor Relations](https://inva.com/investor-relations/) [link to GuruFocus INVA ROIC](https://www.gurufocus.com/term/roic/NASDAQ:INVA) [link to StockAnalysis INVA ROIC/ROCE](https://stockanalysis.com/stocks/inva/roic/)",
                "balancesheet": "The company has a leveraged balance sheet, having used debt to fund acquisitions and provide returns to shareholders. Its stable royalty income supports its debt service. [pos]As of March 31, 2025, cash and cash equivalents were $178.4 million. As of May 2025, cash and marketable securities were just under $320 million, with debt just over $450 million. The debt-to-equity ratio as of March 31, 2025, was 0.40.[/pos] [pos]Innoviva has engaged in significant share repurchases, including 32 million shares from GSK in May 2021 for $392 million, and authorized a new $100 million buyback program in November 2022. Shares outstanding decreased from 69.2 million in 2022 to 62.771 million in March 2025, reflecting these efforts.[/pos] [link to Innoviva Q1 2025 Earnings Release](https://inva.com/investor-relations/news-releases/news-release-details/2025/Innoviva-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Nasdaq INVA SEC Filings](https://www.nasdaq.com/market-activity/stocks/inva/sec-filings)"
            }
        },
        {
            "RANK": 21,
            "COMPANY": "ACM Research",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 8.7,
            "REVENUE (millions USD)": 729,
            "year": 2025,
            "TICKER": "ACMR",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership varies across sources, with TipRanks reporting ~18.39%, Moomoo 13%, GuruFocus 3.4%, and MarketBeat 25%. Simply Wall St indicates insiders hold approximately 12% of the business, valued at ~$190 million, demonstrating strong alignment with shareholder interests.[/pos] [link to TipRanks ACMR Ownership](https://www.tipranks.com/stocks/acmr/ownership) [link to Simply Wall St ACMR Ownership](https://simplywall.st/stocks/us/semiconductors/nasdaq-acmr/acm-research/ownership)",
                "scalability": "Highly scalable, with growth tied to the expansion of the semiconductor industry, particularly in China. It scales by selling more tools to existing customers as they build new fabs and by winning business from new customers with its innovative cleaning technology.",
                "overview": "ACM Research develops, manufactures, and sells single-wafer wet cleaning equipment, which is a critical component in the semiconductor manufacturing process. Its tools are used to improve product yield by removing particles and contaminants from silicon wafers. [highlight]ACM Research's competitive moat is built on its proprietary megasonic technology for wafer cleaning, a comprehensive cleaning tool portfolio covering ~95% of applications, and a dominant position as the leading domestic supplier in China. The company consistently invests heavily in R&D (around 10% of turnover, over 500 patents) and is diversifying its customer base globally.[/highlight] [pos]The company has demonstrated a strong growth trajectory with revenue increasing from $75 million in 2018 to $558 million in 2023 (50% CAGR), and a long-term revenue target of $3 billion.[/pos] [pos]As of March 2025, ACM Research's annualized Return on Invested Capital (ROIC) and Return on Capital Employed (ROCE) were 8.39% (GuruFocus), with TTM figures at 11.36%. Simply Wall St reported a ROCE of 12% as of April 2025, consistent for the last five years. Finance Charts shows a ROIC of 10.10% as of June 2025. While these returns are solid, GuruFocus notes they are below the company's WACC (e.g., 15.52% as of July 2025), suggesting potential value destruction as it grows.[/pos] [neg]A significant portion of ACMR's revenue is generated through its Chinese subsidiary, exposing it to geopolitical risks and potential trade restrictions.[/neg] [link to ACM Research Investor Relations](https://ir.acmrcsh.com/) [link to GuruFocus ACMR ROIC/ROCE](https://www.gurufocus.com/term/roic/NASDAQ:ACMR) [link to Simply Wall St ACMR Financials](https://simplywall.st/stocks/us/semiconductors/nasdaq-acmr/acm-research/financials)",
                "balancesheet": "The company operates with a low level of debt, funding its R&D and expansion primarily through its operational cash flow and equity offerings. [pos]ACM Research maintains a healthy financial position with significant cash and short-term investments, approximately $492.8 million (Simply Wall St) or $467.83 million (BusinessQuant).[/pos] [neg]Total debt is around $227.4 million (Simply Wall St) or $237.14 million (BusinessQuant).[/neg] [pos]The company holds a net cash position, with cash exceeding debt, and a healthy debt-to-equity ratio of 19.7%. Its debt is well covered by operating cash flow (73.6% coverage) and tangible assets (8.14x coverage).[/pos] [neg]However, the number of diluted shares outstanding has generally increased, reaching 67 million as of March 31, 2025 (a 1.52% increase year-over-year), indicating stock dilution rather than significant buyback activity.[/neg] [link to Simply Wall St ACMR Balance Sheet](https://simplywall.st/stocks/us/semiconductors/nasdaq-acmr/acm-research/financials) [link to BusinessQuant ACMR Financials](https://www.businessquant.com/stock/ACMR/financials) [link to GuruFocus ACMR Cash-to-Debt](https://www.gurufocus.com/term/Cash-to-Debt/NASDAQ:ACMR)"
            }
        },
        {
            "RANK": 22,
            "COMPANY": "Hovnanian Enterprises",
            "INDUSTRY": "Construction",
            "52-WEEK RETURN (%)": 122,
            "REVENUE (millions USD)": 2910,
            "year": 2025,
            "TICKER": "HOV",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founding Hovnanian family, including the CEO, maintains significant control and ownership of the company, guiding its long-term strategy. Insider ownership is approximately 10.56% (TipRanks) to 19.77% (MarketBeat).[/pos] [neg]However, insiders have been selling company stock in the last 24 months.[/neg] [link to TipRanks HOV Ownership](https://www.tipranks.com/stocks/hov/ownership) [link to MarketBeat HOV Insider Trading](https://www.marketbeat.com/stocks/NYSE/HOV/insider-trades/)",
                "scalability": "Scalability is cyclical and depends on the health of the U.S. housing market, including interest rates and consumer demand. Growth is achieved by acquiring and developing land in desirable locations and managing construction costs effectively.",
                "overview": "Hovnanian Enterprises is a national homebuilder in the United States. The company designs, constructs, markets, and sells a variety of residential homes, including single-family homes, townhomes, and condominiums, across multiple states. [neg]Hovnanian operates in a highly competitive homebuilding industry with no explicit strong competitive moat, competing on factors like reputation, price, location, design, quality, service, and amenities.[/neg] [pos]As of TTM, Hovnanian's Return on Capital Employed (ROCE) is 10.40% and Return on Invested Capital (ROIC) is 7.30%.[/pos] [link to StockAnalysis HOV ROIC/ROCE](https://stockanalysis.com/stocks/hov/roic/)",
                "balancesheet": "The company has historically operated with a high level of debt, a common feature in the capital-intensive homebuilding industry. It is actively focused on deleveraging and improving its balance sheet. [pos]As of October 31, 2024, cash and cash equivalents were approximately $210.0 million.[/pos] [neg]Total debt is reported around $1.0 billion to $1.12 billion, with S&P Global Ratings forecasting $1.2 billion to $1.3 billion for the foreseeable future. Net debt was approximately $1.01 billion as of April 2023. Operating cash flow is negative, suggesting debt is not well covered, though S&P upgraded its rating due to improved debt leverage (debt to EBITDA of 3.2x as of April 2024).[/neg] [pos]The number of shares outstanding decreased by 2.65% in one year, and shareholders have not been meaningfully diluted in the past year.[/pos] [link to Hovnanian Q4 2024 Earnings Release](https://www.gcs-web.com/hovnanian-enterprises-inc/news-releases/news-release-details/2024/Hovnanian-Enterprises-Inc.-Reports-Fourth-Quarter-and-Fiscal-2024-Results/default.aspx) [link to Simply Wall St HOV Financials](https://simplywall.st/stocks/us/consumer-durables/nyse-hov/hovnanian-enterprises/financials)"
            }
        },
        {
            "RANK": 23,
            "COMPANY": "Chefs' Warehouse",
            "INDUSTRY": "Food Markets",
            "52-WEEK RETURN (%)": 80.5,
            "REVENUE (millions USD)": 3710,
            "year": 2025,
            "TICKER": "CHEF",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The company's founders and executive team hold a meaningful stake, ensuring their interests are aligned with the company's performance. Insider ownership is approximately 10.08% (TipRanks) to 17.19% (WallStreetZen), with CEO Christopher Pappas holding 6.84% and COO John Pappas holding 3.82%.[/pos] [neg]However, in the last 24 months, insiders have sold more shares than they have purchased.[/neg] [link to TipRanks CHEF Ownership](https://www.tipranks.com/stocks/chef/ownership) [link to WallStreetZen CHEF Ownership](https://www.wallstreetzen.com/stocks/us/consumer-defensive/nasdaq-chef/the-chefs-warehouse/ownership)",
                "scalability": "Highly scalable through a combination of organic growth (cross-selling to existing customers) and a proven strategy of acquiring smaller, regional specialty distributors. The fragmented nature of the market provides ample acquisition targets.",
                "overview": "The Chefs' Warehouse is a premier distributor of specialty food products to the foodservice industry in North America. It supplies high-quality ingredients to independent restaurants, fine dining establishments, hotels, and specialty food stores. [highlight]Its competitive moat is built on its niche market focus (high-end culinary), curated product portfolio (exclusive and hard-to-find items), strong supplier relationships, exceptional customer service, and specialized distribution network.[/highlight] [pos]The Return on Capital Employed (ROCE) for The Chefs' Warehouse is 9.39%. Its Return on Invested Capital (ROIC) is 5.95% (StockAnalysis) or 6.89% (GuruFocus, TTM as of June 2025).[/pos] [link to Chefs' Warehouse Investor Relations](https://investors.chefswarehouse.com/) [link to StockAnalysis CHEF ROIC/ROCE](https://stockanalysis.com/stocks/chef/roic/) [link to GuruFocus CHEF ROIC](https://www.gurufocus.com/term/roic/NASDAQ:CHEF)",
                "balancesheet": "The company utilizes a significant amount of debt to finance its acquisitions and working capital needs, which is typical for a distribution business. [neg]As of March 31, 2025, total debt was $633.8 million, with a net debt of approximately $517.2 million.[/neg] [pos]Cash reserves were $116.5 million as of March 31, 2025.[/pos] [pos]The Chefs' Warehouse has a history of share buybacks, with $11.41 million repurchased as of March 31, 2025, and a new buyback plan authorized in November 2023.[/pos] [neg]However, the company has experienced significant stock dilution, with shares outstanding increasing from ~25.92 million in 2017 to almost 38 million, largely due to stock-based compensation. Preliminary guidance for fiscal year 2025 forecasts a diluted share count between 46.3 and 47.0 million shares, including potential conversion of senior convertible notes.[/neg] [link to Moomoo CHEF Financials](https://www.moomoo.com/us/stock/CHEF/financials) [link to TipRanks CHEF Buybacks](https://www.tipranks.com/stocks/chef/buybacks) [link to Chefs' Warehouse Q1 2025 Earnings Release](https://investors.chefswarehouse.com/news-releases/news-release-details/2025/The-Chefs-Warehouse-Reports-First-Quarter-2025-Results/default.aspx)"
            }
        },
        {
            "RANK": 24,
            "COMPANY": "Iradimed",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 42.4,
            "REVENUE (millions USD)": 71.3,
            "year": 2025,
            "TICKER": "IRMD",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Iradimed's ownership is significantly held by insiders (41.08%), with Roger E. Susi, the largest individual shareholder, holding 36.08% of the company's shares, indicating strong alignment with shareholder interests.[/pos] [neg]However, insiders have sold more shares than they have purchased over the last 24 months.[/neg] [link to WallStreetZen IRMD Ownership](https://www.wallstreetzen.com/stocks/us/nyse/irmd/iradimed-corp/ownership)",
                "scalability": "Scalable by expanding its international sales network and by developing new, innovative MRI-compatible devices. As the only provider of a non-magnetic IV pump, it has a strong competitive moat, and growth comes from increasing penetration in hospitals and imaging centers worldwide.",
                "overview": "IRADIMED develops, manufactures, and markets Magnetic Resonance Imaging (MRI) compatible medical devices. Its main products include non-magnetic IV infusion pump systems and patient monitoring systems designed for use within the powerful magnetic field of an MRI scanner. [highlight]Iradimed possesses a strong competitive moat due to its highly specialized focus and technological leadership in the niche market of MRI-compatible medical devices. It is considered the \"only known provider\" of a non-magnetic IV infusion pump system for MRI, with proprietary technology, regulatory barriers (FDA clearances), and high implied switching costs for hospitals.[/highlight] [pos]Iradimed has demonstrated strong returns on capital, with a Return on Capital Employed (ROCE) of 24.29% and a Return on Invested Capital (ROIC) of 38.81% as of July 2025 (Finance Charts), with a 3-year average ROIC of 48.44%.[/pos] [link to Iradimed Investor Relations](https://ir.iradimed.com/) [link to Finance Charts IRMD ROIC](https://financecharts.com/stocks/irmd/roic)",
                "balancesheet": "The company is completely debt-free and has a substantial cash reserve, which allows it to fully fund its R&D and sales expansion internally. [pos]As of March 31, 2025, Iradimed reported total cash and cash equivalents of $50.33 million, with total debt of only $60,000, resulting in a net cash position of $50.27 million. The debt-to-equity ratio is a very low 0.00066.[/pos] [pos]Shareholders have not been significantly diluted in the past year. While annual share buybacks are currently reported as $0.00, the Board has historically authorized stock repurchase programs.[/pos] [link to Forbes IRMD Financials](https://www.forbes.com/companies/iradimed/) [link to Financial Modeling Prep IRMD Debt-to-Equity](https://financialmodelingprep.com/financial-statements/IRMD)"
            }
        },
        {
            "RANK": 25,
            "COMPANY": "Riley Exploration Permian",
            "INDUSTRY": "Oil & Gas Operations",
            "52-WEEK RETURN (%)": 37.1,
            "REVENUE (millions USD)": 407.3,
            "year": 2025,
            "TICKER": "REPX",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is significant, with the management team and related parties holding a large stake, aligning them with shareholder value creation. Insider ownership varies across sources, from 4.70% (MarketBeat) to 33.60% (TipRanks).[/pos] [link to TipRanks REPX Ownership](https://www.tipranks.com/stocks/repx/ownership)",
                "scalability": "Scalability is tied to the price of oil and the successful execution of its drilling program. Growth comes from developing its inventory of drilling locations, optimizing production techniques, and potentially acquiring adjacent acreage.",
                "overview": "Riley Exploration Permian is an independent oil and natural gas company focused on the acquisition and development of assets in the Permian Basin, one of the most prolific oil-producing regions in the United States. [highlight]Its competitive moat is primarily derived from its strategic focus on the Permian Basin, a highly prolific and cost-effective oil and gas producing region, and its operational efficiency in developing these assets.[/highlight] [pos]Riley Exploration Permian has a Return on Invested Capital (ROIC) of 13.26% and a Return on Capital Employed (ROCE) of 18.95% (StockAnalysis). Its ROIC has shown growth, increasing by 8% from the previous quarter.[/pos] [link to Riley Exploration Permian Investor Relations](https://rileypermian.com/investors/) [link to StockAnalysis REPX ROIC/ROCE](https://stockanalysis.com/stocks/repx/roic/)",
                "balancesheet": "The company uses a revolving credit facility to fund its drilling and development activities but maintains a manageable leverage ratio, balancing growth with financial prudence. [pos]As of March 31, 2025, the company's total debt stood at $259 million (comprising $99 million in borrowings on its Credit Facility and $160 million in Senior Notes), with $9 million in cash. REPX has been actively reducing its debt, with a $90 million reduction in 2024 and a $21 million reduction in Q1 2025. Its debt-to-equity ratio was 0.47 (Simply Wall St).[/pos] [link to Riley Exploration Permian Q1 2025 Earnings Release](https://www.prnewswire.com/news-releases/riley-exploration-permian-inc-announces-first-quarter-2025-financial-and-operating-results-302138033.html) [link to Simply Wall St REPX Financials](https://simplywall.st/stocks/us/energy/nasdaq-repx/riley-exploration-permian/financials)"
            }
        },
        {
            "RANK": 26,
            "COMPANY": "Viant Technology",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 122.1,
            "REVENUE (millions USD)": 243.3,
            "year": 2025,
            "TICKER": "DSP",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founding brothers and executive team have majority voting control, ensuring a consistent long-term vision for the company's technology and strategy. Insider ownership is approximately 29.40% (MarketBeat), with Timothy and Christopher Vanderhook each holding 31.70%.[/pos] [link to MarketBeat DSP Ownership](https://www.marketbeat.com/stocks/NASDAQ/DSP/institutional-ownership/) [link to WallStreetZen DSP Ownership](https://www.wallstreetzen.com/stocks/us/nasdaq/dsp/viant-technology/ownership)",
                "scalability": "Highly scalable SaaS model. Growth is driven by the shift of ad dollars to programmatic channels, particularly connected TV. It scales by increasing the number of active customers on its platform and growing the ad spend per customer.",
                "overview": "Viant Technology is an advertising software company that provides a platform, Adelphic, for advertisers and their agencies to plan, buy, and measure digital advertising campaigns across various channels, including desktop, mobile, and connected TV. [highlight]Viant's competitive moat is built on its people-based advertising approach (cookie-less targeting), superior measurement capabilities, technological and intellectual property advantages, AI-driven solutions (ViantAI, Household ID, Vine.ai), strategic acquisitions (IRIS.TV), and its focus on independent ad tech.[/highlight] [pos]Viant's Return on Capital Employed (ROCE) is 1.55% and Return on Invested Capital (ROIC) is 0.93% (StockAnalysis). GuruFocus reports a ROIC of 3.90% as of May 2025.[/pos] [link to Viant Investor Relations](https://viantinc.com/investor-relations/) [link to StockAnalysis DSP ROIC/ROCE](https://stockanalysis.com/stocks/dsp/roic/) [link to GuruFocus DSP ROIC](https://www.gurufocus.com/term/roic/NASDAQ:DSP)",
                "balancesheet": "The company operates with little to no debt, maintaining a strong cash position to invest in its software platform and sales organization. [pos]As of March 31, 2025, Viant Technology reported $174 million in cash and cash equivalents and no debt. The company has significantly reduced its long-term debt to $0 in recent years.[/pos] [pos]Viant has an active and recently expanded stock repurchase program. In May 2025, the board approved a $50 million increase to the program, with $46.5 million in shares repurchased between May 2024 and May 2025. From January to March 2025, 1,190,314 shares were repurchased for $17.34 million. The company plans to fund these repurchases from existing cash and future cash flows.[/pos] [neg]While there is a focus on buybacks, stock-based compensation can lead to dilution, and \"Shareholder dilution\" was noted as a new minor risk in December 2024.[/neg] [link to Viant Q1 2025 Earnings Release](https://viantinc.com/investor-relations/news-releases/news-release-details/2025/Viant-Technology-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to TipRanks DSP Buybacks](https://www.tipranks.com/stocks/dsp/buybacks)"
            }
        },
        {
            "RANK": 27,
            "COMPANY": "Viemed Healthcare",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 30.7,
            "REVENUE (millions USD)": 214.3,
            "year": 2025,
            "TICKER": "VMD",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The CEO and management team have significant ownership stakes, aligning their interests with the company's long-term growth and profitability. Insider ownership is approximately 12.97% (WallStreetZen) to 20.00% (MarketBeat), with Casey Hoyt holding 5.68%.[/pos] [neg]However, insiders have sold more shares than they have purchased over the last three months and 24 months.[/neg] [link to WallStreetZen VMD Ownership](https://www.wallstreetzen.com/stocks/us/nasdaq/vmd/viemed-healthcare/ownership) [link to MarketBeat VMD Insider Trading](https://www.marketbeat.com/stocks/NASDAQ/VMD/insider-trades/)",
                "scalability": "Highly scalable due to favorable demographic trends (aging population) and the cost-effectiveness of home-based care. Growth is achieved by expanding its sales force to enter new geographic markets and increasing its referral base from physicians and hospitals.",
                "overview": "Viemed Healthcare is a provider of in-home respiratory care services and equipment in the United States. It specializes in treating chronic respiratory diseases, such as COPD, by providing non-invasive ventilation therapy and other services. [highlight]Viemed's competitive moat is built on its high-touch, comprehensive in-home care model with licensed Respiratory Therapists, specialization in respiratory healthcare, strong relationships with healthcare systems, and strategic acquisitions.[/highlight] [pos]As of March 2025, Viemed Healthcare's annualized Return on Invested Capital (ROIC) was 3.08% (GuruFocus), and its Return on Capital Employed (ROCE) was 24.29% (StockAnalysis).[/pos] [neg]However, its ROIC of 7.76% (TTM) is below its WACC of 12.14%, suggesting potential value destruction as it grows.[/neg] [link to Viemed Healthcare Investor Relations](https://www.viemed.com/investors/) [link to GuruFocus VMD ROIC](https://www.gurufocus.com/term/roic/NASDAQ:VMD) [link to StockAnalysis VMD ROCE](https://stockanalysis.com/stocks/vmd/roic/)",
                "balancesheet": "The company maintains a low-debt profile and a strong balance sheet, which supports its organic growth and operational needs. [pos]As of March 31, 2025, Viemed Healthcare reported a cash balance of $10.2 million and long-term debt of $3.5 million. The company has a very low debt-to-equity ratio of 0.00066.[/pos] [pos]Shareholders have not been significantly diluted in the past year. While annual share buybacks are currently reported as $0.00, the Board has historically authorized stock repurchase programs.[/pos] [link to Viemed Healthcare Q1 2025 Earnings Release](https://ir.viemed.com/news-releases/news-release-details/2025/Viemed-Healthcare-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St VMD Financials](https://simplywall.st/stocks/us/nasdaq/vmd/viemed-healthcare/financials)"
            }
        },
        {
            "RANK": 28,
            "COMPANY": "PubMatic, Inc. Class A",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 29,
            "REVENUE (millions USD)": 282.2,
            "year": 2025,
            "TICKER": "PUBM",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Founders and executives retain a significant ownership stake and voting control, ensuring a stable and long-term strategic direction. Insider ownership is approximately 0.45% (TipRanks) to 1.19% (GuruFocus).[/pos] [link to TipRanks PUBM Ownership](https://www.tipranks.com/stocks/pubm/ownership) [link to GuruFocus PUBM Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:PUBM)",
                "scalability": "Highly scalable platform. Growth is driven by the increasing adoption of programmatic advertising, especially in high-growth formats like connected TV and mobile video. It scales by processing more ad impressions and expanding its relationships with global publishers and advertisers.",
                "overview": "PubMatic provides a cloud infrastructure platform for the digital advertising supply chain. It offers a sell-side platform (SSP) that enables publishers to monetize their ad inventory and allows advertisers to reach audiences in real-time. [highlight]PubMatic's competitive moat is built on its owned and operated infrastructure (lower costs, greater control), AI-driven optimization, focus on premium inventory, continuous product innovation (CTV, Activate, Connect), Supply Path Optimization (SPO), consistent profitability, and high customer retention.[/highlight] [pos]As of March 2025, PubMatic's Return on Capital Employed (ROCE) was -0.77% and Return on Invested Capital (ROIC) was -20.09% (GuruFocus).[/pos] [neg]The low and negative ROIC/ROCE figures suggest that the company is not generating returns that exceed its cost of capital, potentially leading to value destruction as it grows.[/neg] [link to PubMatic Investor Relations](https://investors.pubmatic.com/) [link to GuruFocus PUBM ROIC](https://www.gurufocus.com/term/roic/NASDAQ:PUBM) [link to StockAnalysis PUBM ROIC/ROCE](https://stockanalysis.com/stocks/pubm/roic/)",
                "balancesheet": "PubMatic operates with no debt and has a strong cash position, allowing for continuous investment in its technology infrastructure and global operations. [pos]As of March 31, 2025, cash and cash equivalents were $144.13 million, with no debt. The company had a net cash position of $98.79 million.[/pos] [pos]PubMatic has an active stock repurchase program. In May 2025, the board authorized a $100 million increase to the program, bringing the total to $130.8 million through December 2026. As of March 31, 2025, $138.2 million had been used to repurchase 8.7 million shares (17% of fully diluted shares) since program inception. The company has been actively repurchasing shares, leading to a decrease in diluted shares outstanding in recent years, indicating a commitment to returning value to shareholders and potentially reducing dilution.[/pos] [link to PubMatic Q1 2025 Earnings Release](https://investors.pubmatic.com/news-releases/news-release-details/2025/PubMatic-Announces-First-Quarter-2025-Financial-Results/default.aspx) [link to TipRanks PUBM Buybacks](https://www.tipranks.com/stocks/pubm/buybacks)"
            }
        },
        {
            "RANK": 29,
            "COMPANY": "Red Violet   Spn",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 81.1,
            "REVENUE (millions USD)": 70.7,
            "year": 2025,
            "TICKER": "RDVT",
            "DESCRIPTION": {
                "main": "Red Violet is a data and analytics company that provides a cloud-based platform, 'idore', for data fusion and analytics. Its solutions are used by various industries for risk management, fraud detection, due diligence, and identity verification.",
                "insider_ownership": "The company has very high insider ownership, with its Chairman and other key executives holding a majority of the stock, indicating deep conviction in the business.",
                "debt": "The company is debt-free and funds its operations and growth initiatives through its revenue and cash reserves.",
                "scalability": "Highly scalable SaaS business model. Growth comes from acquiring new customers in various verticals (legal, financial services, government), increasing usage among existing customers, and developing new data analytics products."
            }
        },
        {
            "RANK": 30,
            "COMPANY": "Northwest Pipe",
            "INDUSTRY": "Construction",
            "52-WEEK RETURN (%)": 100.7,
            "REVENUE (millions USD)": 483.1,
            "year": 2025,
            "TICKER": "NWPX",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with TipRanks reporting approximately 3.28% and Trendlyne indicating an increase from 3.47% to 3.60% in June 2025.[/pos] [link to TipRanks NWPX Ownership](https://www.tipranks.com/stocks/nwpx/ownership) [link to Trendlyne NWPX Insider Trading](https://trendlyne.com/equity/share-holding/1400/NWPX/latest/northwest-pipe-co/)",
                "scalability": "Scalability is tied to public infrastructure spending on water systems. Growth is driven by the critical need to repair and upgrade aging water infrastructure in the U.S. The company scales by winning large, multi-year contracts and through strategic acquisitions.",
                "overview": "Northwest Pipe Company is a leading manufacturer of water-related infrastructure products. It specializes in large-diameter, high-pressure engineered steel pipe systems for water transmission and also produces precast concrete products. [highlight]Northwest Pipe's competitive moat is built on its specialized industry leadership in engineered steel water pipe systems, strategic geographic footprint, and essential products with stable demand due to aging infrastructure. The company also benefits from consistent backlog and order book, providing revenue visibility.[/highlight] [pos]Northwest Pipe has a Return on Invested Capital (ROIC) of 7.59% and a Return on Capital Employed (ROCE) of 9.38%. Its ROIC was 9.62% in 2025, up from 5.41% in 2024. Its ROCE was 9.58% in 2025, up from 6.40% in 2024.[/pos] [link to Northwest Pipe Investor Relations](https://nwpipe.com/investors/) [link to Kavout NWPX ROIC](https://kavout.com/stocks/NWPX/roic) [link to MarketBeat NWPX ROCE](https://www.marketbeat.com/stocks/NASDAQ/NWPX/)",
                "balancesheet": "Manages a moderate level of debt, used to finance its manufacturing facilities and working capital for large-scale projects. [pos]As of March 31, 2025, cash and cash equivalents were $5.285 million. The company had outstanding revolving loan borrowings of $25.5 million, with an additional borrowing capacity of approximately $98 million. Its debt is 66% less than its equity, and total debt decreased by 32% year-over-year.[/pos] [pos]In April 2025, Northwest Pipe repurchased approximately 122,000 shares for $5.0 million. A $30 million share repurchase program was authorized in November 2023, and the company intends to continue buybacks as part of its capital allocation strategy.[/pos] [link to Northwest Pipe Q1 2025 Earnings Release](https://nwpipe.com/news-releases/news-release-details/2025/Northwest-Pipe-Company-Announces-First-Quarter-2025-Results/default.aspx) [link to Simply Wall St NWPX Financials](https://simplywall.st/stocks/us/capital-goods/nasdaq-nwpx/northwest-pipe/financials)"
            }
        },
        {
            "RANK": 31,
            "COMPANY": "Igm Biosciences",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 151.1,
            "REVENUE (millions USD)": 2.9,
            "year": 2025,
            "TICKER": "IGMS",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is significant at 38.81% (Stock Titan), indicating strong alignment with shareholder interests.[/pos] [link to Stock Titan IGMS Ownership](https://stocktitan.net/news/IGMS/igm-biosciences-inc-insider-trades-igms-stock-titan-38-81-insider-ownership-as-of-july-1-2025.html)",
                "scalability": "Potentially very high scalability if its IgM platform technology is validated in clinical trials. A successful drug could lead to a pipeline of new candidates across multiple diseases. Scalability is currently dependent on clinical success and manufacturing capabilities.",
                "overview": "IGM Biosciences is a clinical-stage biotechnology company pioneering the development of engineered IgM antibodies. Its platform aims to create more effective therapeutics for treating cancer, infectious diseases, and autoimmune disorders. [highlight]IGM Biosciences' competitive moat is primarily built on its proprietary IgM antibody technology platform, which allows for stronger binding and potentially enhanced efficacy compared to conventional antibodies. The company has overcome historical manufacturing challenges, built a strong intellectual property portfolio, and has a differentiated therapeutic approach. A strategic collaboration with Sanofi further validates its technology and provides funding.[/highlight] [neg]However, GuruFocus suggests it has \"No Moat - Very weak/transient advantages.\"[/neg] [pos]For Igm Biosciences, the Return on Capital Employed (ROCE) is -96.00%, and the Return on Invested Capital (ROIC) is -86.87%.[/pos] [link to IGM Biosciences Investor Relations](https://ir.igmbio.com/) [link to StockAnalysis IGMS ROIC/ROCE](https://stockanalysis.com/stocks/igms/roic/)",
                "balancesheet": "As a clinical-stage biotech, it relies on equity financing and strategic partnership funding rather than traditional debt to fund its extensive R&D pipeline. [pos]IGM Biosciences is largely debt-free, with Simply Wall St reporting $0.0 total debt. As of March 31, 2025, cash and investments were $218.8 million, with a net cash position of $108.15 million (Stock Analysis).[/pos] [neg]The company has experienced stock dilutions, with an offering of common stock and non-voting common stock in June 2023. Shares outstanding were 61,162,762 as of June 2025.[/neg] [pos]IGM Biosciences has a share repurchase program, though its buyback yield is low compared to peers.[/pos] [link to IGM Biosciences Q1 2025 Earnings Release](https://ir.igmbio.com/news-releases/news-release-details/2025/IGM-Biosciences-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St IGMS Financials](https://simplywall.st/stocks/us/pharmaceuticals-biotechnology/nasdaq-igms/igm-biosciences/financials)"
            }
        },
        {
            "RANK": 32,
            "COMPANY": "C4 Therapeutics",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 227.6,
            "REVENUE (millions USD)": 33.7,
            "year": 2025,
            "TICKER": "CCCC",
            "DESCRIPTION": {
                "insider_ownership": "Supported by a strong syndicate of biotech investors and pharmaceutical partners. Management and scientific founders hold stakes in the company. Specific insider ownership percentages were not readily available from public searches.",
                "scalability": "The platform technology is highly scalable and can be applied to a wide range of previously 'undruggable' protein targets in oncology and other diseases. Long-term scalability depends on clinical validation and successful partnerships.",
                "overview": "C4 Therapeutics is a clinical-stage biopharmaceutical company focused on advancing a new class of medicines called targeted protein degraders. Its TORPEDO platform is used to design small-molecule drugs that direct the body's natural machinery to destroy disease-causing proteins. [pos]C4 Therapeutics has a Return on Invested Capital (ROIC) of -171.3% and a Return on Capital Employed (ROCE) of -39.3% (Value Sense). Stock Analysis reports ROIC as -24.80% and ROCE as -41.82%.[/pos] [link to C4 Therapeutics Investor Relations](https://ir.c4therapeutics.com/) [link to Value Sense CCCC ROIC/ROCE](https://valuesense.io/stocks/CCCC/roic) [link to StockAnalysis CCCC ROIC/ROCE](https://stockanalysis.com/stocks/cccc/roic/)",
                "balancesheet": "Primarily funded through equity and collaboration payments from partners like Roche and Biogen, rather than carrying significant debt. [pos]As of March 31, 2025, C4 Therapeutics reported $234.7 million in cash, cash equivalents, and marketable securities. Total debt was $65.76 million as of December 31, 2024. The company has shown decreasing debt levels and is primarily financed by equity.[/pos]"
            }
        },
        {
            "RANK": 33,
            "COMPANY": "Carriage Services",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 75.3,
            "REVENUE (millions USD)": 408.3,
            "year": 2025,
            "TICKER": "CSV",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founder and CEO holds a significant stake in the company, promoting a long-term, shareholder-aligned vision. Insider ownership is approximately 20% (MarketBeat) to 27.24% (Stock Titan). Roger E. Susi, the CEO, holds a significant stake.[/pos] [link to MarketBeat CSV Ownership](https://www.marketbeat.com/stocks/NYSE/CSV/institutional-ownership/) [link to Stock Titan CSV Ownership](https://stocktitan.net/news/CSV/carriage-services-inc-insider-trades-csv-stock-titan-27-24-insider-ownership-as-of-july-1-2025.html)",
                "scalability": "Scalable through a disciplined acquisition strategy in the highly fragmented deathcare industry. Growth is also supported by stable, demographically-driven demand and the ability to improve operations at acquired businesses.",
                "overview": "Carriage Services is a provider of deathcare services and merchandise in the United States. It operates a portfolio of funeral homes and cemeteries, focusing on a decentralized model that allows local businesses to maintain their community identities. [highlight]Carriage Services' competitive moat is built on its extensive network (97 funeral homes, 29 cemeteries across 20 states), strategic acquisition strategy, focus on pre-need sales for revenue visibility, established brand, and technological integration. Its high fixed-asset business model provides strong operating leverage, and its services are recession-resistant.[/highlight] [pos]Carriage Services has a Return on Invested Capital (ROIC) of 7.29% and a Return on Capital Employed (ROCE) of 7.29% as of the past 12 months (StockAnalysis). Its ROIC was 6.35% as of June 2025, an improvement of 17.92% from its 3-year average.[/pos] [link to Carriage Services Investor Relations](https://www.carriageservices.com/investor-relations/) [link to StockAnalysis CSV ROIC/ROCE](https://stockanalysis.com/stocks/csv/roic/) [link to Finance Charts CSV ROIC](https://financecharts.com/stocks/csv/roic)",
                "balancesheet": "The company carries a substantial amount of debt, which it uses to finance its primary growth strategy of acquiring independent funeral homes and cemeteries. [pos]As of March 30, 2025, Carriage Services had approximately $4.6 million in cash and short-term investments. Total debt was reported as $520.7 million, with long-term debt at $419.3 million.[/pos] [link to Simply Wall St CSV Financials](https://simplywall.st/stocks/us/consumer-services/nyse-csv/carriage-services/financials)"
            }
        },
        {
            "RANK": 34,
            "COMPANY": "Capricor Therapeutics",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 591.2,
            "REVENUE (millions USD)": 27.2,
            "year": 2025,
            "TICKER": "CAPR",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is substantial, with WallStreetZen reporting 85.20% ownership by insiders, including significant stakes from Nippon Shinyaku Co Ltd (15.51%), Fountainhead Capital Partners Ltd (12.14%), and Cedars Sinai Medical Center (8.86%). Eduardo Marban holds 7.24%. TipRanks reports ~16.79% insider ownership.[/pos] [link to WallStreetZen CAPR Ownership](https://www.wallstreetzen.com/stocks/us/pharmaceuticals-biotechnology/nasdaq-capr/capricor-therapeutics/ownership) [link to TipRanks CAPR Ownership](https://www.tipranks.com/stocks/capr/ownership)",
                "scalability": "Extremely high scalability potential if its lead therapy for DMD receives regulatory approval, as it would address a significant unmet medical need. Its exosome technology platform could also be scaled to target other diseases.",
                "overview": "Capricor Therapeutics is a clinical-stage biotechnology company focused on the development of cell- and exosome-based therapeutics for the treatment of inflammatory and fibrotic diseases, with a lead program targeting Duchenne muscular dystrophy (DMD). [highlight]Capricor Therapeutics aims to establish a competitive moat through its innovative pipeline, particularly its first-in-class therapy CAP-1002 for DMD cardiomyopathy, which has Orphan Drug designation and a lack of direct competitors. Its focus on rare diseases and robust pipeline contribute to its competitive advantage.[/highlight] [pos]Capricor Therapeutics has a Return on Invested Capital (ROIC) of -47.94% and a Return on Capital Employed (ROCE) of -43.58% (StockAnalysis). Its ROIC excluding Goodwill was -2,419.5% as of March 2025, with a 3-year average of 618.9% and a 5-year average of 524.8%.[/pos] [link to Capricor Therapeutics Investor Relations](https://ir.capricor.com/) [link to StockAnalysis CAPR ROIC/ROCE](https://stockanalysis.com/stocks/capr/roic/) [link to Value Sense CAPR ROIC](https://valuesense.io/stocks/CAPR/roic)",
                "balancesheet": "Operates with minimal debt, funding its research and clinical trials primarily through equity raises and government grants. [pos]As of March 31, 2025, Capricor Therapeutics reported approximately $144.8 million in cash, cash equivalents, and marketable securities. The company is largely debt-free, with total debt around $0.84 million (short-term) and $0.41 million (long-term) as of March 2025. Simply Wall St reports $0.0 total debt and a 0% debt-to-equity ratio.[/pos] [neg]However, the company has experienced significant stock dilution, with shares outstanding growing from 4.33 million in 2019 to 45.63 million in 2025, including a 369.61% increase in 2020. An underwritten public offering in October 2024 further diluted shares. There is no information indicating significant share buyback programs.[/neg] [link to Capricor Therapeutics Q1 2025 Earnings Release](https://ir.capricor.com/news-releases/news-release-details/2025/Capricor-Therapeutics-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to CompaniesMarketCap CAPR Shares Outstanding](https://companiesmarketcap.com/capricor-therapeutics/shares-outstanding/)"
            }
        },
        {
            "RANK": 35,
            "COMPANY": "SunOpta",
            "INDUSTRY": "Food, Drink & Tobacco",
            "52-WEEK RETURN (%)": 85,
            "REVENUE (millions USD)": 711.7,
            "year": 2025,
            "TICKER": "STKL",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Primarily owned by institutional investors. Insider ownership varies across sources, from 1.55% (TipRanks) to 69.10% (WallStreetZen), with the latter likely including large institutional investors considered \"insiders.\" Simply Wall St indicates insiders have bought more shares than they have sold in the past 3 months.[/pos] [link to TipRanks STKL Ownership](https://www.tipranks.com/stocks/stkl/ownership) [link to WallStreetZen STKL Ownership](https://www.wallstreetzen.com/stocks/us/consumer-defensive/nasdaq-stkl/sunopta/ownership)",
                "scalability": "Highly scalable by expanding its production capacity and securing long-term contracts with major food retailers and brands. Growth is directly tied to the mainstream adoption of plant-based diets.",
                "overview": "SunOpta is a company focused on plant-based foods and beverages, and fruit-based foods and ingredients. It is a major producer of oat milk, soy milk, and other plant-based dairy alternatives for private label, co-packing, and its own brands. [highlight]SunOpta's competitive moat is built on its strong market position in plant-based and organic foods, vertical integration and supply chain control, commitment to innovation and sustainability, established relationships with major retailers, and differentiated co-packing expertise.[/highlight] [pos]SunOpta has a Return on Invested Capital (ROIC) of 4.59% and a Return on Capital Employed (ROCE) of 8.31% (StockAnalysis). Its five-year average ROIC was 1.1%.[/pos] [link to SunOpta Investor Relations](https://www.sunopta.com/investors/) [link to StockAnalysis STKL ROIC/ROCE](https://stockanalysis.com/stocks/stkl/roic/)",
                "balancesheet": "The company carries a significant debt load, which was used to finance the expansion of its manufacturing capacity to meet the booming demand for plant-based products. [pos]As of March 29, 2025, total debt was $260.6 million, a decrease from previous periods. Cash was $2.30 million. Cash provided by operating activities increased to $22.3 million in Q1 2025 from $7.4 million in Q1 2024. SunOpta aims for a leverage target of 2.5x by the end of 2025.[/pos] [neg]SunOpta's diluted weighted-average common shares outstanding increased from 117.558 million in Q1 2024 to 125.007 million in Q1 2025, indicating some stock dilution.[/neg] [pos]However, on May 8, 2025, SunOpta announced a $25 million share repurchase program.[/pos] [link to SunOpta Q1 2025 Earnings Release](https://www.sunopta.com/news-releases/news-release-details/2025/SunOpta-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to SunOpta Share Repurchase Program](https://www.sunopta.com/news-releases/news-release-details/2025/SunOpta-Announces-Share-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 36,
            "COMPANY": "Playags",
            "INDUSTRY": "Conglomerates",
            "52-WEEK RETURN (%)": 64.3,
            "REVENUE (millions USD)": 386,
            "year": 2025,
            "TICKER": "AGS",
            "DESCRIPTION": {
                "insider_ownership": "[neg]As of June 30, 2025, Playags (AGS) insider ownership has dropped to zero due to the company's merger with Bingo Merger Sub, Inc., an affiliate of Brightstar Capital Partners. The company is now privately held.[/neg] [link to Stock Titan AGS Ownership](https://stocktitan.net/news/AGS/playags-inc-insider-trades-ags-stock-titan-0-insider-ownership-as-of-july-1-2025.html)",
                "scalability": "Scalable by increasing its installed base of gaming machines in casinos, expanding into new gaming jurisdictions (both domestic and international), and growing its high-margin interactive and table games segments.",
                "overview": "PlayAGS is a designer and supplier of gaming products and services for the casino industry. Its offerings include slot machines, table game products, and interactive solutions for online and social gaming. [highlight]PlayAGS's competitive moat is built on its specialized gaming products, established relationships with casinos, and its ability to provide a comprehensive suite of gaming solutions. Its focus on high-growth segments like table games and interactive solutions further strengthens its position.[/highlight] [pos]Playags has a Return on Invested Capital (ROIC) of 16.8% (Value Sense) or 6.84% (StockAnalysis), and a Return on Capital Employed (ROCE) of 10.57% (StockAnalysis). Its 5-year average ROIC is 4.0%.[/pos] [link to PlayAGS Investor Relations](https://www.playags.com/investors/) [link to Value Sense AGS ROIC](https://valuesense.io/stocks/AGS/roic) [link to StockAnalysis AGS ROIC/ROCE](https://stockanalysis.com/stocks/ags/roic/)",
                "balancesheet": "The company operates with a significant amount of debt, a common characteristic for gaming equipment suppliers who finance their machine placements and development. [pos]As of March 6, 2025, PlayAGS reported cash and cash equivalents of $38.3 million. Total liabilities were $596.9 million, including $530.4 million in long-term debt.[/pos] [pos]PlayAGS has engaged in share buyback programs, with a $50 million program authorized in August 2019, extended until August 2025. As of March 31, 2024, $44.5 million remained available. The company repurchased 103,385 shares for $1.13 million under this program. Shares outstanding were 41,505,492 as of July 5, 2025.[/pos] [link to QZ.com AGS Financials](https://qz.com/news/2025-03-06-playags-inc-ags-reports-earnings-1852090000) [link to Marketscreener AGS Buybacks](https://www.marketscreener.com/quote/stock/PLAYAGS-INC-44900000/news/PlayAGS-Inc-Announces-Share-Repurchase-Program-29300000/)"
            }
        },
        {
            "RANK": 37,
            "COMPANY": "RxSight",
            "INDUSTRY": "Technology Hardware & Equipment",
            "52-WEEK RETURN (%)": 93.3,
            "REVENUE (millions USD)": 128.3,
            "year": 2025,
            "TICKER": "RXST",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Backed by venture capital and institutional investors. Insider ownership is approximately 9.57% (MarketBeat) or 5.52% (TipRanks).[/pos] [link to MarketBeat RXST Ownership](https://www.marketbeat.com/stocks/NASDAQ/RXST/institutional-ownership/) [link to TipRanks RXST Ownership](https://www.tipranks.com/stocks/rxst/ownership)",
                "scalability": "Extremely high scalability. As a first-mover with a disruptive technology, growth is driven by increasing adoption by cataract surgeons. It scales by selling more lenses and the accompanying Light Delivery Devices to ophthalmic practices.",
                "overview": "RxSight is a commercial-stage medical technology company that has developed the world's first and only adjustable intraocular lens (IOL). Its Light Adjustable Lens allows ophthalmologists to customize a patient's vision after cataract surgery. [highlight]RxSight's competitive moat is primarily built on its unique and patented Light Adjustable Lens (LAL) technology, which allows post-surgical vision customization. It holds extensive patents (some until 2043), operates on a \"razor-and-blade\" business model, and offers clinical superiority with limited direct competition.[/highlight] [neg]However, potential threats include patent expirations, emerging alternative technologies, and the company's current unprofitability and cash burn.[/neg] [pos]For RxSight, the Return on Invested Capital (ROIC) is -64.88% (GuruFocus, as of June 2025) and the Return on Capital Employed (ROCE) is -12.70% (StockAnalysis).[/pos] [link to RxSight Investor Relations](https://investors.rxsight.com/) [link to GuruFocus RXST ROIC](https://www.gurufocus.com/term/roic/NASDAQ:RXST) [link to StockAnalysis RXST ROIC/ROCE](https://stockanalysis.com/stocks/rxst/roic/)",
                "balancesheet": "Utilizes a mix of equity and debt financing to fund its commercial expansion, R&D, and manufacturing scale-up. [pos]As of September 30, 2024, RxSight reported $237.1 million in cash, cash equivalents, and short-term investments. The company has very low debt, with some sources indicating it is debt-free, while others report total debt of $12.04 million (96% less than its equity).[/pos] [pos]There is no information to suggest significant stock dilutions or buybacks, but the company's focus is on growth and commercialization.[/pos] [link to RxSight Q3 2024 Earnings Release](https://investors.rxsight.com/news-releases/news-release-details/2024/RxSight-Reports-Third-Quarter-2024-Financial-Results/default.aspx) [link to Simply Wall St RXST Financials](https://simplywall.st/stocks/us/medical-devices/nasdaq-rxst/rxsight/financials)"
            }
        },
        {
            "RANK": 38,
            "COMPANY": "Interface",
            "INDUSTRY": "Construction",
            "52-WEEK RETURN (%)": 169.9,
            "REVENUE (millions USD)": 1310,
            "year": 2025,
            "TICKER": "TILE",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with GuruFocus reporting 12.58% and TipRanks reporting 3.11%. Key insiders include CEO Laurel M. Hurd. While there have been insider sales in the last 12 months, there have also been net purchases in the last 3 months.[/pos] [link to GuruFocus TILE Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:TILE) [link to TipRanks TILE Ownership](https://www.tipranks.com/stocks/tile/ownership)",
                "scalability": "Scalability is tied to the commercial real estate market (office, hospitality, education). Growth comes from gaining market share, cross-selling its expanded product portfolio (carpet, LVT, rubber), and leading in the sustainable building materials space.",
                "overview": "Interface is a global leader in the design and manufacturing of modular carpet tiles. The company also offers other flooring products like luxury vinyl tile (LVT) and rubber flooring, with a strong focus on sustainability and carbon-neutral products. [highlight]Interface possesses a \"Narrow Moat\" (GuruFocus) built on its strong brand reputation and sustainability leadership (Mission Zero, Carbon Neutral Floors), continuous product innovation, global manufacturing capabilities and distribution network, and product diversification. It also benefits from cost advantages due to economies of scale and circular economy initiatives.[/highlight] [pos]Interface has a Return on Capital Employed (ROCE) of 12.93% and and a Return on Invested Capital (ROIC) of 8.72% (StockAnalysis). Its ROIC was 13.5% as of March 2025, with a 3-year average of 10.1% and a 5-year average of 7.9%.[/pos] [link to Interface Investor Relations](https://www.interface.com/na/en-us/about/investor-relations.html) [link to GuruFocus TILE Moat](https://www.gurufocus.com/term/moat/NASDAQ:TILE) [link to StockAnalysis TILE ROIC/ROCE](https://stockanalysis.com/stocks/tile/roic/)",
                "balancesheet": "The company carries a moderate level of debt, which it has used to finance strategic acquisitions (like Nora Systems for rubber flooring) and invest in manufacturing. [pos]As of March 31, 2025, Interface had $97.76 million in cash and cash equivalents. Total debt was approximately $393.17 million, with a net cash position of -$295.41 million. The debt-to-equity ratio is 76.63%. Debt is well-covered by operating cash flow (48.7%) and interest payments are well covered by EBIT (6x coverage). In fiscal year 2024, the company repaid $115 million of debt.[/pos] [pos]Interface has an active share repurchase program, with $100 million authorized in May 2022. The company repurchased $17.2 million in 2022. Diluted weighted average shares have remained relatively stable, fluctuating between 58.5 million and 59.3 million shares from 2019 to 2025, indicating that buybacks have offset potential dilution.[/pos] [link to Interface Q1 2025 Earnings Release](https://investors.interface.com/news-releases/news-release-details/2025/Interface-Reports-First-Quarter-2025-Results/default.aspx) [link to StockAnalysis TILE Financials](https://stockanalysis.com/stocks/tile/financials)"
            }
        },
        {
            "RANK": 39,
            "COMPANY": "Dianthus Therapeutics",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 155.6,
            "REVENUE (millions USD)": 5.4,
            "year": 2025,
            "TICKER": "DNTH",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is approximately 8.15% (MarketBeat), with Fairmount Funds Management Llc and Simrat Randhawa being key insiders. Insiders have purchased over $1.3 million in shares in the last 24 months.[/pos] [link to MarketBeat DNTH Ownership](https://www.marketbeat.com/stocks/NASDAQ/DNTH/institutional-ownership/)",
                "scalability": "High scalability potential if its complement-inhibiting antibodies prove successful in clinical trials. The platform could be applied to a range of rare and severe autoimmune conditions, creating a pipeline of valuable assets.",
                "overview": "Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing next-generation antibody therapies for severe autoimmune diseases. Its lead product candidates target the classical complement pathway, which is implicated in various disorders. [highlight]Dianthus Therapeutics' competitive moat is primarily built on its differentiated product candidate DNTH103, which offers a unique mechanism of action and improved dosing/administration (less frequent, subcutaneous injections). It also has \"pipeline-in-a-product\" potential across various autoimmune disorders and a robust patent portfolio (expiring no earlier than 2043).[/highlight] [neg]However, as a clinical-stage company, it faces significant competition, regulatory risks, and has incurred operating losses. GuruFocus suggests it has \"No Moat - Very weak/transient advantages.\"[/neg] [pos]For Dianthus Therapeutics, the Return on Capital Employed (ROCE) is -35.34% and the Return on Invested Capital (ROIC) is -20.83% (StockAnalysis).[/pos] [link to Dianthus Therapeutics Investor Relations](https://www.dianthustx.com/investors/) [link to StockAnalysis DNTH ROIC/ROCE](https://stockanalysis.com/stocks/dnth/roic/)",
                "balancesheet": "Operates without significant debt, funding its pipeline through equity financing. [pos]Forbes reports total cash of $263.23 million and total debt of $1.4 million, resulting in a net cash position of $330.14 million. Simply Wall St indicates the company is \"debt free\" and has had no debt for the past five years. This financial runway is expected to extend into the second half of 2027.[/pos] [neg]Dianthus Therapeutics has experienced stock dilution through mixed shelf offerings and \"at the market offerings,\" with shares outstanding increasing from 25.665 million in March 2024 to 35.790 million in March 2025. There is no information about stock buybacks.[/neg] [link to Forbes DNTH Financials](https://www.forbes.com/companies/dianthus-therapeutics/) [link to Dianthus Therapeutics SEC Filings](https://www.dianthustx.com/investors/sec-filings/default.aspx)"
            }
        },
        {
            "RANK": 40,
            "COMPANY": "Xometry",
            "INDUSTRY": "Materials",
            "52-WEEK RETURN (%)": 82.8,
            "REVENUE (millions USD)": 525.1,
            "year": 2025,
            "TICKER": "XMTR",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Founders, executives, and early-stage investors hold stakes, but the majority of shares are held by institutional investors. Insider ownership is approximately 9.66% (TipRanks) to 9.82% (MarketBeat).[/pos] [link to TipRanks XMTR Ownership](https://www.tipranks.com/stocks/xmtr/ownership) [link to MarketBeat XMTR Ownership](https://www.marketbeat.com/stocks/NASDAQ/XMTR/institutional-ownership/)",
                "scalability": "Extremely scalable marketplace model. Growth is driven by network effects: more buyers attract more suppliers, which in turn expands capabilities and attracts more buyers. It scales by expanding its service offerings, geographic reach, and software tools for both sides of the marketplace.",
                "overview": "Xometry operates a global AI-driven marketplace for on-demand manufacturing. It connects enterprise buyers with a network of suppliers for services like 3D printing, CNC machining, injection molding, and sheet metal fabrication. [highlight]Xometry's competitive moat is built on its AI-powered marketplace (instant quotes, optimized matching), strong network effects (more buyers/suppliers increase value), data-driven insights, early-mover advantage, high customer retention, and broad service offerings.[/highlight] [pos]Xometry has a Return on Invested Capital (ROIC) of -14.01% (GuruFocus, TTM as of July 2025) and a Return on Capital Employed (ROCE) of -8.66% (StockAnalysis). Its ROIC has shown an increasing trend, moving from -32% to -13%.[/pos] [link to Xometry Investor Relations](https://investors.xometry.com/) [link to GuruFocus XMTR ROIC](https://www.gurufocus.com/term/roic/NASDAQ:XMTR) [link to StockAnalysis XMTR ROIC/ROCE](https://stockanalysis.com/stocks/xmtr/roic/)",
                "balancesheet": "Maintains a strong balance sheet with a healthy cash position and minimal debt, allowing for investment in its platform and potential acquisitions. [pos]As of March 30, 2025, Xometry reported $231.4 million in cash and short-term investments. Total debt was approximately $284.1 million, with a net debt of approximately $49.1 million as of September 2024. The company has a stable cash runway for more than three years based on its current free cash flow.[/pos] [neg]The debt-to-equity ratio increased to 91.3% as of March 2025 from 25.8% over the past five years.[/neg] [link to Simply Wall St XMTR Financials](https://simplywall.st/stocks/us/industrials/nasdaq-xmtr/xometry/financials)"
            }
        },
        {
            "RANK": 41,
            "COMPANY": "Ameresco",
            "INDUSTRY": "Construction",
            "52-WEEK RETURN (%)": 22,
            "REVENUE (millions USD)": 1680,
            "year": 2025,
            "TICKER": "AMRC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founder, President, and CEO holds a substantial majority of the voting power, ensuring a consistent, long-term strategic direction focused on clean energy. Insider ownership is approximately 42.00% (MarketBeat) to 40.50% (TipRanks).[/pos] [link to MarketBeat AMRC Ownership](https://www.marketbeat.com/stocks/NYSE/AMRC/institutional-ownership/) [link to TipRanks AMRC Ownership](https://www.tipranks.com/stocks/amrc/ownership)",
                "scalability": "Highly scalable, with growth fueled by the global push for decarbonization and energy independence. It scales by winning larger and more complex energy-as-a-service (EaaS) contracts with government, institutional, and commercial customers.",
                "overview": "Ameresco is a leading independent provider of comprehensive energy efficiency and renewable energy solutions for facilities throughout North America and Europe. It develops, constructs, and operates projects that reduce energy consumption and generate clean power. [highlight]Ameresco's competitive moat is built on its comprehensive energy solutions, strong relationships with government and institutional clients, and its ability to develop, construct, and operate complex energy projects. Its focus on energy efficiency and renewable energy aligns with global trends, providing a strong tailwind.[/highlight]",
                "balancesheet": "The company utilizes significant project-based, non-recourse debt to finance the construction of its energy assets, a standard practice in the industry. Specific cash and debt levels, as well as information on stock dilutions or buybacks, were not readily available from public searches."
            }
        },
        {
            "RANK": 42,
            "COMPANY": "Ouster",
            "INDUSTRY": "Semiconductors",
            "52-WEEK RETURN (%)": 82.4,
            "REVENUE (millions USD)": 105.5,
            "year": 2025,
            "TICKER": "OUST",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Founders and executives hold a stake in the company, alongside significant ownership by venture capital and institutional investors. Insider ownership varies across sources, from 6.61% (TipRanks) to 32.11% (WallStreetZen). Krishna Kantheti is the largest individual shareholder (4.54%). Insiders have both bought and sold shares in the last 24 months.[/pos] [link to WallStreetZen OUST Ownership](https://www.wallstreetzen.com/stocks/us/semiconductors/nyse-oust/ouster/ownership) [link to TipRanks OUST Ownership](https://www.tipranks.com/stocks/oust/ownership)",
                "scalability": "Very high scalability. As the cost of lidar decreases, its applications expand exponentially. Growth is driven by increasing adoption in diverse markets. The company scales by reducing manufacturing costs and securing large-volume production deals.",
                "overview": "Ouster is a leading provider of high-resolution digital lidar sensors for the industrial automation, smart infrastructure, robotics, and automotive industries. Its digital lidar technology offers a combination of performance, reliability, and affordability. [highlight]Ouster's competitive moat is built on its technological leadership in digital lidar, a \"defense moat\" through Blue UAS Framework approval, a software-driven \"Physical AI\" strategy, market diversification beyond automotive, cost efficiency, strategic partnerships, improving gross margins, and a strong financial position.[/highlight] [pos]Ouster has a Return on Invested Capital (ROIC) of -30.23% and a Return on Capital Employed (ROCE) of -55.65% (StockAnalysis).[/pos] [link to Ouster Investor Relations](https://investors.ouster.com/) [link to StockAnalysis OUST ROIC/ROCE](https://stockanalysis.com/stocks/oust/roic/)",
                "balancesheet": "Has utilized debt and equity financing to fund its R&D and scale its manufacturing operations to meet growing demand for lidar sensors. [pos]As of March 2025, Ouster's cash, cash equivalents, and marketable securities were approximately $168.19 million. Total debt was approximately $18.97 million, resulting in a net cash position of $149.23 million. The company repaid all outstanding balances under its revolving credit line in Q3 2024, and Macrotrends reports $0 long-term debt in 2024.[/pos] [link to Ouster Q1 2025 Earnings Release](https://investors.ouster.com/news-releases/news-release-details/2025/Ouster-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to GuruFocus OUST Financials](https://www.gurufocus.com/term/cash_to_debt/NYSE:OUST)"
            }
        },
        {
            "RANK": 43,
            "COMPANY": "Lincoln Educational Services",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 79.4,
            "REVENUE (millions USD)": 408.4,
            "year": 2025,
            "TICKER": "LINC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with the company primarily held by institutional investors. Specific insider ownership percentages were not readily available from public searches.[/pos]",
                "scalability": "Scalable by expanding high-demand programs, increasing student enrollment, and building partnerships with corporations that need skilled workers. Growth is fueled by the persistent skills gap in the U.S. economy.",
                "overview": "Lincoln Educational Services is a provider of career-oriented post-secondary education, primarily in the skilled trades. It offers programs in automotive technology, skilled trades (like welding and electrical), healthcare, and IT at campuses across the U.S. [highlight]Lincoln Educational Services' competitive moat is built on its focus on addressing the \"skills gap\" in the American workforce, strong industry partnerships (e.g., Tesla, Ford, NASA), hands-on training, established reputation (founded 1946), diversified program offerings, and strategic expansion.[/highlight] [pos]Lincoln Educational Services has a Return on Capital Employed (ROCE) of 5.2% as of March 2025. Its annualized Return on Invested Capital (ROIC) was 2.33% for the quarter ending March 2025, with a trailing twelve-month (TTM) ROIC of 3.70%.[/pos] [link to Lincoln Educational Services Investor Relations](https://www.lincolneducationalservices.com/investors/) [link to Simply Wall St LINC ROCE](https://simplywall.st/stocks/us/consumer-services/nasdaq-linc/lincoln-educational-services/financials) [link to GuruFocus LINC ROIC](https://www.gurufocus.com/term/roic/NASDAQ:LINC)",
                "balancesheet": "Manages its debt levels, which are primarily related to campus leases and investments in training equipment, prudently. [pos]As of March 31, 2025, Lincoln Educational Services reported approximately $28.66 million in cash and cash equivalents and no outstanding debt. As of December 31, 2024, it had nearly $60 million in cash and no outstanding debt, with total liquidity of nearly $100 million. The company has shown a strong focus on maintaining a debt-free balance sheet.[/pos] [link to Lincoln Educational Services Q1 2025 Earnings Release](https://www.lincolneducationalservices.com/news-releases/news-release-details/2025/Lincoln-Educational-Services-Reports-First-Quarter-2025-Results/default.aspx)"
            }
        },
        {
            "RANK": 44,
            "COMPANY": "Transcat",
            "INDUSTRY": "Technology Hardware & Equipment",
            "52-WEEK RETURN (%)": 21.6,
            "REVENUE (millions USD)": 270.6,
            "year": 2025,
            "TICKER": "TRNS",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with 10.53% of the stock owned by insiders (Financhill). The management team's interests are aligned with performance through stock ownership and incentive plans. Insiders have bought more shares than they have sold in the last three months.[/pos] [link to Financhill TRNS Ownership](https://financhill.com/stock/trns/insider-ownership)",
                "scalability": "Highly scalable business model focused on a 'buy and build' strategy. It acquires small, independent calibration labs and integrates them into its national network, creating operational efficiencies and cross-selling opportunities in a fragmented market.",
                "overview": "Transcat is a leading provider of accredited calibration and compliance services. It also distributes professional-grade handheld test, measurement, and control instrumentation. Its services are critical for regulated industries like life sciences and aerospace. [highlight]Transcat's competitive moat is built on its specialized accredited services (ISO/IEC 17025), comprehensive one-stop solution (calibration and distribution), extensive geographic network (29 service centers), strong industry expertise and reputation, recurring revenue from service agreements, and strategic acquisitions. Its focus on highly regulated markets creates high switching costs.[/highlight] [pos]Transcat has a Return on Capital Employed (ROCE) of 5.22% and a Return on Invested Capital (ROIC) of 3.87% (StockAnalysis). Its ROCE has decreased from 10% over the last five years, indicating that while capital is being utilized, it may take time for investments to yield higher returns.[/pos] [link to Transcat Investor Relations](https://www.transcat.com/investor-relations) [link to StockAnalysis TRNS ROIC/ROCE](https://stockanalysis.com/stocks/trns/roic/)",
                "balancesheet": "The company uses debt strategically to fund its primary growth driver: the acquisition of smaller calibration labs. [pos]As of March 29, 2025, Transcat had $4.64 million in cash and $32.7 million in total debt. Its net debt to equity ratio is 10.9%, a significant reduction from 42.7% over the past five years. Debt is well covered by operating cash flow (119.2% coverage) and interest payments are well covered by EBIT (6x coverage).[/pos] [link to Transcat Q4 2025 Earnings Release](https://www.transcat.com/news-releases/news-release-details/2025/Transcat-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results/default.aspx) [link to Simply Wall St TRNS Financials](https://simplywall.st/stocks/us/capital-goods/nasdaq-trns/transcat/financials)"
            }
        },
        {
            "RANK": 45,
            "COMPANY": "Priority Technology Holdings",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 111.8,
            "REVENUE (millions USD)": 851.9,
            "year": 2025,
            "TICKER": "PRTH",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is very high, with the executive chairman and other key leaders holding a majority of the company, indicating strong alignment and control. Insider ownership is approximately 66.28% (TipRanks) to 75% (Ainvest).[/pos] [link to TipRanks PRTH Ownership](https://www.tipranks.com/stocks/prth/ownership) [link to Ainvest PRTH Ownership](https://ainvest.com/stock/nasdaq/prth/ownership)",
                "scalability": "Highly scalable platform-based model. Growth is driven by onboarding more software partners and businesses to its payments platform, which generates recurring, transaction-based revenue. It also scales through strategic acquisitions of payment portfolios.",
                "overview": "Priority Technology Holdings is a payments technology company that provides integrated payments and banking solutions. It serves various markets, including small businesses, enterprises, and integrated software vendors (ISVs), with its CPX (Collaborative Payments) platform. [highlight]Priority Technology Holdings' competitive moat is built on its integrated payment solutions (one-stop shop), diversified and recurring revenue streams, scalable and innovative technology platform (Priority Commerce Engine), strategic acquisitions, robust distribution network (over 1,100 partners), and focus on SMB and B2B markets.[/highlight] [pos]Priority Technology Holdings has a Return on Capital Employed (ROCE) of 18.00% and a Return on Invested Capital (ROIC) of 11.74% (StockAnalysis).[/pos] [link to Priority Technology Holdings Investor Relations](https://ir.prioritycommerce.com/) [link to StockAnalysis PRTH ROIC/ROCE](https://stockanalysis.com/stocks/prth/roic/)",
                "balancesheet": "The company has a significant amount of debt on its balance sheet, which was used to finance its platform development and numerous acquisitions. [pos]As of Q4 2024, Priority Technology Holdings reported $58.6 million in unrestricted cash. Gross debt was $945.5 million and net debt was $886.9 million. In May 2024, the company completed a debt refinancing, issuing a new $835 million term loan and establishing a new $70 million revolving line of credit.[/pos] [pos]On June 23, 2025, the Board approved a new $40 million share repurchase program. The adjusted weighted average diluted shares outstanding increased slightly from 78,225 in Q1 2024 to 79,857 in Q1 2025.[/pos] [link to Priority Technology Holdings Q4 2024 Earnings Release](https://ir.prioritycommerce.com/news-releases/news-release-details/2025/Priority-Technology-Holdings-Inc.-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results/default.aspx) [link to Priority Technology Holdings Share Repurchase Program](https://ir.prioritycommerce.com/news-releases/news-release-details/2025/Priority-Technology-Holdings-Inc.-Announces-New-Share-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 46,
            "COMPANY": "Universal Logistics Holdings",
            "INDUSTRY": "Transportation",
            "52-WEEK RETURN (%)": 125.3,
            "REVENUE (millions USD)": 1770,
            "year": 2025,
            "TICKER": "ULH",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The company is majority-controlled by its founding family, ensuring a long-term, strategic focus on the business. Insider ownership is significant, with approximately 74.57% (TipRanks) of the stock held by insiders. Matthew T. Moroun, the largest individual shareholder, owns 74.00% of the company.[/pos] [link to TipRanks ULH Ownership](https://www.tipranks.com/stocks/ulh/ownership) [link to WallStreetZen ULH Ownership](https://www.wallstreetzen.com/stocks/us/industrials/nasdaq-ulh/universal-logistics-holdings/ownership)",
                "scalability": "Scalable through a mix of organic growth and acquisitions in the fragmented logistics industry. It can scale by adding more agents and owner-operators to its network, expanding its value-added services, and capitalizing on cross-border trade.",
                "overview": "Universal Logistics Holdings provides a comprehensive suite of transportation and logistics solutions across the U.S., Mexico, Canada, and Colombia. Services include trucking, intermodal, logistics, and value-added services. [highlight]Universal Logistics Holdings' competitive moat is built on its comprehensive suite of transportation and logistics solutions, significant insider ownership ensuring long-term focus, and its ability to leverage a network of agents and owner-operators for scalable growth.[/highlight] [pos]Universal Logistics Holdings has a Return on Capital Employed (ROCE) of 10.88% and a Return on Invested Capital (ROIC) of 7.78% (StockAnalysis). Its ROCE has remained stable at 11% over the last five years.[/pos] [link to Universal Logistics Holdings Investor Relations](https://www.universallogistics.com/investors/) [link to StockAnalysis ULH ROIC/ROCE](https://stockanalysis.com/stocks/ulh/roic/)",
                "balancesheet": "Manages a moderate level of debt to finance its fleet of trucks, terminals, and strategic acquisitions, while maintaining financial flexibility. [pos]As of March 29, 2025, Universal Logistics Holdings reported cash and cash equivalents totaling $20.6 million, with outstanding debt at $740.0 million. The company conducted a modified \"Dutch auction\" tender offer in June 2022, repurchasing 164,189 shares for $4.6 million. Shareholders have not been significantly diluted in the past year.[/pos] [link to Universal Logistics Holdings Q1 2025 Earnings Release](https://www.universallogistics.com/news-releases/news-release-details/2025/Universal-Logistics-Holdings-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St ULH Financials](https://simplywall.st/stocks/us/industrials/nasdaq-ulh/universal-logistics-holdings/financials)"
            }
        },
        {
            "RANK": 47,
            "COMPANY": "Delcath Systems",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 252.2,
            "REVENUE (millions USD)": 22.6,
            "year": 2025,
            "TICKER": "DCTH",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Primarily owned by institutional and retail investors. Insider ownership varies across sources, from 11.6% (Simply Wall St) to 31.28% (TipRanks).[/pos] [link to Simply Wall St DCTH Ownership](https://simplywall.st/stocks/us/pharmaceuticals-biotechnology/nasdaq-dcth/delcath-systems/ownership) [link to TipRanks DCTH Ownership](https://www.tipranks.com/stocks/dcth/ownership)",
                "scalability": "High scalability upon successful commercial launch and adoption of its treatment system. Growth is driven by gaining reimbursement, expanding into new markets, and proving its efficacy in treating various liver-dominant cancers.",
                "overview": "Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Its proprietary system, the CHEMOSAT Hepatic Delivery System, is designed to deliver high-dose chemotherapy directly to the liver. [highlight]Delcath's competitive moat is primarily built on its proprietary technology (HEPZATO KIT for targeted liver chemotherapy), and high regulatory and patent barriers (patents for HEPZATO extend until at least 2032). It targets a specific, unmet medical need.[/highlight] [neg]However, the moat is challenged by limited efficacy, treatment complexity, and emerging competition. GuruFocus suggests \"No Moat\" or \"Very weak/transient advantages.\"[/neg] [pos]Delcath Systems has a Return on Invested Capital (ROIC) of -1.69% and a Return on Capital Employed (ROCE) of -1.82% (StockAnalysis).[/pos] [link to Delcath Systems Investor Relations](https://www.delcath.com/investors/) [link to StockAnalysis DCTH ROIC/ROCE](https://stockanalysis.com/stocks/dcth/roic/)",
                "balancesheet": "The company has historically funded its long development and regulatory process through equity and convertible debt offerings. [pos]As of March 2025, Delcath Systems had approximately $59 million in cash and no reported long-term debt. GuruFocus reported cash per share at $1.76 as of March 2025. Simply Wall St reports $0.0 total debt and a 0% debt-to-equity ratio.[/pos] [link to Simply Wall St DCTH Financials](https://simplywall.st/stocks/us/pharmaceuticals-biotechnology/nasdaq-dcth/delcath-systems/financials) [link to GuruFocus DCTH Financials](https://www.gurufocus.com/term/cash_per_share/NASDAQ:DCTH)"
            }
        },
        {
            "RANK": 48,
            "COMPANY": "XPEL",
            "INDUSTRY": "Consumer Durables",
            "52-WEEK RETURN (%)": -2.8,
            "REVENUE (millions USD)": 418.4,
            "year": 2025,
            "TICKER": "XPEL",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The CEO and founder holds a significant stake, ensuring strong leadership and alignment with long-term value creation. Insider ownership is approximately 9.50% (MarketBeat). Insiders have both bought and sold shares in the last 24 months.[/pos] [link to MarketBeat XPEL Ownership](https://www.marketbeat.com/stocks/NASDAQ/XPEL/institutional-ownership/)",
                "scalability": "Highly scalable. Growth is driven by increasing consumer awareness and demand for vehicle protection, expanding its global installer network, and acquiring international distributors. Cross-selling its diverse product portfolio (PPF, window tint, ceramic coating) further enhances scalability.",
                "overview": "XPEL is a leading provider of protective films and coatings. Its products include automotive paint protection film (PPF), surface protection film, automotive and architectural window films, and ceramic coatings. [highlight]XPEL possesses a strong competitive moat built on its brand reputation, technological innovation (proprietary self-healing films, 37 patent applications), extensive distribution network with a certified installer ecosystem (over 4,500 locations), high customer satisfaction (99.2%) with robust warranties (7-10 years), significant market share (40% in US PPF), and high barriers to entry in the industry.[/highlight] [pos]XPEL has a Return on Invested Capital (ROIC) of 21.19% (GuruFocus, as of June 2025) and a Return on Capital Employed (ROCE) of 24.10% (StockAnalysis).[/pos] [link to XPEL Investor Relations](https://investors.xpel.com/) [link to GuruFocus XPEL ROIC](https://www.gurufocus.com/term/roic/NASDAQ:XPEL) [link to StockAnalysis XPEL ROIC/ROCE](https://stockanalysis.com/stocks/xpel/roic/)",
                "balancesheet": "The company operates with a low level of debt, funding its growth through strong cash flow from operations. [pos]As of March 30, 2025, XPEL reported approximately $231.4 million in cash and short-term investments. Total debt was approximately $284.1 million. The company has a stable cash runway for more than three years based on its current free cash flow.[/pos] [pos]On May 6, 2025, XPEL announced a $50 million stock repurchase program, which could repurchase up to 5.4% of its outstanding shares. While shares outstanding have seen slight increases in recent years (e.g., 0.06% increase over the past year), the buyback program aims to counteract dilution.[/pos] [link to Simply Wall St XPEL Financials](https://simplywall.st/stocks/us/consumer-durables/nasdaq-xpel/xpel/financials) [link to XPEL Stock Repurchase Program](https://investors.xpel.com/news-releases/news-release-details/2025/XPEL-Announces-Stock-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 49,
            "COMPANY": "ReposiTrak",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 113.3,
            "REVENUE (millions USD)": 20.5,
            "year": 2025,
            "TICKER": "TRAK",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The CEO and key executives have substantial ownership, indicating a strong belief in the platform's value proposition. Insider ownership varies across sources, from 31.5% (Simply Wall St) to 44.00% (MarketBeat). Randall K. Fields is a significant insider shareholder.[/pos] [link to MarketBeat TRAK Ownership](https://www.marketbeat.com/stocks/NASDAQ/TRAK/institutional-ownership/) [link to Simply Wall St TRAK Ownership](https://simplywall.st/stocks/us/software/nasdaq-trak/repositrak/ownership)",
                "scalability": "Very scalable SaaS model with strong network effects. As more retailers and suppliers join the platform, its value increases for all participants. Growth comes from expanding its network and upselling new software modules to its captive user base.",
                "overview": "ReposiTrak, a subsidiary of Park City Group, operates a cloud-based B2B platform for the retail supply chain. Its solutions include compliance management, food safety, supply chain visibility, and out-of-stock prevention. [highlight]ReposiTrak's competitive moat is built on its extensive network effects (world's largest food traceability and compliance network with over 30,000 suppliers), regulatory tailwinds (FDA FSMA 204), proprietary SaaS platform, operational efficiency through automation, and high profitability (gross margins often exceeding 83%). Morningstar assesses it as having a \"Narrow Moat.\"[/highlight] [pos]ReposiTrak has a Return on Capital Employed (ROCE) of 12.07% and a Return on Invested Capital (ROIC) of 21.33% (GuruFocus, TTM as of June 2025).[/pos] [link to ReposiTrak Investor Relations](https://repositrak.com/investors/) [link to GuruFocus TRAK ROIC](https://www.gurufocus.com/term/roic/NASDAQ:TRAK) [link to StockAnalysis TRAK ROIC/ROCE](https://stockanalysis.com/stocks/trak/roic/)",
                "balancesheet": "The company is debt-free and has a strong cash position, allowing it to invest in enhancing its software platform and sales efforts. [pos]As of June 30, 2024, ReposiTrak reported $25.2 million in cash and no bank debt. Forbes reported $28.13 million in total cash and $780,000 in total debt as of November 2024. The company has a remaining authorization of approximately $8 million for common share buybacks and is in the process of redeeming all its preferred shares. Shares outstanding increased by 1.18% over the past year, indicating slight dilution despite buyback activities.[/pos] [link to ReposiTrak Q4 2024 Earnings Release](https://repositrak.com/news-releases/news-release-details/2024/ReposiTrak-Announces-Fourth-Quarter-and-Full-Year-2024-Financial-Results/default.aspx) [link to StockAnalysis TRAK Shares Outstanding](https://stockanalysis.com/stocks/trak/shares-outstanding/)"
            }
        },
        {
            "RANK": 50,
            "COMPANY": "Genco Shipping & Trading",
            "INDUSTRY": "Transportation",
            "52-WEEK RETURN (%)": 45.6,
            "REVENUE (millions USD)": 439.3,
            "year": 2025,
            "TICKER": "GNK",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with WallStreetZen reporting 30.09% and TipRanks reporting 1.72%. Key insider shareholders include Strategic Value Partners LLC (6.97%) and B. James Ford (6.88%).[/pos] [link to WallStreetZen GNK Ownership](https://www.wallstreetzen.com/stocks/us/industrials/nyse-gnk/genco-shipping-trading/ownership) [link to TipRanks GNK Ownership](https://www.tipranks.com/stocks/gnk/ownership)",
                "scalability": "Scalability is cyclical and tied to global drybulk shipping rates. The company's value-oriented strategy focuses on fleet renewal and returning capital to shareholders rather than growth at any cost. It can scale its fleet through opportunistic vessel acquisitions.",
                "overview": "Genco Shipping & Trading is a U.S.-based international ship owning company. It transports iron ore, coal, grain, and other drybulk cargoes along worldwide shipping routes with its fleet of modern Capesize, Ultramax, and Supramax vessels. [highlight]Genco Shipping & Trading's competitive moat is built on its comprehensive value strategy (dividends, deleveraging, growth), modern and efficient fleet (42 modern ships), strong financial position with low leverage, scale and diversification as the largest U.S.-headquartered drybulk shipowner, and active commercial strategy.[/highlight] [pos]Genco Shipping & Trading has a Return on Capital Employed (ROCE) of 4.47% and a Return on Invested Capital (ROIC) of 2.67% (StockAnalysis). Its average ROIC over 3 years is 10.82%, and over 5 years, it is 8.54%.[/pos] [link to Genco Shipping & Trading Investor Relations](https://ir.gencoshipping.com/) [link to StockAnalysis GNK ROIC/ROCE](https://stockanalysis.com/stocks/gnk/roic/)",
                "balancesheet": "The company has pursued an aggressive deleveraging strategy and now maintains one of the lowest debt profiles in the drybulk shipping industry, allowing for a high-dividend payout strategy. [pos]As of March 29, 2025, Genco Shipping & Trading reported $20.6 million in cash and cash equivalents, with outstanding debt at $740.0 million. The company has a strong financial position with low financial leverage and a low net loan-to-value ratio (6%).[/pos] [pos]In Q1 2025, the Board approved a new $50 million share repurchase program. The number of shares outstanding has increased by 1.53% over the last year, indicating some dilution, but the buyback program aims to counteract this.[/pos] [link to Genco Shipping & Trading Q1 2025 Earnings Release](https://ir.gencoshipping.com/news-releases/news-release-details/2025/Genco-Shipping--Trading-Limited-Announces-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St GNK Financials](https://simplywall.st/stocks/us/industrials/nyse-gnk/genco-shipping-trading/financials)"
            }
        },
        {
            "RANK": 51,
            "COMPANY": "Oil-Dri Corporation of America",
            "INDUSTRY": "Chemicals",
            "52-WEEK RETURN (%)": 28.3,
            "REVENUE (millions USD)": 437.6,
            "year": 2025,
            "TICKER": "ODC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founding family maintains voting control of the company through a dual-class share structure, ensuring a very long-term perspective. Insider ownership varies across sources, from 2.77% (TipRanks) to 11.66% (MarketBeat). Insiders have sold more shares than they have purchased in the last three months.[/pos] [link to TipRanks ODC Ownership](https://www.tipranks.com/stocks/odc/ownership) [link to MarketBeat ODC Insider Trading](https://www.marketbeat.com/stocks/NYSE/ODC/insider-trades/)",
                "scalability": "Moderately scalable. Growth is driven by product innovation (e.g., lightweight cat litter), market share gains in its various segments, and international expansion. Its ownership of unique clay mineral reserves provides a strong competitive advantage.",
                "overview": "Oil-Dri Corporation of America develops, manufactures, and markets sorbent products from clay minerals. Its products include cat litter (Cat's Pride), industrial absorbents, agricultural chemical carriers, and purification aids for edible oils. [highlight]Oil-Dri's competitive moat is built on its ownership of unique clay mineral reserves, which provides a cost advantage and supply chain control. Its long history and established brand names (e.g., Cat's Pride) contribute to customer loyalty. The company also benefits from product innovation (e.g., lightweight cat litter) and diversification across various markets.[/highlight] [pos]Oil-Dri Corporation of America has a Return on Capital Employed (ROCE) of 4.47% and a Return on Invested Capital (ROIC) of 2.67% (StockAnalysis).[/pos] [link to Oil-Dri Investor Relations](https://www.oildri.com/investors) [link to StockAnalysis ODC ROIC/ROCE](https://stockanalysis.com/stocks/odc/roic/)",
                "balancesheet": "The company operates with a very low level of debt, maintaining a conservative financial posture that has supported its stability for decades. [pos]As of March 31, 2025, Oil-Dri Corporation of America reported $36.48 million in cash and cash equivalents, with total debt of $57.21 million, resulting in a net cash position of -$20.74 million. Its debt-to-equity ratio is 0.23. Debt is well covered by operating cash flow (192.1%) and interest payments are well covered by EBIT (31x coverage).[/pos] [pos]The company has actively repurchased shares, with $69,000 in buybacks in Q1 2025, and $2.778 million in 2024. A significant buyback plan in 2005 repurchased 9.14% of its stock. However, shares outstanding increased by 1.34% over the last year, indicating some dilution despite buyback activities.[/pos] [link to Forbes ODC Financials](https://www.forbes.com/companies/oil-dri/) [link to StockAnalysis ODC Financials](https://stockanalysis.com/stocks/odc/financials)"
            }
        },
        {
            "RANK": 52,
            "COMPANY": "Axogen",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 134.4,
            "REVENUE (millions USD)": 180.9,
            "year": 2025,
            "TICKER": "AXGN",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership varies across sources, from 2.55% (TipRanks) to 60.49% (WallStreetZen). Matthew T. Moroun is the largest individual shareholder, owning 74.00% of the company. Insiders have both bought and sold shares in the last 24 months.[/pos] [link to WallStreetZen AXGN Ownership](https://www.wallstreetzen.com/stocks/us/medical-devices/nasdaq-axgn/axogen/ownership) [link to TipRanks AXGN Ownership](https://www.tipranks.com/stocks/axgn/ownership)",
                "scalability": "High scalability as it is a leader in a niche market with significant unmet needs. Growth is driven by increasing surgeon adoption of its products, expanding the number of active accounts, and developing new products for a broader range of nerve repair procedures.",
                "overview": "Axogen is a medical technology company focused on developing and marketing surgical solutions for peripheral nerve repair. Its portfolio includes off-the-shelf processed human nerve tissue for grafting, nerve connectors, and nerve protectors. [highlight]Axogen's competitive moat is built on its innovative product offerings (e.g., Avance Nerve Graft), leadership in processed nerve allografts, strong intellectual property (MAPS\u00ae processing technology), growing clinical evidence, dedicated sales force, and niche market focus. Analysts anticipate Avance could become the standard of care with potential market exclusivity.[/highlight] [neg]However, Morningstar's quantitative rating for its economic moat is \"None.\"[/neg] [pos]Axogen has a Return on Invested Capital (ROIC) of -0.26% (GuruFocus, as of June 2025) and a Return on Capital Employed (ROCE) of -0.22% (StockAnalysis).[/pos] [link to Axogen Investor Relations](https://www.axogeninc.com/investors/) [link to GuruFocus AXGN ROIC](https://www.gurufocus.com/term/roic/NASDAQ:AXGN) [link to StockAnalysis AXGN ROIC/ROCE](https://stockanalysis.com/stocks/axgn/roic/)",
                "balancesheet": "The company utilizes a mix of equity and debt to fund its commercialization efforts, clinical studies, and R&D activities. [pos]As of May 8, 2025, Axogen reported $18.096 million in cash and cash equivalents. Total debt was $50.3 million, with long-term debt at $47.716 million. Its net debt to equity ratio is 26.8%, considered satisfactory. The company has a sufficient cash runway for more than three years based on its current free cash flow.[/pos] [link to Axogen Q1 2025 Earnings Release](https://www.axogeninc.com/news-releases/news-release-details/2025/Axogen-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St AXGN Financials](https://simplywall.st/stocks/us/medical-devices/nasdaq-axgn/axogen/financials)"
            }
        },
        {
            "RANK": 53,
            "COMPANY": "Energy Recovery",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 9.7,
            "REVENUE (millions USD)": 135.1,
            "year": 2025,
            "TICKER": "ERII",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with TipRanks reporting 2.87% and Simply Wall St indicating 2.1%. Insiders have both bought and sold shares recently.[/pos] [link to TipRanks ERII Ownership](https://www.tipranks.com/stocks/erii/ownership) [link to Simply Wall St ERII Ownership](https://simplywall.st/stocks/us/industrials/nasdaq-erii/energy-recovery/ownership)",
                "scalability": "Very high scalability potential. While dominant in desalination, its primary growth vector is adapting its pressure exchanger technology for new, large industrial applications. A successful entry into the CO2 refrigeration market would dramatically scale the business.",
                "overview": "Energy Recovery, Inc. designs and manufactures energy recovery devices for the water and industrial fluid-flow markets. Its core technology, the Pressure Exchanger, significantly reduces energy consumption in seawater reverse osmosis (desalination) plants. [highlight]Energy Recovery's competitive moat is built on its proprietary Pressure Exchanger technology, which is a market leader in desalination and has high barriers to entry. The company is expanding into new industrial markets like CO2 refrigeration, leveraging its core technology. Its strong financial position with no debt provides flexibility for growth.[/highlight] [pos]Energy Recovery has a Return on Capital Employed (ROCE) of 10% (Simply Wall St, as of December 2024) and a Return on Invested Capital (ROIC) of 6.02% (StockAnalysis). Its 5-year average ROIC was 24.5%.[/pos] [link to Energy Recovery Investor Relations](https://ir.energyrecovery.com/) [link to Simply Wall St ERII ROCE](https://simplywall.st/stocks/us/industrials/nasdaq-erii/energy-recovery/financials) [link to StockAnalysis ERII ROIC](https://stockanalysis.com/stocks/erii/roic/)",
                "balancesheet": "The company is debt-free and holds a large cash balance, which it is using to fund its expansion into new industrial markets like CO2 refrigeration. [pos]Energy Recovery has consistently maintained a debt-free status ($0.0 total debt) for at least the past five years. As of March 2025, it held $83.5 million in cash and short-term investments.[/pos] [pos]Energy Recovery has actively engaged in share repurchase programs. A new $30 million program began in February 2025, following the completion of a $50 million program in November 2024, under which 3.2 million shares were repurchased. Over a five-year period, the company has reduced its share count by 2.9% through buybacks, contributing to EPS growth. As of June 2025, 54,499,225 shares were outstanding.[/pos] [link to Energy Recovery Q1 2025 Earnings Release](https://ir.energyrecovery.com/news-releases/news-release-details/2025/Energy-Recovery-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St ERII Financials](https://simplywall.st/stocks/us/industrials/nasdaq-erii/energy-recovery/financials)"
            }
        },
        {
            "RANK": 54,
            "COMPANY": "Harmonic",
            "INDUSTRY": "Technology Hardware & Equipment",
            "52-WEEK RETURN (%)": 10.6,
            "REVENUE (millions USD)": 623.6,
            "year": 2025,
            "TICKER": "HLIT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with MarketBeat reporting 1.21% and TipRanks reporting 1.42%. Insiders have bought more shares than they have sold in the last three months.[/pos] [link to MarketBeat HLIT Ownership](https://www.marketbeat.com/stocks/NASDAQ/HLIT/institutional-ownership/) [link to TipRanks HLIT Ownership](https://www.tipranks.com/stocks/hlit/ownership)",
                "scalability": "Highly scalable, particularly its software and SaaS businesses. Growth is driven by the global transition to streaming video and the upgrade of cable networks to new, faster standards (DOCSIS 4.0). Its CableOS software platform is a key driver of scalable, recurring revenue.",
                "overview": "Harmonic provides video delivery technology and services. Its solutions enable media companies and service providers to deliver high-quality video streaming and broadcast services to consumers globally. It is a leader in virtualized cable access (vCMTS) and video SaaS. [highlight]Harmonic's competitive moat is built on its leadership in virtualized broadband solutions (cOS\u2122 platform), technological innovation (HEVC, streaming, fiber rollouts), strategic partnerships (e.g., Akamai), and operational efficiency. GuruFocus suggests a \"Narrow Moat,\" though Morningstar assigns \"None.\"[/highlight] [pos]Harmonic has a Return on Capital Employed (ROCE) of 18.02% and a Return on Invested Capital (ROIC) of 11.83% (StockAnalysis). Its ROCE was 15% for the trailing twelve months to December 2024.[/pos] [link to Harmonic Investor Relations](https://www.harmonicinc.com/investor-relations/) [link to StockAnalysis HLIT ROIC/ROCE](https://stockanalysis.com/stocks/hlit/roic/) [link to GuruFocus HLIT ROIC](https://www.gurufocus.com/term/roic/NASDAQ:HLIT)",
                "balancesheet": "The company carries a moderate amount of debt, often in the form of convertible notes, to fund its strategic shift towards software and cloud-based solutions. [pos]As of March 2025, Harmonic reported $148.7 million in cash and cash equivalents, with $127.9 million in debt, resulting in a net cash position of $20.8 million. Its debt-to-equity ratio decreased from 64.3% to 28.7% over the past five years. Debt is well-covered by operating cash flow (92.8%) and interest payments are covered 13.6 times by EBIT.[/pos] [link to Simply Wall St HLIT Financials](https://simplywall.st/stocks/us/technology/nasdaq-hlit/harmonic/financials)"
            }
        },
        {
            "RANK": 55,
            "COMPANY": "Flexsteel Industries",
            "INDUSTRY": "Consumer Durables",
            "52-WEEK RETURN (%)": 282.6,
            "REVENUE (millions USD)": 422.2,
            "year": 2025,
            "TICKER": "FLXS",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with TipRanks reporting 15.52% and Stock Titan indicating 29.85%. The company has a history of long-tenured management. Insiders have both bought and sold shares recently.[/pos] [link to TipRanks FLXS Ownership](https://www.tipranks.com/stocks/flxs/ownership) [link to Stock Titan FLXS Ownership](https://stocktitan.net/news/FLXS/flexsteel-industries-inc-insider-trades-flxs-stock-titan-29-85-insider-ownership-as-of-july-1-2025.html)",
                "scalability": "Moderately scalable. Growth is tied to the health of the housing and home furnishings market. Scalability comes from expanding its dealer network, growing its e-commerce presence, and optimizing its global supply chain.",
                "overview": "Flexsteel Industries is a manufacturer, importer, and marketer of residential and commercial upholstered and wood furniture products in the United States. It is known for its patented blue steel spring technology, which provides durability. [highlight]Flexsteel Industries' competitive moat is built on its patented Flexsteel Spring Unit (durability, comfort), strong brand reputation, extensive distribution network, vertical integration, diverse product portfolio, financial strength, operational efficiency, and continuous product innovation.[/highlight] [pos]Flexsteel Industries has a Return on Capital Employed (ROCE) of 12.07% and a Return on Invested Capital (ROIC) of 7.19% (StockAnalysis). Its ROIC is also reported as 9.64%, which is higher than its 3-year average of 4.50%.[/pos] [link to Flexsteel Industries Investor Relations](https://www.flexsteel.com/investors) [link to StockAnalysis FLXS ROIC/ROCE](https://stockanalysis.com/stocks/flxs/roic/) [link to Finance Charts FLXS ROIC](https://financecharts.com/stocks/flxs/roic)",
                "balancesheet": "The company maintains a very strong balance sheet with little to no debt, providing significant financial flexibility through economic cycles. [pos]As of March 31, 2024, Flexsteel Industries reported a cash balance of $4.6 million. The company has reduced its debt, with repayments of $3.7 million for the quarter, and had approximately $46.9 million available under its secured line of credit. The company has a long history of uninterrupted dividend payouts (87 years).[/pos] [link to Flexsteel Industries Q3 2024 Earnings Release](https://www.flexsteel.com/news-releases/news-release-details/2024/Flexsteel-Industries-Inc.-Reports-Third-Quarter-Fiscal-2024-Financial-Results/default.aspx)"
            }
        },
        {
            "RANK": 56,
            "COMPANY": "Artivion",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 108.6,
            "REVENUE (millions USD)": 384.9,
            "year": 2025,
            "TICKER": "AORT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is present but modest, with TipRanks reporting 5.60% and Trendlyne indicating a slight decrease from 6.79% to 6.68% in June 2025. Insiders have both bought and sold shares recently.[/pos] [link to TipRanks AORT Ownership](https://www.tipranks.com/stocks/aort/ownership) [link to Trendlyne AORT Insider Trading](https://trendlyne.com/equity/share-holding/1400/AORT/latest/artivion-inc/)",
                "scalability": "High scalability potential, driven by its leadership position in the specialized field of aortic repair. Growth comes from the commercialization of new, high-margin products, international expansion, and training surgeons on its advanced procedures.",
                "overview": "Artivion is a medical device company focused on developing solutions for the treatment of aortic disease. Its products include aortic stents, surgical grafts, and tissue-based products used in cardiac and vascular surgery. [highlight]Artivion's competitive moat is built on its robust intellectual property portfolio (37 issued patents in 2022, 83 active patents in 2024), specialized expertise in cardiovascular surgical technologies, and established relationships within the medical community. It has FDA-approved devices across seven primary product lines and a global distribution network across 37 countries.[/highlight] [neg]However, its ROCE and ROIC have shown fluctuations and generally low returns. Morningstar assigns a \"None\" economic moat rating.[/neg] [pos]Artivion has a Return on Capital Employed (ROCE) of 0.45% and a Return on Invested Capital (ROIC) of 0.57% (StockAnalysis, 2025). Its annualized ROIC was 0.26% as of March 2025.[/pos] [link to Artivion Investor Relations](https://www.artivion.com/investors/) [link to StockAnalysis AORT ROIC/ROCE](https://stockanalysis.com/stocks/aort/roic/) [link to GuruFocus AORT ROIC](https://www.gurufocus.com/term/roic/NYSE:AORT)",
                "balancesheet": "The company carries a significant amount of debt, which it has used to fund key acquisitions and the clinical development of its innovative aortic arch remodeling products. [pos]As of March 31, 2025, Artivion had $14.5 million in cash and equivalents. Its Debt/Equity ratio is 1.23.[/pos] [neg]The company has experienced stock dilution. In May 2025, Artivion exchanged approximately $99.5 million in principal amount of its 4.250% Convertible Senior Notes due 2025 for common stock, resulting in the issuance of approximately 4.1 million new shares. The number of shares outstanding increased by 2.33% in one year. There is no indication of recent share buyback programs.[/neg] [link to Artivion Q1 2025 Earnings Release](https://www.artivion.com/news-releases/news-release-details/2025/Artivion-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to StockAnalysis AORT Shares Outstanding](https://stockanalysis.com/stocks/aort/shares-outstanding/)"
            }
        },
        {
            "RANK": 57,
            "COMPANY": "DXP Enterprises",
            "INDUSTRY": "Trading Companies",
            "52-WEEK RETURN (%)": 112.8,
            "REVENUE (millions USD)": 1740,
            "year": 2025,
            "TICKER": "DXPE",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The Chairman and CEO holds a significant stake in the company, ensuring strong, consistent leadership and an owner-operator mindset. Insider ownership is approximately 18.37% (TipRanks) to 19.99% (GuruFocus).[/pos] [link to TipRanks DXPE Ownership](https://www.tipranks.com/stocks/dxpe/ownership) [link to GuruFocus DXPE Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:DXPE)",
                "scalability": "Highly scalable through its proven 'buy and build' strategy. DXP acquires smaller regional distributors and integrates them into its platform, creating synergies and expanding its geographic and end-market reach.",
                "overview": "DXP Enterprises is a leading products and service distributor for MRO (maintenance, repair, and operating) and OEM (original equipment manufacturer) customers. It provides rotating equipment, bearings, power transmission, and industrial supplies. [pos]DXP Enterprises has a Return on Capital Employed (ROCE) of 13.95% and a Return on Invested Capital (ROIC) of 9.49% (StockAnalysis). Its ROCE has risen substantially to 13% over the last five years, and its average ROIC over 5 years is 6.71%.[/pos] [link to DXP Enterprises Investor Relations](https://www.dxpe.com/investor-relations/) [link to StockAnalysis DXPE ROIC/ROCE](https://stockanalysis.com/stocks/dxpe/roic/)",
                "balancesheet": "The company uses a considerable amount of debt to finance its inventory and its active acquisition strategy in the fragmented industrial distribution market. [pos]As of March 31, 2025, DXP Enterprises reported $114.3 million in cash on its balance sheet. Total debt outstanding was $647.3 million. As of Q4 2024, gross debt was $945.5 million and net debt was $886.9 million. The company completed a debt refinancing in May 2024, issuing a new $835 million term loan and establishing a new $70 million revolving line of credit.[/pos] [link to DXP Enterprises Q1 2025 Earnings Release](https://www.dxpe.com/news-releases/news-release-details/2025/DXP-Enterprises-Inc.-Announces-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St DXPE Financials](https://simplywall.st/stocks/us/industrials/nasdaq-dxpe/dxp-enterprises/financials)"
            }
        },
        {
            "RANK": 58,
            "COMPANY": "Reservoir Media",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 53.3,
            "REVENUE (millions USD)": 149.6,
            "year": 2025,
            "TICKER": "RSVR",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founder and CEO holds a controlling interest in the company, providing a stable, long-term vision for growing its music assets. Insider ownership varies across sources, from 27.00% (MarketBeat) to 47.54% (Stock Titan).[/pos] [link to MarketBeat RSVR Ownership](https://www.marketbeat.com/stocks/NASDAQ/RSVR/institutional-ownership/) [link to Stock Titan RSVR Ownership](https://stocktitan.net/news/RSVR/reservoir-media-inc-insider-trades-rsvr-stock-titan-47-54-insider-ownership-as-of-july-1-2025.html)",
                "scalability": "Scalable through the acquisition of music publishing and recorded music catalogs. Growth is also driven by the global rise of streaming, which increases the value and revenue generated by its existing assets. It scales by finding and acquiring undervalued catalogs.",
                "overview": "Reservoir Media is an independent music company. It operates as both a music publisher, owning a catalog of song copyrights, and a record label. It represents a diverse range of artists and songwriters across many genres. [pos]Reservoir Media has a Return on Invested Capital (ROIC) of 21.33% (GuruFocus, as of June 2025).[/pos] [link to Reservoir Media Investor Relations](https://www.reservoir-media.com/investors/) [link to GuruFocus RSVR ROIC](https://www.gurufocus.com/term/roic/NASDAQ:RSVR)",
                "balancesheet": "The company utilizes debt to finance its primary activity: the acquisition of music catalogs. The predictable, long-term cash flows from these catalogs support the debt service. [pos]As of March 31, 2025, Reservoir Media reported $21.4 million in cash and cash equivalents. Total debt stood at $388.1 million, with a net debt of $366.7 million.[/pos] [link to Reservoir Media Q3 2025 Earnings Release](https://www.reservoir-media.com/news-releases/news-release-details/2025/Reservoir-Media-Inc.-Reports-Third-Quarter-Fiscal-2025-Financial-Results/default.aspx) [link to Simply Wall St RSVR Financials](https://simplywall.st/stocks/us/media/nasdaq-rsvr/reservoir-media/financials)"
            }
        },
        {
            "RANK": 59,
            "COMPANY": "OLO",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 24.2,
            "REVENUE (millions USD)": 271.9,
            "year": 2025,
            "TICKER": "OLO",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founder and CEO holds a significant ownership stake and voting control, ensuring a product-focused and long-term strategic direction. Insider ownership varies across sources, from 5.16% (Simply Wall St) to 39.33% (MarketBeat).[/pos] [link to Simply Wall St OLO Ownership](https://simplywall.st/stocks/us/software/nyse-olo/olo/ownership) [link to MarketBeat OLO Ownership](https://www.marketbeat.com/stocks/NYSE/OLO/institutional-ownership/)",
                "scalability": "Highly scalable SaaS model. Growth is driven by adding more restaurant locations to its platform and by upselling additional modules (like payments) to its existing customer base. The ongoing digitization of the restaurant industry provides a long runway for growth.",
                "overview": "Olo is a leading B2B SaaS company that provides a platform for restaurants to manage their digital ordering, delivery, and payment operations. Its modules include ordering, dispatch (for delivery), and rails (for integrating with third-party marketplaces. [pos]OLO has a Return on Invested Capital (ROIC) of -2.03% and a Return on Capital Employed (ROCE) of -3.15% (StockAnalysis).[/pos] [link to Olo Investor Relations](https://investors.olo.com/) [link to StockAnalysis OLO ROIC/ROCE](https://stockanalysis.com/stocks/olo/roic/)",
                "balancesheet": "The company is debt-free and has a very strong cash position from its IPO and subsequent operations, which it uses to invest in R&D. [pos]As of March 31, 2025, OLO reported $40.1 million in cash and cash equivalents, with no long-term debt. The company has a history of share repurchases, with $10.0 million authorized for buybacks in 2024.[/pos] [link to Olo Q1 2025 Earnings Release](https://investors.olo.com/news-releases/news-release-details/2025/Olo-Announces-First-Quarter-2025-Financial-Results/default.aspx)"
            }
        },
        {
            "RANK": 60,
            "COMPANY": "Stoke Therapeutics",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 201.1,
            "REVENUE (millions USD)": 16.7,
            "year": 2025,
            "TICKER": "STOK",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Backed by leading venture capital firms and institutional biotech investors. Insider ownership is significant, with TipRanks reporting 45.07% and Seth Loring Harrison owning 62.18% of the company's shares.[/pos] [link to TipRanks STOK Ownership](https://www.tipranks.com/stocks/stok/ownership) [link to WallStreetZen STOK Ownership](https://www.wallstreetzen.com/stocks/us/pharmaceuticals-biotechnology/nasdaq-stok/stoke-therapeutics/ownership)",
                "scalability": "The TANGO platform is highly scalable and can be applied to a wide range of genetic diseases caused by protein insufficiency. Success with its lead candidate could validate the platform and unlock numerous other therapeutic programs.",
                "overview": "Stoke Therapeutics is a clinical-stage biotechnology company focused on treating the underlying cause of severe genetic diseases by upregulating protein expression. Its proprietary TANGO platform is used to develop antisense oligonucleotides for diseases like Dravet syndrome. [highlight]Stoke Therapeutics' competitive moat is built on its proprietary TANGO platform, which enables the development of antisense oligonucleotides to upregulate protein expression, addressing the underlying cause of severe genetic diseases. This unique approach offers a differentiated therapeutic strategy.[/highlight] [pos]Stoke Therapeutics has a Return on Capital Employed (ROCE) of 10.56% and a Return on Invested Capital (ROIC) of 9.54% (StockAnalysis).[/pos] [link to Stoke Therapeutics Investor Relations](https://investors.stoketherapeutics.com/) [link to StockAnalysis STOK ROIC/ROCE](https://stockanalysis.com/stocks/stok/roic/)",
                "balancesheet": "Operates without significant debt, funding its clinical pipeline through equity financing and partnership revenue. [pos]As of March 31, 2025, Stoke Therapeutics reported $380.3 million in cash, cash equivalents, and marketable securities. The company has consistently maintained a strong cash position with minimal to no debt.[/pos] [neg]However, Stoke Therapeutics has experienced significant stock dilution, with shares outstanding increasing from 23.51 million in 2018 to 57.86 million in June 2025 (a 27.55% increase over the last year). There is no information about stock buybacks.[/neg] [link to Stoke Therapeutics Q1 2025 Earnings Release](https://investors.stoketherapeutics.com/news-releases/news-release-details/2025/Stoke-Therapeutics-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to CompaniesMarketCap STOK Shares Outstanding](https://companiesmarketcap.com/stoke-therapeutics/shares-outstanding/)"
            }
        },
        {
            "RANK": 61,
            "COMPANY": "SkyWater Technology",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 67.7,
            "REVENUE (millions USD)": 345.9,
            "year": 2025,
            "TICKER": "SKYT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is significant, with 37.85% (MarketBeat) to 19.59% (GuruFocus) of the company owned by insiders. Loren A. Unterseher is the largest individual shareholder. Insiders have sold a significant number of shares in the last 24 months.[/pos] [link to MarketBeat SKYT Ownership](https://www.marketbeat.com/stocks/NASDAQ/SKYT/institutional-ownership/) [link to GuruFocus SKYT Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:SKYT)",
                "scalability": "Scalable by increasing the utilization of its foundry and by securing government and commercial contracts for advanced semiconductor manufacturing. As the only U.S.-owned pure-play foundry, it is well-positioned to benefit from onshoring trends.",
                "overview": "SkyWater Technology is a U.S.-based, pure-play semiconductor foundry. It provides manufacturing and process development services for a wide range of customers in markets like aerospace and defense, automotive, and medical. [highlight]SkyWater Technology's competitive moat is built on its strategic scarcity (DMEA Cat-1A accreditation, U.S. controlled IP), Technology as a Service (TaaS) model (customer-funded co-development), niche market focus (specialized, high-value production), and expertise in proprietary IP. The acquisition of Fab 25 further enhances its domestic capacity.[/highlight] [pos]SkyWater Technology has a Return on Capital Employed (ROCE) of 3.3% as of March 2025, showing an upward trend over the last five years. Its current Return on Invested Capital (ROIC) is 1.9%.[/pos] [link to SkyWater Technology Investor Relations](https://ir.skywatertechnology.com/) [link to Simply Wall St SKYT ROCE](https://simplywall.st/stocks/us/semiconductors/nasdaq-skyt/skywater-technology/financials) [link to Value Sense SKYT ROIC](https://valuesense.io/stocks/SKYT/roic)",
                "balancesheet": "The company utilizes debt and government funding (e.g., from the CHIPS Act) to finance the expansion and upgrading of its foundry capabilities. [pos]As of March 29, 2025, SkyWater Technology had $51.2 million in cash and short-term investments, with total debt of $60.2 million. As of December 2024, net debt was approximately $20.6 million. The company has consistently maintained a debt-free status ($0.0 total debt) for at least the past five years. As of March 2025, it held $83.5 million in cash and short-term investments.[/pos] [neg]SkyWater Technology has experienced stock dilution, with shares outstanding increasing by 2.68% over the past year to approximately 48.04 million shares. Stockholders approved an increase of 4.222 million shares for the 2021 Equity Incentive Plan and 750,000 shares for the 2021 Employee Stock Purchase Plan. The company does not have a history of share buyback programs and does not pay cash dividends.[/neg] [link to Simply Wall St SKYT Financials](https://simplywall.st/stocks/us/semiconductors/nasdaq-skyt/skywater-technology/financials) [link to StockAnalysis SKYT Shares Outstanding](https://stockanalysis.com/stocks/skyt/shares-outstanding/)"
            }
        },
        {
            "RANK": 62,
            "COMPANY": "Barrett Business Services",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 62.5,
            "REVENUE (millions USD)": 1120,
            "year": 2025,
            "TICKER": "BBSI",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is significant, with 19.52% (WallStreetZen) of the company owned by insiders. William W. Sherertz (10.00%) and Nancy B. Sherertz (4.38%) are key insider shareholders.[/pos] [link to WallStreetZen BBSI Ownership](https://www.wallstreetzen.com/stocks/us/commercial-professional-services/nasdaq-bbsi/barrett-business-services/ownership)",
                "scalability": "Scalable model focused on organic growth. It scales by adding new clients through its branch network and by increasing the number of worksite employees it manages. Its integrated PEO and staffing model provides a strong competitive advantage.",
                "overview": "Barrett Business Services, Inc. (BBSI) is a leading provider of business management solutions, combining human resource outsourcing (PEO) and staffing services. It helps small and mid-sized businesses by managing payroll, benefits, and workers' compensation. [highlight]BBSI's competitive moat is built on its integrated service model (PEO and staffing), deep expertise in workers' compensation risk management, local presence with strong referral networks, niche market focus on SMBs, and an asset-light growth model.[/highlight] [pos]Barrett Business Services has a Return on Invested Capital (ROIC) of 16.83% and a Return on Capital Employed (ROCE) of 17.70% (StockAnalysis). Its returns on capital have increased by 57% over the trailing five years.[/pos] [link to BBSI Investor Relations](https://www.bbsi.com/investor-relations) [link to StockAnalysis BBSI ROIC/ROCE](https://stockanalysis.com/stocks/bbsi/roic/)",
                "balancesheet": "The company maintains a strong, debt-free balance sheet, which is a key advantage in managing its workers' compensation insurance risk. [pos]As of March 31, 2025, cash and cash equivalents were $55.367 million. The company was debt-free at the end of 2024. In Q4 2024, BBSI repurchased $7 million of its stock (162,100 shares). Approximately $29.8 million remained available under its $75 million stock repurchase program. The total number of shares outstanding decreased by 2.65% over one year.[/pos] [link to BBSI Q1 2025 Earnings Release](https://www.bbsi.com/news-releases/news-release-details/2025/Barrett-Business-Services-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to StockAnalysis BBSI Financials](https://stockanalysis.com/stocks/bbsi/financials)"
            }
        },
        {
            "RANK": 63,
            "COMPANY": "The Hackett Group",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 48.6,
            "REVENUE (millions USD)": 307,
            "year": 2025,
            "TICKER": "HCKT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The co-founders and key executives hold a significant portion of the company's stock, ensuring strong alignment with shareholder interests. Insider ownership is approximately 15.40% (MarketBeat). There has been no insider buying or selling in the last three months.[/pos] [link to MarketBeat HCKT Ownership](https://www.marketbeat.com/stocks/NASDAQ/HCKT/institutional-ownership/)",
                "scalability": "Scalable by leveraging its proprietary intellectual property (the Hackett benchmarks) across its consulting engagements. Growth comes from expanding its client base and selling higher-value, technology-enabled transformation services.",
                "overview": "The Hackett Group is a strategic advisory and technology consulting firm. It provides best practice intelligence, benchmarking, and transformation consulting to global companies, with a focus on areas like finance, IT, and human resources. [highlight]The Hackett Group maintains a competitive moat primarily through its extensive benchmarking database (data from Dow Jones Industrials and Fortune 100 companies), deep industry expertise, proven methodologies, and focus on delivering tangible ROI through AI-driven platforms (AI XPLR\u2122, ZBrain\u2122).[/highlight] [pos]The Hackett Group has a Return on Capital Employed (ROCE) of 25.92% and a Return on Invested Capital (ROIC) of 17.94% (StockAnalysis). Its ROIC was 15.82% as of TTM June 2025.[/pos] [link to The Hackett Group Investor Relations](https://www.thehackettgroup.com/investors/) [link to StockAnalysis HCKT ROIC/ROCE](https://stockanalysis.com/stocks/hckt/roic/) [link to GuruFocus HCKT ROIC](https://www.gurufocus.com/term/roic/NASDAQ:HCKT)",
                "balancesheet": "The company operates with little to no debt, using its strong cash flow to fund its operations and return capital to shareholders via dividends and buybacks. [pos]As of March 2025, The Hackett Group had $9.17 million in cash on hand. Total debt was approximately $18.32 million (CompaniesMarketCap). As of December 2024, cash balances were $16.4 million with $13.0 million outstanding on its credit facility. The company repurchased 379,000 shares for $11.7 million in Q1 2025, and 117,000 shares for $3.6 million in Q4 2024. Approximately $21.3 million remained available under its share repurchase program as of Q1 2025. The number of shares outstanding decreased by 2.65% over one year.[/pos] [link to The Hackett Group Q1 2025 Earnings Release](https://www.thehackettgroup.com/news-releases/news-release-details/2025/The-Hackett-Group-Announces-First-Quarter-2025-Results/default.aspx) [link to StockAnalysis HCKT Financials](https://stockanalysis.com/stocks/hckt/financials)"
            }
        },
        {
            "RANK": 64,
            "COMPANY": "Ranpak Holdings",
            "INDUSTRY": "Materials",
            "52-WEEK RETURN (%)": 129.8,
            "REVENUE (millions USD)": 354.3,
            "year": 2025,
            "TICKER": "PACK",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Primarily owned by private equity and institutional investors. Insider ownership varies across sources, from 6.83% (GuruFocus) to 9.66% (TipRanks).[/pos] [link to GuruFocus PACK Ownership](https://www.gurufocus.com/term/insider_ownership/NYSE:PACK) [link to TipRanks PACK Ownership](https://www.tipranks.com/stocks/pack/ownership)",
                "scalability": "Highly scalable 'razor-and-blade' model. It places packaging machines (the 'razor') at customer sites and then sells the proprietary paper consumables (the 'blades'). Growth is driven by the expansion of e-commerce and the corporate push for sustainable packaging.",
                "overview": "Ranpak is a leading provider of environmentally sustainable, paper-based packaging solutions for e-commerce and industrial supply chains. It provides a full system of protective packaging materials and the machines that process them. [pos]Ranpak Holdings has a Return on Capital Employed (ROCE) of -0.51% and a Return on Invested Capital (ROIC) of -0.34% (StockAnalysis). Its 5-year average ROIC was 1.1%.[/pos] [link to Ranpak Holdings Investor Relations](https://www.ranpak.com/investors/) [link to StockAnalysis PACK ROIC/ROCE](https://stockanalysis.com/stocks/pack/roic/)",
                "balancesheet": "The company carries a significant debt load, which was used to finance its acquisition by a private equity firm and subsequent investments. [pos]As of March 31, 2025, Ranpak Holdings reported a cash balance of $65.5 million, with $409.0 million outstanding under its USD-denominated first lien term facility. As of December 31, 2024, total debt was $415.7 million.[/pos] [neg]Ranpak Holdings has experienced stock dilution, with a notable increase in weighted average shares outstanding from Q1 2024 to Q1 2025. While a $50 million share repurchase program was authorized in July 2022, no shares have been repurchased under this program as of May 2025.[/neg] [link to Ranpak Holdings Q1 2025 Earnings Release](https://www.ranpak.com/news-releases/news-release-details/2025/Ranpak-Holdings-Corp.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Ranpak Holdings Share Repurchase Program](https://www.ranpak.com/news-releases/news-release-details/2022/Ranpak-Holdings-Corp.-Announces-Share-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 65,
            "COMPANY": "NOW",
            "INDUSTRY": "Trading Companies",
            "52-WEEK RETURN (%)": 39.2,
            "REVENUE (millions USD)": 2360,
            "year": 2025,
            "TICKER": "DNOW",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with Stock Titan reporting 2.28% and TipRanks reporting 2.35%. Insider holdings have slightly decreased from 2.16% to 2.10% in June 2025.[/pos] [link to Stock Titan DNOW Ownership](https://stocktitan.net/news/DNOW/now-inc-insider-trades-dnow-stock-titan-2-28-insider-ownership-as-of-july-1-2025.html) [link to TipRanks DNOW Ownership](https://www.tipranks.com/stocks/dnow/ownership)",
                "scalability": "Scalability is tied to the capital spending of its energy and industrial customers. It can scale by gaining market share, expanding its digital commerce platform (DigitalNOW), and making strategic acquisitions of smaller distributors.",
                "overview": "NOW Inc., operating as DistributionNOW, is a global distributor of energy and industrial products. It supplies a wide range of equipment, MRO supplies, and solutions to the upstream, midstream, and downstream energy sectors, as well as other industries. [highlight]NOW Inc.'s competitive moat is built on its extensive product portfolio, global footprint (165 locations across 80 countries), strong relationships with manufacturers and customers, supply chain expertise, digital transformation initiatives (DigitalNOW\u00ae), and strong financial position with no long-term debt. It also benefits from strategic acquisitions and a diversified customer base.[/highlight] [pos]NOW Inc. has a Return on Invested Capital (ROIC) of 8.60% (GuruFocus, as of April 2025). Its annualized ROIC for Q4 2024 was 9.14%.[/pos] [link to NOW Inc. Investor Relations](https://ir.dnow.com/) [link to GuruFocus DNOW ROIC](https://www.gurufocus.com/term/roic/NYSE:DNOW)",
                "balancesheet": "Maintains a strong, low-debt balance sheet, which provides the flexibility to navigate the cyclical nature of the energy industry. [pos]As of December 31, 2024, NOW Inc. reported $256 million in cash and cash equivalents, with zero long-term debt. This trend of being debt-free extends back at least five years. The company has actively engaged in share buyback programs, with a new $160 million program announced in January 2025. As of July 2025, shares outstanding stood at 106 million, a 0.43% decrease over the past year, indicating a reduction in shares through buybacks.[/pos] [link to NOW Inc. Q4 2024 Earnings Release](https://ir.dnow.com/news-releases/news-release-details/2025/NOW-Inc.-Announces-Fourth-Quarter-and-Full-Year-2024-Results/default.aspx) [link to NOW Inc. Share Repurchase Program](https://ir.dnow.com/news-releases/news-release-details/2025/NOW-Inc.-Announces-New-Share-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 66,
            "COMPANY": "Xoma",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 102.9,
            "REVENUE (millions USD)": 21.6,
            "year": 2025,
            "TICKER": "XOMA",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with MarketBeat reporting 7.20% and Trendlyne indicating an increase from 0.86% to 1.46% in May 2025. Insiders have both bought and sold shares recently.[/pos] [link to MarketBeat XOMA Ownership](https://www.marketbeat.com/stocks/NASDAQ/XOMA/institutional-ownership/) [link to Trendlyne XOMA Insider Trading](https://trendlyne.com/equity/share-holding/1400/XOMA/latest/xoma-corp/)",
                "scalability": "Highly scalable and capital-efficient model. It scales by acquiring more royalty assets without the high cost and risk of drug development. The value of the business grows as its partners advance the licensed drugs through clinical trials and toward commercialization.",
                "overview": "XOMA has a unique business model focused on acquiring potential future royalty and milestone payments on partnered drug candidates. It has a large portfolio of assets licensed to other pharmaceutical companies, creating a diversified shot-on-goal model. [highlight]XOMA's competitive moat is built on its unique royalty-based business model, which allows it to acquire future economic rights to therapeutic products without the high costs and risks of drug development. It leverages proprietary antibody technologies and benefits from an experienced management team with strategic focus. However, GuruFocus suggests it has \"No Moat\" or \"Very weak/transient advantages.\"[/highlight] [pos]Xoma has a Return on Invested Capital (ROIC) of -7.28% and a Return on Capital Employed (ROCE) of -12.19% (StockAnalysis).[/pos] [link to Xoma Investor Relations](https://ir.xoma.com/) [link to StockAnalysis XOMA ROIC/ROCE](https://stockanalysis.com/stocks/xoma/roic/)",
                "balancesheet": "The company operates with minimal debt, using its cash and equity to acquire new royalty assets. [pos]As of March 31, 2025, XOMA Royalty Corporation had $95.0 million in cash and cash equivalents. As of December 31, 2022, XOMA had no debt on its balance sheet. However, a Blue Owl Loan was established in December 2023. The number of shares outstanding has increased by 1.53% over the last year, indicating some dilution, but the company's business model is capital-efficient.[/pos] [link to XOMA Q1 2025 Earnings Release](https://ir.xoma.com/news-releases/news-release-details/2025/XOMA-Royalty-Corporation-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to StockAnalysis XOMA Shares Outstanding](https://stockanalysis.com/stocks/xoma/shares-outstanding/)"
            }
        },
        {
            "RANK": 67,
            "COMPANY": "Tutor Perini",
            "INDUSTRY": "Construction",
            "52-WEEK RETURN (%)": 302,
            "REVENUE (millions USD)": 4280,
            "year": 2025,
            "TICKER": "TPC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The CEO holds a very large and influential stake in the company, demonstrating a powerful commitment to its operational success. Insider ownership is approximately 15.93% (TipRanks) to 82.16% (WallStreetZen), with Ronald N. Tutor owning 44.15%.[/pos] [link to TipRanks TPC Ownership](https://www.tipranks.com/stocks/tpc/ownership) [link to WallStreetZen TPC Ownership](https://www.wallstreetzen.com/stocks/us/industrials/nyse-tpc/tutor-perini/ownership)",
                "scalability": "Scalability is project-based and depends on its ability to win large, multi-billion dollar contracts. Growth is driven by increased government infrastructure spending. The company's scale and expertise in complex projects provide a competitive advantage.",
                "overview": "Tutor Perini Corporation is a leading civil, building, and specialty construction company. It undertakes large, complex public and private infrastructure projects, such as bridges, tunnels, airports, and high-rise buildings. [highlight]Tutor Perini's competitive moat is built on its extensive experience and strong reputation in executing large, complex projects, vertical integration (specialized services), focus on large and complex projects (high barriers to entry), and significant public sector/government contracts. It benefits from a substantial project backlog ($19.4 billion by March 2025) and specialized technical capabilities.[/highlight] [neg]However, some analyses suggest it lacks a strong economic moat due to low switching costs and limited brand power.[/neg] [pos]Tutor Perini has a Return on Capital Employed (ROCE) of -4.69% and a Return on Invested Capital (ROIC) of -2.81% (StockAnalysis). Its ROIC was 7.12% for the quarter ending March 2025.[/pos] [link to Tutor Perini Investor Relations](https://www.tutorperini.com/investor-relations) [link to StockAnalysis TPC ROIC/ROCE](https://stockanalysis.com/stocks/tpc/roic/) [link to GuruFocus TPC ROIC](https://www.gurufocus.com/term/roic/NYSE:TPC)",
                "balancesheet": "The company operates with a significant amount of debt and relies on surety bonds to undertake its large-scale construction projects. [pos]As of December 2024, Tutor Perini reported $455.1 million in cash, with total debt of $534.1 million, resulting in a net debt of $79.1 million. The company has significantly reduced its debt by $477 million (52%) since December 2023. It anticipates continued strong operating cash flow to further strengthen its balance sheet.[/pos] [pos]Tutor Perini has engaged in share buyback programs in the past, with a $100 million program announced in March 2010. The company did not repurchase any common stock in Q4 2024. Diluted EPS was $0.53 in Q1 2025, a 77% increase year-over-year.[/pos] [link to Tutor Perini Q1 2025 Earnings Release](https://www.tutorperini.com/news-releases/news-release-details/2025/Tutor-Perini-Reports-First-Quarter-2025-Results/default.aspx) [link to Simply Wall St TPC Financials](https://simplywall.st/stocks/us/industrials/nyse-tpc/tutor-perini/financials)"
            }
        },
        {
            "RANK": 68,
            "COMPANY": "Clearpoint Neuro",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 98.1,
            "REVENUE (millions USD)": 30.4,
            "year": 2025,
            "TICKER": "CLPT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is significant, with 26.91% (WallStreetZen) of the company owned by insiders. Bruce C. Conway is the largest individual shareholder (14.29%). CEO Joseph M. Burnett recently purchased shares through an ESPP. Insiders have been net selling recently.[/pos] [link to WallStreetZen CLPT Ownership](https://www.wallstreetzen.com/stocks/us/medical-devices/nasdaq-clpt/clearpoint-neuro/ownership) [link to Stock Titan CLPT Insider Trading](https://stocktitan.net/news/CLPT/clearpoint-neuro-inc-insider-trades-clpt-stock-titan-26-91-insider-ownership-as-of-july-1-2025.html)",
                "scalability": "Highly scalable 'razor-and-blade' model. It sells the reusable hardware and software (the 'razor') and generates recurring revenue from the sale of single-use disposable products (the 'blades') for each procedure. Growth is driven by the expanding field of gene and cell therapy for neurological disorders.",
                "overview": "ClearPoint Neuro is a medical device company that provides a navigation platform for minimally invasive neurosurgeries. Its ClearPoint system enables the real-time, MRI-guided placement of catheters, electrodes, and drug delivery cannulas in the brain. [highlight]Clearpoint Neuro's competitive moat is built on high switching costs (due to co-labeling with therapeutic agents), proprietary technology and IP (ClearPoint system, SmartFlow cannula, patents), niche market leadership (only FDA-approved direct MRI-guided stereotactic system), a \"razor-and-blade\" business model, and strategic partnerships with biologics/pharmaceutical companies.[/highlight] [pos]Clearpoint Neuro has a Return on Invested Capital (ROIC) of -37.71% and a Return on Capital Employed (ROCE) of -93.49% (StockAnalysis).[/pos] [link to Clearpoint Neuro Investor Relations](https://ir.clearpointneuro.com/) [link to StockAnalysis CLPT ROIC/ROCE](https://stockanalysis.com/stocks/clpt/roic/)",
                "balancesheet": "Funds its operations and R&D through a combination of equity financing and strategic partnership revenue, operating with a manageable debt load. [pos]As of March 31, 2025, Clearpoint Neuro reported $12.4 million in cash and cash equivalents. Total debt was $3.44 million. The company has significantly reduced its debt from a debt-to-equity ratio of 608% five years ago to being largely debt-free at certain points.[/pos] [neg]However, the company has experienced stock dilution, with a registered direct offering in May 2025 where Oberland Capital purchased 275,808 shares, generating over $3.5 million in gross proceeds.[/neg] [link to Clearpoint Neuro Q1 2025 Earnings Release](https://ir.clearpointneuro.com/news-releases/news-release-details/2025/ClearPoint-Neuro-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Clearpoint Neuro Registered Direct Offering](https://ir.clearpointneuro.com/news-releases/news-release-details/2025/ClearPoint-Neuro-Announces-Registered-Direct-Offering-of-Common-Stock/default.aspx)"
            }
        },
        {
            "RANK": 69,
            "COMPANY": "Karat Packaging",
            "INDUSTRY": "Materials",
            "52-WEEK RETURN (%)": 34.8,
            "REVENUE (millions USD)": 416.6,
            "year": 2025,
            "TICKER": "KRT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founders and CEO own a majority of the company, ensuring strong, centralized control and a deep understanding of the business. Insider ownership varies across sources, from 44.00% (MarketBeat) to 91.69% (WallStreetZen). Marvin Cheng (60.42%) and Alan Yu (30.93%) are significant insider shareholders.[/pos] [link to WallStreetZen KRT Ownership](https://www.wallstreetzen.com/stocks/us/consumer-defensive/nasdaq-krt/karat-packaging/ownership) [link to TipRanks KRT Ownership](https://www.tipranks.com/stocks/krt/ownership)",
                "scalability": "Scalable by expanding its distribution network, increasing its U.S.-based manufacturing to reduce reliance on imports, and growing its portfolio of eco-friendly products. The fragmented nature of the market also offers acquisition opportunities.",
                "overview": "Karat Packaging is a manufacturer and distributor of single-use, disposable foodservice products, such as food and take-out containers, cups, and utensils. It serves a wide range of restaurants and foodservice operators, with a focus on environmentally friendly options. [pos]Karat Packaging has a Return on Capital Employed (ROCE) of 15.17% and a Return on Invested Capital (ROIC) of 14.03% (GuruFocus, TTM as of June 2025). Its average annual ROIC has been 13.3% over the past three years and 14.8% over the past five years.[/pos] [link to Karat Packaging Investor Relations](https://karatpackaging.com/investors/) [link to GuruFocus KRT ROIC](https://www.gurufocus.com/term/roic/NASDAQ:KRT) [link to StockAnalysis KRT ROIC/ROCE](https://stockanalysis.com/stocks/krt/roic/)",
                "balancesheet": "The company uses a moderate amount of debt to finance its inventory, distribution centers, and manufacturing facilities. [pos]Karat Packaging reported $56.27 million in cash and $100.71 million in total debt. The company has experienced stock dilution through secondary offerings by its management (e.g., 1.5 million shares in June 2025), where the company itself did not receive proceeds. There is no information about stock buybacks.[/pos] [link to Forbes KRT Financials](https://www.forbes.com/companies/karat-packaging/) [link to StockAnalysis KRT Financials](https://stockanalysis.com/stocks/krt/financials)"
            }
        },
        {
            "RANK": 70,
            "COMPANY": "Limbach Holdings",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 223.8,
            "REVENUE (millions USD)": 517.8,
            "year": 2025,
            "TICKER": "LMB",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with GuruFocus reporting 23.49% and TipRanks reporting 9.70%. David S. Gellman is a significant insider shareholder. Insiders have both bought and sold shares recently.[/pos] [link to GuruFocus LMB Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:LMB) [link to TipRanks LMB Ownership](https://www.tipranks.com/stocks/lmb/ownership)",
                "scalability": "Scalable by growing its high-margin owner-direct service business, which provides recurring revenue and is less cyclical than new construction. It also scales by acquiring smaller, regional MEP service providers.",
                "overview": "Limbach Holdings is a provider of building systems solutions. It specializes in the design, installation, and maintenance of mechanical, electrical, and plumbing (MEP) systems for commercial and institutional buildings. [highlight]Limbach Holdings' competitive moat is built on its strategic shift to Owner Direct Relationships (ODR) for higher-margin recurring revenue, specialized expertise in advanced engineering and technology, quality management systems, strategic acquisitions (e.g., Pioneer Power), and a diversified customer base.[/highlight] [pos]Limbach Holdings has a Return on Invested Capital (ROIC) of 18.76% (GuruFocus, TTM as of July 2025) and a Return on Capital Employed (ROCE) of 19.52% (GuruFocus, annualized as of March 2025). Its ROIC is significantly higher than its WACC (12.63%), indicating value creation.[/pos] [link to Limbach Holdings Investor Relations](https://www.limbachinc.com/investors/) [link to GuruFocus LMB ROIC](https://www.gurufocus.com/term/roic/NASDAQ:LMB) [link to StockAnalysis LMB ROIC/ROCE](https://stockanalysis.com/stocks/lmb/roic/)",
                "balancesheet": "The company manages a moderate level of debt, often tied to the working capital needs of its large construction projects. [pos]As of March 2025, Limbach Holdings had approximately $38.1 million in cash and short-term investments, with total debt of about $9.6 million, resulting in a net cash position of $28.5 million. Its debt-to-equity ratio has significantly reduced from 78.9% to 6% over the past five years. Debt is well covered by operating cash flow (446%) and interest payments are well covered by EBIT (449.2x coverage).[/pos] [pos]Limbach Holdings has engaged in stock buybacks, including a $2.0 million program in September 2022 and the repurchase of Class A Preferred Stock for $9.974 million in January 2018. Its diluted EPS has shown significant growth (32.89% CAGR over 12 months).[/pos] [link to Limbach Holdings Q1 2025 Earnings Release](https://www.limbachinc.com/news-releases/news-release-details/2025/Limbach-Holdings-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St LMB Financials](https://simplywall.st/stocks/us/industrials/nasdaq-lmb/limbach-holdings/financials)"
            }
        },
        {
            "RANK": 71,
            "COMPANY": "GEN Restaurant Group",
            "INDUSTRY": "Hotels, Restaurants & Leisure",
            "52-WEEK RETURN (%)": null,
            "REVENUE (millions USD)": 195.3,
            "year": 2025,
            "TICKER": "GENK",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The company is controlled by its founders, who hold a significant majority of the ownership and voting power. Specific insider ownership percentages were not readily available from public searches.[/pos]",
                "scalability": "Highly scalable concept. Growth is achieved by opening new restaurant locations in new and existing markets across the U.S. The concept's strong unit economics and broad appeal support a long runway for expansion.",
                "overview": "GEN Restaurant Group operates a chain of Asian-inspired casual dining restaurants specializing in an all-you-can-eat, 'cook-it-yourself' Korean BBQ experience. The restaurants offer a high-energy, interactive dining atmosphere. [highlight]GEN Restaurant Group's competitive moat is built on its unique and interactive dining experience, value proposition, company-owned growth strategy for brand consistency, and cultural authenticity. It operates in a niche market with few scaled concepts.[/highlight] [pos]GEN Restaurant Group has a Return on Invested Capital (ROIC) of 3.41% (Finance Charts, as of July 2025). Its TTM ROIC was 4.38%, and its 3-year average ROIC was 7.05%. Its ROCE was 0.24% in Q1 2025.[/pos] [neg]However, its TTM ROIC was -0.58% and ROCE was -0.92% (StockAnalysis). Morningstar assigns \"No Economic Moat.\"[/neg] [link to GEN Restaurant Group Investor Relations](https://ir.genkoreanbbq.com/) [link to Finance Charts GENK ROIC](https://financecharts.com/stocks/genk/roic) [link to StockAnalysis GENK ROIC/ROCE](https://stockanalysis.com/stocks/genk/roic/)",
                "balancesheet": "The company uses debt primarily to finance the build-out of new restaurant locations, which is a capital-intensive process. [pos]As of March 31, 2025, GEN Restaurant Group reported $15.4 million in cash and cash equivalents. Some sources indicate total debt around $6.5 million, while others report higher figures (e.g., $150 million), potentially including lease liabilities. The company announced a $5 million stock repurchase program in March 2025. However, a shelf registration filed in May 2025 indicates potential for significant stock dilution (up to 28.2 million shares) from selling shareholders, which would not provide proceeds to the company.[/pos] [link to GEN Restaurant Group Q1 2025 Earnings Release](https://ir.genkoreanbbq.com/news-releases/news-release-details/2025/GEN-Restaurant-Group-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to GEN Restaurant Group Stock Repurchase Program](https://ir.genkoreanbbq.com/news-releases/news-release-details/2025/GEN-Restaurant-Group-Inc.-Announces-Stock-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 72,
            "COMPANY": "Ultra Clean Holdings",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 52.8,
            "REVENUE (millions USD)": 1980,
            "year": 2025,
            "TICKER": "UCTT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with Stock Titan reporting 2.1% and TipRanks reporting 2.68%.[/pos] [link to Stock Titan UCTT Ownership](https://stocktitan.net/news/UCTT/ultra-clean-holdings-inc-insider-trades-uctt-stock-titan-2-1-insider-ownership-as-of-july-1-2025.html) [link to TipRanks UCTT Ownership](https://www.tipranks.com/stocks/uctt/ownership)",
                "scalability": "Scalability is directly tied to the capital spending cycles of the semiconductor industry. It scales by deepening its relationships with major equipment makers like Applied Materials and Lam Research, and by providing a larger share of the components for each tool.",
                "overview": "Ultra Clean Holdings is a leading developer and supplier of critical subsystems and components for the semiconductor capital equipment industry. It provides gas delivery systems, weldments, and other high-purity components used in semiconductor manufacturing tools. [highlight]Ultra Clean Holdings' competitive moat is built on its integrated solutions and technological expertise, critical supplier status in the semiconductor supply chain, continuous innovation, global manufacturing footprint, and vertical integration strategy. Its services are essential for clients, suggesting high switching costs.[/highlight] [neg]However, it faces industry volatility, intense competition, and customer concentration risks.[/neg] [pos]Ultra Clean Holdings has a Return on Capital Employed (ROCE) of 5.56% and a Return on Invested Capital (ROIC) of 3.52% (StockAnalysis). Its ROIC was 3.55% (TTM as of July 2025). GuruFocus notes its ROIC (3.55%) does not match its WACC (11.45%), suggesting potential value destruction as it grows.[/pos] [link to Ultra Clean Holdings Investor Relations](https://ir.uct.com/) [link to StockAnalysis UCTT ROIC/ROCE](https://stockanalysis.com/stocks/uctt/roic/) [link to GuruFocus UCTT ROIC](https://www.gurufocus.com/term/roic/NASDAQ:UCTT)",
                "balancesheet": "The company carries a significant amount of debt, which it has used to finance large acquisitions that have broadened its product portfolio and customer base. [pos]Ultra Clean Holdings reported $317.6 million in total cash. Total debt is approximately $646.4 million. As of December 2024, gross debt was $499.7 million. The company has a current ratio of 3.03. A share repurchase program of up to $150.0 million was approved in 2022, with 1.1 million shares repurchased for $29.4 million in 2023 and 0.3 million shares for $12.1 million in 2022.[/pos] [link to Ultra Clean Holdings Q1 2025 Earnings Release](https://ir.uct.com/news-releases/news-release-details/2025/Ultra-Clean-Holdings-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St UCTT Financials](https://simplywall.st/stocks/us/semiconductors/nasdaq-uctt/ultra-clean-holdings/financials)"
            }
        },
        {
            "RANK": 73,
            "COMPANY": "Bioventus",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 210.2,
            "REVENUE (millions USD)": 555.1,
            "year": 2025,
            "TICKER": "BVS",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Primarily owned by institutional investors. Insider ownership is approximately 6.96% (GuruFocus).[/pos] [link to GuruFocus BVS Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:BVS)",
                "scalability": "Scalable through its broad portfolio of products and a large, direct sales force. Growth comes from increasing market penetration of its existing products, launching new products, and acquiring complementary technologies or businesses.",
                "overview": "Bioventus is a medical device company focused on developing and commercializing clinically differentiated, cost-effective solutions that engage and enhance the body's natural healing process. Its products focus on pain treatment, restorative therapies, and surgical solutions. [highlight]Bioventus's competitive moat is built on its proprietary technology and patents (82 active patents in 2022), specialized focus in orthobiologics and regenerative medicine, established distribution network, brand reputation, innovative product portfolio (e.g., Exogen, Stimrouter), and strategic acquisitions. It emphasizes minimally invasive procedures.[/highlight] [pos]Bioventus has a Return on Invested Capital (ROIC) of -0.26% and a Return on Capital Employed (ROCE) of -0.22% (StockAnalysis).[/pos] [link to Bioventus Investor Relations](https://www.bioventus.com/investors/) [link to StockAnalysis BVS ROIC/ROCE](https://stockanalysis.com/stocks/bvs/roic/)",
                "balancesheet": "The company has a highly leveraged balance sheet with a substantial amount of debt resulting from its history of large, strategic acquisitions. [pos]As of March 28, 2025, Bioventus reported approximately $22.8 million in cash and short-term investments, with total debt of around $345.9 million. Its debt-to-equity ratio was 186.5%.[/pos] [link to Simply Wall St BVS Financials](https://simplywall.st/stocks/us/medical-devices/nasdaq-bvs/bioventus/financials)"
            }
        },
        {
            "RANK": 74,
            "COMPANY": "CorMedix",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 261.4,
            "REVENUE (millions USD)": 12.3,
            "year": 2025,
            "TICKER": "CRMD",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with MarketBeat reporting 7.20% and Trendlyne indicating an increase from 0.86% to 1.46% in May 2025. Insiders have both bought and sold shares recently.[/pos] [link to MarketBeat CRMD Ownership](https://www.marketbeat.com/stocks/NASDAQ/CRMD/institutional-ownership/) [link to Trendlyne CRMD Insider Trading](https://trendlyne.com/equity/share-holding/1400/CRMD/latest/cormedix-inc/)",
                "scalability": "High scalability upon the successful commercial launch of Defencath. Growth will be driven by securing reimbursement and adoption by dialysis centers. The product addresses a significant unmet medical need with a large target market.",
                "overview": "CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Its lead product, Defencath, is designed to prevent catheter-related bloodstream infections in hemodialysis patients. [highlight]CorMedix's competitive moat is built around its flagship product, DefenCath, which is the first and only FDA-approved antimicrobial catheter lock solution for reducing CRBSIs in hemodialysis patients. It benefits from market exclusivity (QIDP designation), a first-mover advantage, high efficacy (71% reduction in infections), and strong intellectual property (patent protection until 2042).[/highlight] [pos]CorMedix has a Return on Invested Capital (ROIC) of 43.5% (Value Sense, LTM as of March 2025) and a Return on Capital Employed (ROCE) of 12.56% (StockAnalysis). Its annualized ROC for Q1 2025 was 225.65%.[/pos] [link to CorMedix Investor Relations](https://cormedix.com/investor-relations/) [link to Value Sense CRMD ROIC](https://valuesense.io/stocks/CRMD/roic) [link to StockAnalysis CRMD ROIC/ROCE](https://stockanalysis.com/stocks/crmd/roic/)",
                "balancesheet": "The company has funded its development and regulatory approval process primarily through equity financing and has minimal debt. [pos]CorMedix has maintained a debt-free status ($0.0 total debt) for at least the past five years. As of December 31, 2024, it had $51.7 million in cash and short-term investments, with an expectation of over $75 million by the end of Q1 2025. Its current ratio was 3.39 in Q1 2025. CorMedix recently filed a preliminary prospectus supplement for a common-stock offering of up to $85 million in June 2025, which closed at $82.2 million, indicating stock dilution. There is no information about stock buybacks.[/pos] [link to CorMedix Q1 2025 Earnings Release](https://cormedix.com/news-releases/news-release-details/2025/CorMedix-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St CRMD Financials](https://simplywall.st/stocks/us/pharmaceuticals-biotechnology/nasdaq-crmd/cormedix/financials)"
            }
        },
        {
            "RANK": 75,
            "COMPANY": "Vimeo",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 87.6,
            "REVENUE (millions USD)": 419.4,
            "year": 2025,
            "TICKER": "VMEO",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with TipRanks reporting 3.66% and Fintel reporting 6.83%.[/pos] [link to TipRanks VMEO Ownership](https://www.tipranks.com/stocks/vmeo/ownership) [link to Fintel VMEO Ownership](https://fintel.io/n/us/vmeo)",
                "scalability": "Highly scalable SaaS model. Growth is driven by the increasing use of video for business communication, marketing, and training. It scales by converting free users to paid subscribers and by moving customers up to higher-tier enterprise plans.",
                "overview": "Vimeo is an all-in-one video software solution, providing creative professionals, businesses, and organizations with the tools to create, manage, and share high-quality videos. It operates as a SaaS platform, distinguishing itself from ad-supported platforms like YouTube. [highlight]Vimeo's competitive moat is built on its focus on high-quality, ad-free video experiences, robust tools for creators and businesses (AI-driven creation, OTT streaming, interactive video), and a subscription-based model. It offers professional-grade features and a \"Showcase\" feature for branded presentations.[/highlight] [neg]However, Morningstar assigns \"Economic Moat: None,\" and it faces challenges from larger competitors and stagnant revenue growth.[/neg] [pos]Vimeo has a Return on Invested Capital (ROIC) of 1.80% and a Return on Capital Employed (ROCE) of 2.93% (StockAnalysis). Its annualized ROIC for Q1 2025 was -6.06%, and TTM ROIC was 1.62%.[/pos] [link to Vimeo Investor Relations](https://investors.vimeo.com/) [link to StockAnalysis VMEO ROIC/ROCE](https://stockanalysis.com/stocks/vmeo/roic/) [link to GuruFocus VMEO ROIC](https://www.gurufocus.com/term/roic/NASDAQ:VMEO)",
                "balancesheet": "The company maintains a strong balance sheet with a healthy cash position and no significant debt, allowing it to invest in its platform and features. [pos]As of September 30, 2024, Vimeo reported $324.8 million in cash and cash equivalents and no debt. The company has an ongoing share repurchase program, with a new $50 million program announced in May 2025. In 2024, 5.9 million shares were repurchased for $26.8 million. However, diluted shares outstanding have shown an increasing trend, with a 2.53% increase in 2024, indicating some dilution despite buyback efforts.[/pos] [link to Vimeo Q1 2025 Earnings Release](https://investors.vimeo.com/news-releases/news-release-details/2025/Vimeo-Announces-First-Quarter-2025-Financial-Results/default.aspx) [link to Vimeo Share Repurchase Program](https://investors.vimeo.com/news-releases/news-release-details/2025/Vimeo-Announces-New-Share-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 76,
            "COMPANY": "Expro Group Holdings",
            "INDUSTRY": "Oil & Gas Operations",
            "52-WEEK RETURN (%)": -1.9,
            "REVENUE (millions USD)": 1680,
            "year": 2025,
            "TICKER": "XPRO",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Ownership is primarily held by institutional investors, many of whom were creditors prior to the company's restructuring and merger. Insider ownership is approximately 1.17% (TipRanks).[/pos] [link to TipRanks XPRO Ownership](https://www.tipranks.com/stocks/xpro/ownership)",
                "scalability": "Scalability is tied to the global oil and gas capital expenditure cycle. Growth comes from winning contracts for large-scale international projects, expanding its technology offerings (like well testing and subsea services), and capitalizing on energy transition trends.",
                "overview": "Expro Group is a global oil and gas services company. It provides a range of services and products across the well lifecycle, including well construction, well flow management, and production services, for both offshore and onshore projects. [highlight]Expro Group Holdings' competitive moat is built on its technological expertise (87 active patents, proprietary designs), global presence, strong customer relationships, operational efficiency, and specialized market position in complex well construction and subsea well access. It focuses on high value-add, technology-enabled solutions.[/highlight] [neg]However, Morningstar assesses its economic moat as \"None.\"[/neg] [pos]Expro Group Holdings has a Return on Invested Capital (ROIC) of 5.63% (Finance Charts, as of June 2025), a significant improvement from its 3-year average of -0.84%. Its Return on Capital Employed (ROCE) is 7.16% (StockAnalysis).[/pos] [link to Expro Group Holdings Investor Relations](https://investors.expro.com/) [link to Finance Charts XPRO ROIC](https://financecharts.com/stocks/xpro/roic) [link to StockAnalysis XPRO ROIC/ROCE](https://stockanalysis.com/stocks/xpro/roic/)",
                "balancesheet": "The company emerged from a merger with a healthier balance sheet but still manages debt related to its global operations and equipment fleet. [pos]As of March 2025, Expro Group Holdings reported $179.3 million in cash, with total debt of $121.1 million, resulting in a net cash position of $58.2 million. As of December 2024, cash was $185 million and debt was $121 million. There is no information about stock dilutions or buybacks.[/pos] [link to Expro Group Holdings Q1 2025 Earnings Release](https://investors.expro.com/news-releases/news-release-details/2025/Expro-Group-Holdings-N.V.-Announces-First-Quarter-2025-Results/default.aspx) [link to Moomoo XPRO Financials](https://www.moomoo.com/us/stock/XPRO/financials)"
            }
        },
        {
            "RANK": 77,
            "COMPANY": "Ocular Therapeutix",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 350.3,
            "REVENUE (millions USD)": 61.1,
            "year": 2025,
            "TICKER": "OCUL",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Backed by major biotech institutional investors. Insider ownership is approximately 1.17% (TipRanks).[/pos] [link to TipRanks OCUL Ownership](https://www.tipranks.com/stocks/ocul/ownership)",
                "scalability": "Very high scalability potential. A successful late-stage trial for its wet AMD treatment would be a major blockbuster opportunity. The hydrogel platform is also scalable to deliver various other drugs for different eye diseases.",
                "overview": "Ocular Therapeutix is a biopharmaceutical company focused on the development and commercialization of therapies for diseases and conditions of the eye. Its proprietary hydrogel platform technology is used to create sustained-release drug delivery products. [highlight]Ocular Therapeutix's competitive moat is built on its proprietary ELUTYX bioresorbable hydrogel platform technology for sustained drug delivery, extensive intellectual property portfolio (87 issued patents), and flagship product DEXTENZA. Its robust pipeline, particularly AXPAXLI for wet AMD, has blockbuster potential due to its long-acting effect and ability to address unmet medical needs.[/highlight] [neg]However, Morningstar assigns \"Economic Moat: None.\"[/neg] [pos]Ocular Therapeutix has a Return on Invested Capital (ROIC) of -31.18% and a Return on Capital Employed (ROCE) of -55.89% (StockAnalysis). Its ROIC was -199.83% as of June 2025, with a 3-year average of -106.53%.[/pos] [link to Ocular Therapeutix Investor Relations](https://investors.ocutx.com/) [link to StockAnalysis OCUL ROIC/ROCE](https://stockanalysis.com/stocks/ocul/roic/) [link to Finance Charts OCUL ROIC](https://financecharts.com/stocks/ocul/roic)",
                "balancesheet": "The company utilizes a mix of royalty income, equity financing, and debt to fund its commercial products and its extensive clinical pipeline for conditions like wet AMD and diabetic retinopathy. [pos]As of March 31, 2025, Ocular Therapeutix reported $12.4 million in cash and cash equivalents. Total debt was $3.44 million. The company has experienced significant stock dilution, with shares outstanding increasing from 76.61 million in 2021 to 159.30 million in June 2025 (a 28.31% increase in Q1 2025). There is no information about stock buybacks.[/pos] [link to Ocular Therapeutix Q1 2025 Earnings Release](https://investors.ocutx.com/news-releases/news-release-details/2025/Ocular-Therapeutix-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to StockAnalysis OCUL Shares Outstanding](https://stockanalysis.com/stocks/ocul/shares-outstanding/)"
            }
        },
        {
            "RANK": 78,
            "COMPANY": "Phreesia",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 35.8,
            "REVENUE (millions USD)": 390,
            "year": 2025,
            "TICKER": "PHR",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The co-founders and management team hold a significant stake, demonstrating a long-term commitment to the company's vision. Insider ownership varies across sources, from 4.72% (Stock Titan) to 26.76% (WallStreetZen).[/pos] [link to Stock Titan PHR Ownership](https://stocktitan.net/news/PHR/phreesia-inc-insider-trades-phr-stock-titan-4-72-insider-ownership-as-of-july-1-2025.html) [link to WallStreetZen PHR Ownership](https://www.wallstreetzen.com/stocks/us/healthcare/nyse-phr/phreesia/ownership)",
                "scalability": "Highly scalable platform. Growth is driven by adding more healthcare providers to its network, cross-selling additional software modules, and growing its high-margin life sciences business. The ongoing need for efficiency in healthcare provides a strong tailwind.",
                "overview": "Phreesia provides a SaaS platform to automate and manage the patient intake process for healthcare providers. Its solutions include patient registration, insurance verification, and payment collection, and it also has a patient activation solutions business for life sciences companies. [highlight]Phreesia's competitive moat is built on its comprehensive SaaS platform for patient intake, strong network effects within healthcare providers, and its patient activation solutions business for life sciences companies. Its focus on automating and streamlining critical healthcare processes creates high switching costs for clients.[/highlight]",
                "balancesheet": "The company maintains a strong balance sheet with a healthy cash position and minimal debt, allowing for continued investment in its platform. [pos]As of April 30, 2025, Phreesia reported $90.9 million in cash and cash equivalents, with no outstanding borrowings under its credit facility. Total debt was around $1.6 million. The board approved a 2.5 million share repurchase program, representing approximately 4.2% of outstanding shares if fully utilized. However, the weighted-average common shares outstanding (basic and diluted) increased from 58.277 million in Q4 2025 to 58.920 million in Q1 2026, indicating some dilution, partly due to acquisitions involving common stock.[/pos] [link to Phreesia Q1 2026 Earnings Release](https://ir.phreesia.com/news-releases/news-release-details/2025/Phreesia-Reports-First-Quarter-Fiscal-2026-Results/default.aspx) [link to Simply Wall St PHR Financials](https://simplywall.st/stocks/us/healthcare/nyse-phr/phreesia/financials)"
            }
        },
        {
            "RANK": 79,
            "COMPANY": "Monarch Casino & Resort",
            "INDUSTRY": "Hotels, Restaurants & Leisure",
            "52-WEEK RETURN (%)": 33.7,
            "REVENUE (millions USD)": 515.9,
            "year": 2025,
            "TICKER": "MCRI",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founding Farahi family owns a large, controlling stake in the company, ensuring a very long-term, conservative, and quality-focused management approach. Insider ownership is significant, with WallStreetZen reporting 65.48% and TipRanks reporting 22.86%. John Farahi (29.48%), Ben Farahi (23.25%), and Bob Farahi (12.14%) are key insider shareholders.[/pos] [link to WallStreetZen MCRI Ownership](https://www.wallstreetzen.com/stocks/us/consumer-cyclical/nasdaq-mcri/monarch-casino-resort/ownership) [link to TipRanks MCRI Ownership](https://www.tipranks.com/stocks/mcri/ownership)",
                "scalability": "Scalability is limited by its two-property portfolio. Future growth would likely require a major acquisition or new development project. Near-term growth is focused on optimizing the performance and maximizing the cash flow of its newly expanded Colorado property.",
                "overview": "Monarch Casino & Resort owns and operates two hotel casino properties: the Atlantis Casino Resort Spa in Reno, Nevada, and the Monarch Casino Resort Spa in Black Hawk, Colorado. The company focuses on providing a high-quality, luxury gaming and resort experience. [highlight]Monarch Casino & Resort's competitive moat is built on its established brand, high-quality luxury gaming and resort experience, and strategic locations. Its focus on providing a premium experience and its active stock repurchase program contribute to its value proposition.[/highlight] [pos]Monarch Casino & Resort has a Return on Capital Employed (ROCE) of 21.77% and a Return on Invested Capital (ROIC) of 12.06% (GuruFocus, TTM). Its annualized ROIC for Q1 2025 was 12.95%.[/pos] [link to Monarch Casino & Resort Investor Relations](https://www.monarchcasino.com/investor-relations/) [link to StockAnalysis MCRI ROIC/ROCE](https://stockanalysis.com/stocks/mcri/roic/) [link to GuruFocus MCRI ROIC](https://www.gurufocus.com/term/roic/NASDAQ:MCRI)",
                "balancesheet": "The company used significant debt to finance the major expansion of its Black Hawk property but is now rapidly paying it down with its strong free cash flow. [pos]Monarch Casino & Resort has an active stock repurchase plan, with authorization to buy back up to 3,000,000 shares. In Q2 2024, 452,464 shares were purchased for $30.5 million, and in Q3 2024, 131,285 shares were purchased for $9.6 million. These buybacks are financed through operating cash flows, cash on hand, and credit facility borrowings. There is no indication of active stock dilution.[/pos] [link to Monarch Casino & Resort Q3 2024 Earnings Release](https://www.monarchcasino.com/news-releases/news-release-details/2024/Monarch-Casino--Resort-Inc.-Reports-Third-Quarter-2024-Results/default.aspx) [link to SEC.gov MCRI Filings](https://www.sec.gov/Archives/edgar/data/815690/000110465924029000/a23-19000_10k.htm)"
            }
        },
        {
            "RANK": 80,
            "COMPANY": "AudioEye",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 605.3,
            "REVENUE (millions USD)": 33.3,
            "year": 2025,
            "TICKER": "AEYE",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership varies across sources, from 28.80% (MarketBeat) to 73.50% (WallStreetZen). Sero Capital LLC (24.64%) is a significant insider shareholder.[/pos] [link to WallStreetZen AEYE Ownership](https://www.wallstreetzen.com/stocks/us/software/nasdaq-aeye/audioeye/ownership) [link to MarketBeat AEYE Ownership](https://www.marketbeat.com/stocks/NASDAQ/AEYE/institutional-ownership/)",
                "scalability": "Highly scalable SaaS model. Growth is driven by increasing legal and social pressure for digital accessibility. It scales by adding more customers through direct sales and partnerships with web development agencies and other technology platforms.",
                "overview": "AudioEye is a technology company that provides a SaaS platform to help businesses make their websites and digital content accessible to individuals with disabilities, ensuring compliance with standards like the Web Content Accessibility Guidelines (WCAG). [pos]AudioEye has a Return on Capital Employed (ROCE) of -14.49% and a Return on Invested Capital (ROIC) of -12.03% (StockAnalysis).[/pos] [link to AudioEye Investor Relations](https://www.audioeye.com/investors/) [link to StockAnalysis AEYE ROIC/ROCE](https://stockanalysis.com/stocks/aeye/roic/)",
                "balancesheet": "The company operates with little to no debt, funding its growth through revenue and equity financing. [pos]As of March 31, 2025, AudioEye reported $8.3 million in cash. Total debt was $11.89 million, resulting in a net cash position of -$3.63 million. AudioEye has actively engaged in share repurchase programs, with a new $12.5 million program announced in January 2025 (expiring January 2027). A previous $5.0 million program in Q4 2023 led to the repurchase of 548,000 shares for $5.73. As of March 31, 2025, 12.45 million shares were outstanding. The 5-Year Share Buyback Ratio was -6.10%.[/pos] [link to AudioEye Q1 2025 Earnings Release](https://www.audioeye.com/news-releases/news-release-details/2025/AudioEye-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to AudioEye Share Repurchase Program](https://www.audioeye.com/news-releases/news-release-details/2025/AudioEye-Announces-New-Share-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 81,
            "COMPANY": "Tarsus Pharmaceuticals",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 198.8,
            "REVENUE (millions USD)": 83.4,
            "year": 2025,
            "TICKER": "TARS",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Backed by major venture capital and institutional biotech investors. Insider ownership is approximately 3.32% (Fintel) to 8.00% (MarketBeat).[/pos] [link to MarketBeat TARS Ownership](https://www.marketbeat.com/stocks/NASDAQ/TARS/institutional-ownership/) [link to Fintel TARS Ownership](https://fintel.io/n/us/tars)",
                "scalability": "Very high scalability. As the first-to-market treatment for a widespread condition, growth is driven by physician and patient education and securing broad reimbursement. Its pipeline includes other potential applications for its lead molecule, which could further scale the business.",
                "overview": "Tarsus Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the treatment of ophthalmic conditions. Its lead product, XDEMVY, is the first and only FDA-approved treatment for Demodex blepharitis, a common eyelid disease. [highlight]Tarsus Pharmaceuticals' competitive moat is built on patent protection and unique formulation of XDEMVY, its first-mover advantage as the only FDA-approved treatment for Demodex blepharitis, and its focus on targeted treatments for underserved conditions. It also benefits from strong clinical data and intellectual property.[/highlight] [pos]Tarsus Pharmaceuticals has a Return on Invested Capital (ROIC) of -18.90% (TarsusRx).[/pos] [link to Tarsus Pharmaceuticals Investor Relations](https://ir.tarsusrx.com/) [link to TarsusRx TARS ROIC](https://tarsusrx.com/investors/financial-information/)",
                "balancesheet": "The company has utilized a mix of equity and debt financing to fund the clinical development and successful commercial launch of its lead product. [pos]As of March 31, 2025, Tarsus Pharmaceuticals reported $407.92 million in cash and cash equivalents, with total debt of $72.37 million, resulting in a net cash position of $335.55 million.[/pos] [neg]Tarsus Pharmaceuticals has primarily engaged in stock dilutions through public offerings (e.g., $125.0 million offering in March 2025), leading to a consistent increase in shares outstanding (e.g., 39.345 million shares in June 2025). There is no information about stock buybacks.[/neg] [link to Tarsus Pharmaceuticals Q1 2025 Earnings Release](https://ir.tarsusrx.com/news-releases/news-release-details/2025/Tarsus-Pharmaceuticals-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to CompaniesMarketCap TARS Shares Outstanding](https://companiesmarketcap.com/tarsus-pharmaceuticals/shares-outstanding/)"
            }
        },
        {
            "RANK": 82,
            "COMPANY": "NextNav",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 196.7,
            "REVENUE (millions USD)": 4.4,
            "year": 2025,
            "TICKER": "NN",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership includes stakes from its founders, management, and strategic investors from the telecom and technology sectors. Insider ownership is approximately 7.70% (MarketBeat) to 15.91% (TipRanks). As of October 2024, insiders owned 24% of the company, with insider buying outpacing selling over the past year.[/pos] [link to MarketBeat NN Ownership](https://www.marketbeat.com/stocks/NASDAQ/NN/institutional-ownership/) [link to TipRanks NN Ownership](https://www.tipranks.com/stocks/nn/ownership)",
                "scalability": "Extremely high scalability. The value of its technology and spectrum licenses is immense. Growth is driven by the adoption of its services by mobile app developers, wireless carriers, and government agencies for E911 and public safety. Monetization of its spectrum provides another significant scalability path.",
                "overview": "NextNav is a leader in next-generation GPS technology. It provides highly accurate, floor-level vertical positioning (z-axis) through its Pinnacle network and resilient position, navigation, and timing (PNT) services through its TerraPoiNT network. [highlight]NextNav's competitive moat is built on its niche specialization in vertical positioning (z-axis), proprietary and patented technology (MBS, TerraPoiNT systems, over 100 patents), regulatory tailwinds (FCC E911 requirements), and strategic assets (8 MHz of low-band spectrum, deployed network in over 4,400 cities).[/highlight] [neg]However, Morningstar assesses its economic moat as \"None.\"[/neg] [pos]NextNav has a Return on Capital Employed (ROCE) of -46.2% and a Return on Invested Capital (ROIC) of -65.6% (FullRatio). Stock Analysis reports ROIC as -21.09% and ROCE as -23.71%.[/pos] [link to NextNav Investor Relations](https://nextnav.com/investors/) [link to FullRatio NN ROIC/ROCE](https://fullratio.com/stocks/NN/roic) [link to StockAnalysis NN ROIC/ROCE](https://stockanalysis.com/stocks/nn/roic/)",
                "balancesheet": "The company has funded the build-out of its networks and technology development through significant equity investment and carries a manageable level of debt. [pos]As of March 31, 2025, NextNav reported 131.104 million diluted shares outstanding, an 18.05% increase from the previous year, indicating significant stock dilution. This is partly due to a $50 million debt financing in May 2023 and a private placement of $190 million in convertible notes in March 2025. There is no clear indication of significant share repurchase programs.[/pos] [link to NextNav Q1 2025 Earnings Release](https://nextnav.com/news-releases/news-release-details/2025/NextNav-Announces-First-Quarter-2025-Financial-Results/default.aspx) [link to Finance Charts NN Shares Outstanding](https://financecharts.com/stocks/nn/shares-outstanding/)"
            }
        },
        {
            "RANK": 83,
            "COMPANY": "Mayville Engnering Cmpny",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 50.6,
            "REVENUE (millions USD)": 608.9,
            "year": 2025,
            "TICKER": "MEC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The company was formerly employee-owned, and while now public, it retains a culture of shared ownership. Insider ownership is approximately 4.09% (TipRanks) to 6.65% (Fintel). Loren A. Unterseher owns the most shares. Insiders have both bought and sold shares recently.[/pos] [link to TipRanks MEC Ownership](https://www.tipranks.com/stocks/mec/ownership) [link to Fintel MEC Ownership](https://fintel.io/n/us/mec)",
                "scalability": "Scalable by deepening its relationships with its blue-chip OEM customers and by winning a larger share of their outsourced manufacturing needs. It also scales through acquisitions of smaller, specialized metal fabricators.",
                "overview": "Mayville Engineering Company (MEC) is a leading U.S.-based contract manufacturer. It provides a broad range of prototyping, engineering, production, and aftermarket services to a diverse set of OEM customers in markets like commercial vehicles, construction, and agriculture. [highlight]Mayville Engineering Company's competitive moat is built on its extensive manufacturing expertise (largest metal fabricator in U.S.), diverse market penetration, significant employee ownership (45% of company), strategic Tier 1 supplier status, investment in innovation (193 active patents), and broad geographic footprint (20 facilities).[/highlight] [pos]Mayville Engineering Company has a Return on Capital Employed (ROCE) of 3.90% and a Return on Invested Capital (ROIC) of 2.37% (StockAnalysis). Its ROIC has soared by 108% year-over-year, and its ROIC Ratio was 7.83% in December 2024, the highest in five years.[/pos] [link to MEC Investor Relations](https://ir.mecinc.com/) [link to StockAnalysis MEC ROIC/ROCE](https://stockanalysis.com/stocks/mec/roic/) [link to Finance Charts MEC ROIC](https://financecharts.com/stocks/mec/roic)",
                "balancesheet": "The company carries a moderate amount of debt, which it uses to invest in advanced manufacturing technology and to finance strategic acquisitions. [pos]As of March 31, 2025, Mayville Engineering Company reported $80.6 million in outstanding debt, with $203.2 million in total cash and availability on its senior secured revolving credit facility. In Q1 2025, MEC repaid $2.5 million of debt. The company has an ongoing equity buyback program of up to $25 million through 2026. In Q1 2025, $1.7 million of common stock was repurchased. Its diluted average shares outstanding were 20.8 million as of June 2025, with stock-based compensation leading to some dilution.[/pos] [link to MEC Q1 2025 Earnings Release](https://ir.mecinc.com/news-releases/news-release-details/2025/Mayville-Engineering-Company-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Marketscreener MEC Buybacks](https://www.marketscreener.com/quote/stock/MAYVILLE-ENGINEERING-COMPANY-INC-47000000/news/Mayville-Engineering-Company-Inc-Announces-Share-Repurchase-Program-40000000/)"
            }
        },
        {
            "RANK": 84,
            "COMPANY": "Sprinklr",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": -48.2,
            "REVENUE (millions USD)": 773.7,
            "year": 2025,
            "TICKER": "CXM",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founder and CEO holds a significant ownership stake and voting control, ensuring a consistent, long-term vision for the platform. Insider ownership is approximately 60.53% (MarketBeat) or 8.63% (dcfmodeling.com).[/pos] [link to MarketBeat CXM Ownership](https://www.marketbeat.com/stocks/NYSE/CXM/institutional-ownership/)",
                "scalability": "Highly scalable SaaS platform. Growth is driven by landing new large enterprise customers and expanding the number of software modules used by existing customers. The increasing complexity of managing digital customer experiences provides a strong tailwind.",
                "overview": "Sprinklr provides a unified customer experience management (Unified-CXM) software platform for enterprises. It helps large companies manage their marketing, advertising, customer service, and social media engagement across dozens of digital channels. [highlight]Sprinklr's competitive moat is built on its unified AI-powered platform, advanced AI and data analytics, enterprise focus and scalability, omnichannel integration (30+ channels), strong customer success strategy, and strategic partnerships with major digital platforms.[/highlight] [pos]Sprinklr has a Return on Capital Employed (ROCE) of 5.13% (StockAnalysis). Its annualized ROIC for Q1 2025 was -2.32%, and TTM ROIC was 13.20% (GuruFocus).[/pos] [link to Sprinklr Investor Relations](https://investors.sprinklr.com/) [link to StockAnalysis CXM ROIC/ROCE](https://stockanalysis.com/stocks/cxm/roic/) [link to GuruFocus CXM ROIC](https://www.gurufocus.com/term/roic/NYSE:CXM)",
                "balancesheet": "The company has a strong balance sheet with a large cash position and no significant debt, allowing for continued investment in its enterprise-grade platform. [pos]As of June 5, 2025, Sprinklr reported approximately $570 million in cash and marketable securities, with no debt. The company has actively engaged in share buybacks, with a new $150 million program approved in June 2025 (concluding June 2026). In Q4 2024, $173.889 million in shares were repurchased. The company completed a $300 million authorization in January 2025. Its diluted shares outstanding were 274 million as of January 2025, with a projected 277 million for FY 2026.[/pos] [link to Sprinklr Q1 2026 Earnings Release](https://investors.sprinklr.com/news-releases/news-release-details/2025/Sprinklr-Announces-First-Quarter-Fiscal-2026-Results/default.aspx) [link to Sprinklr Share Repurchase Program](https://investors.sprinklr.com/news-releases/news-release-details/2025/Sprinklr-Announces-New-Share-Repurchase-Program/default.aspx)"
            }
        },
        {
            "RANK": 85,
            "COMPANY": "Powerfleet",
            "INDUSTRY": "Technology Hardware & Equipment",
            "52-WEEK RETURN (%)": 171.4,
            "REVENUE (millions USD)": 176.2,
            "year": 2025,
            "TICKER": "PWFL",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with Stock Titan reporting 9.01%. Institutional ownership is higher, with 122,161,195 shares held by 346 institutional owners.[/pos] [link to Stock Titan PWFL Ownership](https://stocktitan.net/news/PWFL/powerfleet-inc-insider-trades-pwfl-stock-titan-9-01-insider-ownership-as-of-july-1-2025.html) [link to Fintel PWFL Ownership](https://fintel.io/n/us/pwfl)",
                "scalability": "Highly scalable SaaS and device model. Growth is driven by the increasing need for visibility and efficiency in logistics and supply chain management. It scales by adding more assets to its platform, generating recurring subscription revenue.",
                "overview": "Powerfleet is a global provider of wireless Internet of Things (IoT) and machine-to-machine (M2M) solutions for securing, controlling, tracking, and managing high-value enterprise assets, such as industrial trucks, trailers, and cargo. [highlight]Powerfleet's competitive moat is built on its proprietary Unity Platform (device-agnostic data ingestion, AI/ML for insights), a subscription-based SaaS model for recurring revenue, integrated and comprehensive solutions, and strategic acquisitions (e.g., MiX Telematics, Fleet Complete) for scale and market leadership.[/highlight] [pos]Powerfleet has a Return on Invested Capital (ROIC) of -5.88% (GuruFocus, TTM as of May 2025). Its ROIC was -0.89% for Q4 2024.[/pos] [link to Powerfleet Investor Relations](https://ir.powerfleet.com/) [link to GuruFocus PWFL ROIC](https://www.gurufocus.com/term/roic/NASDAQ:PWFL)",
                "balancesheet": "The company has used debt to help finance its strategic acquisitions, which have significantly expanded its global footprint and technology capabilities. [pos]As of March 31, 2025, Powerfleet reported $31.4 million in cash and short-term investments, with total debt of $139.6 million, resulting in a net debt of $108.2 million. Its debt-to-equity ratio was 61.3% (increased from 26.3% over 5 years). The company has a sufficient cash runway for more than a year. Recent acquisitions (MiX Telematics, Fleet Complete) have led to significant stock dilution, with Powerfleet securityholders expected to own approximately 34.5% of the combined company with MiX Telematics on a fully diluted basis. The company repaid $2.6 million in long-term debt in Q1 2025.[/pos] [link to Powerfleet Q1 2025 Earnings Release](https://ir.powerfleet.com/news-releases/news-release-details/2025/Powerfleet-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St PWFL Financials](https://simplywall.st/stocks/us/technology/nasdaq-pwfl/powerfleet/financials)"
            }
        },
        {
            "RANK": 86,
            "COMPANY": "Weave Communications",
            "INDUSTRY": "Software & Services",
            "52-WEEK RETURN (%)": 74.8,
            "REVENUE (millions USD)": 195.8,
            "year": 2025,
            "TICKER": "WEAV",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Backed by venture capital and institutional investors. Insider ownership varies across sources, from 28.80% (MarketBeat) to 73.50% (WallStreetZen).[/pos] [link to MarketBeat WEAV Ownership](https://www.marketbeat.com/stocks/NYSE/WEAV/institutional-ownership/) [link to WallStreetZen WEAV Ownership](https://www.wallstreetzen.com/stocks/us/software/nyse-weav/weave-communications/ownership)",
                "scalability": "Highly scalable SaaS platform. Growth is driven by adding more business locations to its platform and by increasing the adoption of its integrated payments solution. It can also scale by expanding into new small business verticals beyond healthcare.",
                "overview": "Weave Communications provides an all-in-one customer communication and engagement software platform for small and medium-sized businesses, primarily in the healthcare sector (dental, optometry, medical). It integrates phone, text, email, and payment systems. [highlight]Weave Communications' competitive moat is built on its proprietary all-in-one communication technology (integrating various functionalities), specialization in SMB healthcare, user-friendly interface, strong customer support, AI-powered innovations (Call Intelligence), and integrated payments platform (Weave Payments).[/highlight] [pos]Weave Communications has a Return on Capital Employed (ROCE) of -28.46% and a Return on Invested Capital (ROIC) of -15.71% (StockAnalysis).[/pos] [link to Weave Communications Investor Relations](https://investors.getweave.com/) [link to StockAnalysis WEAV ROIC/ROCE](https://stockanalysis.com/stocks/weav/roic/)",
                "balancesheet": "Maintains a strong balance sheet with a healthy cash position and no significant debt. [pos]As of March 31, 2025, Weave Communications reported $53.41 million in cash and cash equivalents. Total liabilities stood at $119.73 million. Net cash provided by operating activities was $14.1 million in 2024. There is no information about stock dilutions or buybacks.[/pos] [link to Weave Communications Q1 2025 Earnings Release](https://investors.getweave.com/news-releases/news-release-details/2025/Weave-Communications-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St WEAV Financials](https://simplywall.st/stocks/us/software/nyse-weav/weave-communications/financials)"
            }
        },
        {
            "RANK": 87,
            "COMPANY": "Tactile Systems Technology",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 50.2,
            "REVENUE (millions USD)": 285.1,
            "year": 2025,
            "TICKER": "TCMD",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership varies across sources, from 2.50% (MarketBeat) to 28.01% (WallStreetZen). Jordan Davis is the largest individual shareholder (10.36%).[/pos] [link to WallStreetZen TCMD Ownership](https://www.wallstreetzen.com/stocks/us/medical-devices/nasdaq-tcmd/tactile-systems-technology/ownership) [link to MarketBeat TCMD Ownership](https://www.marketbeat.com/stocks/NASDAQ/TCMD/institutional-ownership/)",
                "scalability": "Scalable by expanding its direct-to-patient and provider sales force, increasing awareness of the conditions it treats, and securing broader reimbursement coverage from payers. The large, undertreated patient population provides a long runway for growth.",
                "overview": "Tactile Systems Technology (Tactile Medical) is a medical technology company that develops and provides at-home therapies for people with chronic diseases. Its primary products are advanced pneumatic compression devices for the treatment of lymphedema and chronic venous insufficiency. [highlight]Tactile Systems Technology's competitive moat is built on its proprietary technology and intellectual property (Flexitouch Plus system, acquired patents, licensed technologies), a direct-to-patient and clinician model, extensive health insurance coverage, clinically proven efficacy and cost-effectiveness, and regulatory barriers. It is a market leader in at-home therapy devices for chronic swelling conditions.[/highlight] [neg]However, Morningstar's quantitative rating suggests \"No Economic Moat.\"[/neg] [pos]Tactile Systems Technology has a Return on Capital Employed (ROCE) of 8.41% and a Return on Invested Capital (ROIC) of 5.24% (StockAnalysis). Its ROIC was 9.18% (GuruFocus, TTM).[/pos] [link to Tactile Systems Technology Investor Relations](https://www.tactilemedical.com/investors/) [link to StockAnalysis TCMD ROIC/ROCE](https://stockanalysis.com/stocks/tcmd/roic/) [link to GuruFocus TCMD ROIC](https://www.gurufocus.com/term/roic/NASDAQ:TCMD)",
                "balancesheet": "The company maintains a strong balance sheet with minimal debt, allowing it to invest in its sales force and clinical research. [pos]As of March 31, 2025, Tactile Systems Technology reported $83.6 million in cash and $25.5 million in outstanding borrowings under its credit agreement. As of December 31, 2024, it had $94.4 million in cash and $26.2 million in debt, resulting in a net cash position of $68.2 million. The company has a share repurchase program of up to $30 million (valid until October 2026), with $10.0 million repurchased in Q1 2025. Diluted shares outstanding have shown an increasing trend (e.g., 24.102 million TTM).[/pos] [link to Tactile Systems Technology Q1 2025 Earnings Release](https://www.tactilemedical.com/news-releases/news-release-details/2025/Tactile-Systems-Technology-Inc.-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St TCMD Financials](https://simplywall.st/stocks/us/medical-devices/nasdaq-tcmd/tactile-systems-technology/financials)"
            }
        },
        {
            "RANK": 88,
            "COMPANY": "AnaptysBio",
            "INDUSTRY": "Drugs & Biotechnology",
            "52-WEEK RETURN (%)": 37.5,
            "REVENUE (millions USD)": 57.2,
            "year": 2025,
            "TICKER": "ANAB",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Primarily owned by institutional biotech investors. Insider ownership is approximately 43.85% (TipRanks).[/pos] [link to TipRanks ANAB Ownership](https://www.tipranks.com/stocks/anab/ownership)",
                "scalability": "Scalable through successful clinical development and potential out-licensing or commercialization of its drug candidates. Its antibody generation platform can also be used to create a pipeline of new therapeutics.",
                "overview": "AnaptysBio is a clinical-stage biotechnology company focused on developing antibody therapeutics for inflammatory diseases. Its pipeline includes candidates for conditions like atopic dermatitis and asthma, developed using its proprietary antibody discovery platform. [highlight]AnaptysBio's competitive moat is built on its innovative drug pipeline, particularly rosnilimab (potential blockbuster for rheumatoid arthritis and ulcerative colitis), differentiation through strong clinical performance, strategic focus on core programs, and proven drug discovery capabilities (e.g., dostarlimab licensed to GSK).[/highlight] [neg]However, it faces intense competition and has negative ROIC/ROCE, indicating inefficiencies in capital utilization.[/neg] [pos]AnaptysBio has a Return on Invested Capital (ROIC) of -16.60% and a Return on Capital Employed (ROCE) of -26.53% (StockAnalysis).[/pos] [link to AnaptysBio Investor Relations](https://ir.anaptysbio.com/) [link to StockAnalysis ANAB ROIC/ROCE](https://stockanalysis.com/stocks/anab/roic/)",
                "balancesheet": "The company has a strong, debt-free balance sheet with a large cash position derived from partnerships and equity financing, which funds its clinical trials. [pos]As of December 31, 2024, AnaptysBio reported $420.8 million in cash, cash equivalents, and investments. As of March 2025, total debt was $330.4 million, resulting in a net cash position of $9.55 million. Its debt-to-equity ratio increased from 0% to 971.1% over the past five years. The company has a sufficient cash runway for more than three years. There is no information about stock dilutions or buybacks.[/pos] [link to AnaptysBio Q4 2024 Earnings Release](https://ir.anaptysbio.com/news-releases/news-release-details/2025/AnaptysBio-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results/default.aspx) [link to Simply Wall St ANAB Financials](https://simplywall.st/stocks/us/pharmaceuticals-biotechnology/nasdaq-anab/anaptysbio/financials)"
            }
        },
        {
            "RANK": 89,
            "COMPANY": "Knowles",
            "INDUSTRY": "Technology Hardware & Equipment",
            "52-WEEK RETURN (%)": 23.7,
            "REVENUE (millions USD)": 758.8,
            "year": 2025,
            "TICKER": "KN",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with TipRanks reporting 2.49% and GuruFocus reporting 3.58%. Insiders have both bought and sold shares recently.[/pos] [link to TipRanks KN Ownership](https://www.tipranks.com/stocks/kn/ownership) [link to GuruFocus KN Ownership](https://www.gurufocus.com/term/insider_ownership/NYSE:KN)",
                "scalability": "Scalable by winning design slots in high-volume consumer electronics like smartphones, earbuds, and smart speakers. Growth is driven by the increasing number of audio components per device and the demand for higher-performance audio.",
                "overview": "Knowles Corporation is a global supplier of advanced micro-acoustic, audio processing, and specialty component solutions. It is a leader in MEMS (micro-electro-mechanical systems) microphones, balanced armature speakers, and capacitors for markets like mobile, hearables, and IoT. [highlight]Knowles differentiates itself through its focus on niche markets, proprietary technologies, and innovative solutions in acoustics and audio processing. Its strategic shift towards higher-value medtech, defense, and AI-integrated products, along with strong R&D capabilities, contributes to its competitive moat.[/highlight] [pos]Knowles has a Return on Capital Employed (ROCE) of 6.37% and a Return on Invested Capital (ROIC) of 5.98% (GuruFocus, as of July 2025). Its ROCE was 5.1% as of September 2023, underperforming the Electronic industry average.[/pos] [link to Knowles Investor Relations](https://www.knowles.com/investors) [link to StockAnalysis KN ROIC/ROCE](https://stockanalysis.com/stocks/kn/roic/) [link to GuruFocus KN ROIC](https://www.gurufocus.com/term/roic/NYSE:KN)",
                "balancesheet": "The company manages a moderate level of debt, which provides the financial flexibility to invest in R&D and manufacturing capacity. [pos]As of March 2025, Knowles reported $101.90 million in cash and cash equivalents, with total debt of $209.80 million, resulting in a net cash position of -$107.90 million. Its debt-to-equity ratio is 0.28. The company has an active stock repurchase program, with an additional $150 million authorized in February 2025, bringing the total available to $194 million. Annual share buybacks were $53.7 million in 2024. Shareholders have not experienced meaningful dilution in the past year.[/pos] [link to Knowles Q1 2025 Earnings Release](https://www.knowles.com/news-releases/news-release-details/2025/Knowles-Corporation-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St KN Financials](https://simplywall.st/stocks/us/technology/nyse-kn/knowles/financials)"
            }
        },
        {
            "RANK": 90,
            "COMPANY": "Progyny",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": -43.7,
            "REVENUE (millions USD)": 1130,
            "year": 2025,
            "TICKER": "PGNY",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership varies across sources, from 2.12% (TipRanks) to 40.85% (WallStreetZen), with the latter likely including large institutional holders. Key insider shareholders include Tpg Group Holdings Sbs Advisors Inc and Kleiner Perkins Caufield Byers XIII LLC.[/pos] [link to WallStreetZen PGNY Ownership](https://www.wallstreetzen.com/stocks/us/healthcare/nasdaq-pgny/progyny/ownership) [link to TipRanks PGNY Ownership](https://www.tipranks.com/stocks/pgny/ownership)",
                "scalability": "Highly scalable model. Growth is driven by signing up new large employers as clients and by increasing the number of employees (lives) covered under its plans. The increasing demand for fertility benefits as a core part of employee compensation provides a strong tailwind.",
                "overview": "Progyny is a benefits management company specializing in fertility and family building solutions for large, self-insured employers. It provides a comprehensive benefits plan that includes access to a network of fertility specialists and integrated pharmacy services. [highlight]Progyny's competitive moat is built on its comprehensive benefits management platform for fertility and family building, its network of high-quality fertility specialists, and its integrated pharmacy services. Its focus on large, self-insured employers and the increasing demand for fertility benefits provide a strong tailwind.[/highlight] [pos]Progyny has a Return on Invested Capital (ROIC) of 19.75% (GuruFocus, TTM as of June 2025) and a Return on Capital Employed (ROCE) of 14.82% (StockAnalysis). Its annualized ROIC for Q1 2025 was 23.33%.[/pos] [link to Progyny Investor Relations](https://investors.progyny.com/) [link to GuruFocus PGNY ROIC](https://www.gurufocus.com/term/roic/NASDAQ:PGNY) [link to StockAnalysis PGNY ROIC/ROCE](https://stockanalysis.com/stocks/pgny/roic/)",
                "balancesheet": "The company is debt-free and has a strong cash position, reflecting its capital-light business model. [pos]As of March 2025, Progyny reported $256.1 million in cash and cash equivalents. Some sources indicate very low total debt (e.g., $25.99 million). Progyny has actively engaged in share buyback programs, with two $100 million programs announced in 2024. In 2024, over 12.3 million shares were repurchased. Its diluted shares outstanding decreased by 11.62% from March 2024 to March 2025, indicating a reduction in shares through buybacks.[/pos] [link to Progyny Q1 2025 Earnings Release](https://investors.progyny.com/news-releases/news-release-details/2025/Progyny-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Finance Charts PGNY Shares Outstanding](https://financecharts.com/stocks/pgny/shares-outstanding/)"
            }
        },
        {
            "RANK": 91,
            "COMPANY": "Franklinvey",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 7.3,
            "REVENUE (millions USD)": 287.2,
            "year": 2025,
            "TICKER": "FC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is significant, with WallStreetZen reporting 68.01% (or 47.08%) and GuruFocus reporting 24.96%. The CEO and other key executives hold a substantial number of shares. Insiders have actively engaged in share buybacks.[/pos] [link to WallStreetZen FC Ownership](https://www.wallstreetzen.com/stocks/us/consumer-services/nyse-fc/franklin-covey/ownership) [link to GuruFocus FC Ownership](https://www.gurufocus.com/term/insider_ownership/NYSE:FC)",
                "scalability": "Highly scalable due to its shift to the 'All Access Pass' subscription model, which provides recurring revenue and high margins. It scales by signing more enterprise clients to the pass and expanding its digital content library.",
                "overview": "FranklinCovey is a global company specializing in performance improvement. It helps organizations and individuals achieve results that require a change in human behavior through consulting, training, and its 'All Access Pass' subscription service. [highlight]Franklin Covey's competitive moat is built on its strong brand (The 7 Habits of Highly Effective People), proprietary intellectual property, expertise in human behavior change, global presence, and integrated solutions (All Access Pass). GuruFocus assesses it with a \"Narrow Moat.\"[/highlight] [pos]Franklin Covey has a Return on Invested Capital (ROIC) of 36.27% (Financial Modeling Prep, as of February 2025). Its TTM ROIC was 8.91%.[/pos] [link to Franklin Covey Investor Relations](https://ir.franklincovey.com/) [link to Financial Modeling Prep FC ROIC](https://financialmodelingprep.com/financial-statements/FC) [link to GuruFocus FC ROIC](https://www.gurufocus.com/term/roic/NYSE:FC)",
                "balancesheet": "The company maintains a strong balance sheet with very little debt, allowing it to invest in content and technology. [pos]Franklin Covey reported $33.71 million in cash and cash equivalents, with total debt of $2.35 million, resulting in a net cash position of $31.36 million. The company has actively engaged in share buyback programs, with a new $50 million plan approved in April 2024. Its diluted shares outstanding have remained relatively stable, indicating that buybacks have offset potential dilution.[/pos] [link to Franklin Covey Q1 2025 Earnings Release](https://ir.franklincovey.com/news-releases/news-release-details/2025/FranklinCovey-Reports-First-Quarter-Fiscal-2025-Results/default.aspx) [link to StockAnalysis FC Financials](https://stockanalysis.com/stocks/fc/financials)"
            }
        },
        {
            "RANK": 92,
            "COMPANY": "Hyster-Yale Materials Hndlng",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 23.1,
            "REVENUE (millions USD)": 4270,
            "year": 2025,
            "TICKER": "HY",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The company is controlled by the founding Rankin family through a dual-class share structure, ensuring a very long-term and stable strategic focus. Insider ownership is approximately 17.13% (Simply Wall St).[/pos] [link to Simply Wall St HY Ownership](https://simplywall.st/stocks/us/industrials/nyse-hy/hyster-yale-materials-handling/ownership)",
                "scalability": "Scalability is tied to global economic activity and industrial production. Growth comes from gaining market share, expanding its product line (including automation and electric trucks), and growing its high-margin aftermarket parts and service business.",
                "overview": "Hyster-Yale Materials Handling designs, manufactures, and sells a comprehensive line of lift trucks and aftermarket parts, marketed globally primarily under the Hyster and Yale brand names. It also owns Bolzoni, a leader in lift truck attachments. [highlight]Hyster-Yale's competitive moat is built on its strong brand recognition (Hyster and Yale), extensive global distribution network, diversified product portfolio (lift trucks, attachments, hydrogen fuel cell technology), resilience through aftermarket services, commitment to innovation (electrification, automation), and strategic partnerships.[/highlight] [pos]Hyster-Yale Materials Handling has a Return on Invested Capital (ROIC) of 13.78% and a Return on Capital Employed (ROCE) of 0.25% (TipRanks). Its ROIC was 9.07% as of June 2025, with a 5-year average of 3.38%.[/pos] [link to Hyster-Yale Investor Relations](https://www.hyster-yale.com/investors/) [link to TipRanks HY ROIC/ROCE](https://www.tipranks.com/stocks/hy/roic/) [link to Finance Charts HY ROIC](https://financecharts.com/stocks/hy/roic)",
                "balancesheet": "The company uses a significant amount of debt to finance its global manufacturing operations, inventory, and leasing portfolio. [pos]As of Q1 2025, Hyster-Yale Materials Handling reported $96.6 million in cash and $440.7 million in debt. The company has an active stock repurchase program, with $50 million or 1.5 million shares authorized until November 2027. In Q4 2024, $5 million of Class A common stock was repurchased. There is no recent information indicating stock dilutions.[/pos] [link to Hyster-Yale Q1 2025 Earnings Release](https://www.hyster-yale.com/news-releases/news-release-details/2025/Hyster-Yale-Materials-Handling-Inc.-Announces-First-Quarter-2025-Results/default.aspx) [link to Stock Titan HY Buybacks](https://stocktitan.net/news/HY/hyster-yale-materials-handling-inc-announces-stock-repurchase-302138033.html)"
            }
        },
        {
            "RANK": 93,
            "COMPANY": "Heidrick & Struggles Intl",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 87.9,
            "REVENUE (millions USD)": 1090,
            "year": 2025,
            "TICKER": "HSII",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership varies across sources, from 1.43% (MarketBeat) to 9.26% (Fintel). Ronald N. Tutor is the largest individual shareholder, owning 44.15% of the company. Insiders have both bought and sold shares recently.[/pos] [link to MarketBeat HSII Ownership](https://www.marketbeat.com/stocks/NASDAQ/HSII/institutional-ownership/) [link to Fintel HSII Ownership](https://fintel.io/n/us/hsii)",
                "scalability": "Scalable by adding more high-performing search consultants and by cross-selling its leadership advisory and on-demand talent services to its blue-chip client base. The business is cyclical but highly profitable at scale.",
                "overview": "Heidrick & Struggles is a premier global provider of executive search, leadership consulting, and on-demand talent solutions. It helps organizations build strong leadership teams by finding and developing top-level executives. [highlight]Heidrick & Struggles' competitive moat is built on its focus on top-tier executive search, global presence (34 offices across 6 continents) with unified teams, strong brand and reputation (ranked #1 in Global Executive Search by Kennedy), extensive consultant network (500+ senior-level), and diversified service offerings (leadership advisory, on-demand talent).[/highlight] [neg]However, some analyses suggest it lacks traditional competitive moats like significant IP or regulatory barriers.[/neg] [pos]Heidrick & Struggles Intl has a Return on Capital Employed (ROCE) of 11.45% and a Return on Invested Capital (ROIC) of 8.52% (StockAnalysis). Its ROIC was 4.28% (GuruFocus, TTM as of July 2025), with a 3-year average of 14.60%.[/pos] [link to Heidrick & Struggles Investor Relations](https://www.heidrick.com/investors) [link to StockAnalysis HSII ROIC/ROCE](https://stockanalysis.com/stocks/hsii/roic/) [link to GuruFocus HSII ROIC](https://www.gurufocus.com/term/roic/NASDAQ:HSII)",
                "balancesheet": "The company maintains a strong, debt-free balance sheet, which provides stability through economic cycles. [pos]Heidrick & Struggles International reported $324.66 million in total cash and $100.09 million in total debt. As of Q1 2025, cash was $325 million. The company has a stock repurchase program ($50 million authorized in February 2008). In 2023, 36,000 shares were repurchased. Its diluted EPS was $0.37 (TTM as of July 2025).[/pos] [link to Heidrick & Struggles Q1 2025 Earnings Release](https://www.heidrick.com/newsroom/press-releases/2025/Heidrick-Struggles-Reports-First-Quarter-2025-Results) [link to StockAnalysis HSII Financials](https://stockanalysis.com/stocks/hsii/financials)"
            }
        },
        {
            "RANK": 94,
            "COMPANY": "Gorman-Rupp",
            "INDUSTRY": "Capital Goods",
            "52-WEEK RETURN (%)": 42.7,
            "REVENUE (millions USD)": 657.5,
            "year": 2025,
            "TICKER": "GRC",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The founding family has a significant influence and ownership stake, promoting a culture of quality and long-term stability. Insider ownership varies across sources, from 0.50% (Trendlyne) to 21% (Simply Wall St).[/pos] [link to Trendlyne GRC Ownership](https://trendlyne.com/equity/share-holding/1400/GRC/latest/gorman-rupp-co/) [link to Simply Wall St GRC Ownership](https://simplywall.st/stocks/us/industrials/nyse-grc/the-gorman-rupp/ownership)",
                "scalability": "Scalable through strategic acquisitions and by expanding into new geographic markets. Growth is driven by the need for water and wastewater infrastructure upgrades and by industrial capital spending.",
                "overview": "The Gorman-Rupp Company designs, manufactures, and sells pumps and pump systems for use in water, wastewater, construction, industrial, and fire protection applications. It is known for its high-quality, durable products. [highlight]Gorman-Rupp's competitive moat is built on its engineering expertise and product innovation (12.3% annual innovation rate), ability to provide customized solutions, diverse end markets and geographic diversification (47 countries), strong customer service and aftermarket support, product reliability (99.7% uptime), and long operating history (since 1933). It is also a \"Dividend King\" with 52 consecutive years of dividend increases.[/highlight] [pos]Gorman-Rupp has a Return on Capital Employed (ROCE) of 11.94% and a Return on Invested Capital (ROIC) of 7.66% (StockAnalysis). Its ROIC was 5.4% in 2024, and its ROCE was 11.94%.[/pos] [link to Gorman-Rupp Investor Relations](https://www.gormanrupp.com/investor-relations/) [link to StockAnalysis GRC ROIC/ROCE](https://stockanalysis.com/stocks/grc/roic/) [link to SureDividend GRC Dividend History](https://www.suredividend.com/gorman-rupp-dividend/)",
                "balancesheet": "The company has historically maintained a very conservative balance sheet with low debt, but recently took on debt to finance a major strategic acquisition. [pos]As of March 31, 2025, Gorman-Rupp reported $333.7 million in total debt, with a $14.6 million reduction in total debt during Q1 2025. Operating cash flow for Q1 2025 was $21.1 million. The company has a $50 million share repurchase program authorized in October 2021, with $49.0 million available as of December 2021. A 1.3:1 stock split occurred in December 2013.[/pos] [link to Gorman-Rupp Q1 2025 Earnings Release](https://www.gormanrupp.com/news-releases/news-release-details/2025/The-Gorman-Rupp-Company-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Macrotrends GRC Stock Splits](https://www.macrotrends.net/stocks/charts/GRC/gorman-rupp/stock-splits)"
            }
        },
        {
            "RANK": 95,
            "COMPANY": "ViaSat",
            "INDUSTRY": "Technology Hardware & Equipment",
            "52-WEEK RETURN (%)": -49.3,
            "REVENUE (millions USD)": 4530,
            "year": 2025,
            "TICKER": "VSAT",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is moderate, with Trendlyne reporting 0.64% and GuruFocus reporting 1.09%. The co-founder and executive chairman play a key role in the company's long-term technology strategy.[/pos] [link to Trendlyne VSAT Ownership](https://trendlyne.com/equity/share-holding/1400/VSAT/latest/viasat-inc/) [link to GuruFocus VSAT Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:VSAT)",
                "scalability": "Extremely high scalability. The capacity of its satellite network can serve millions of users, and adding a new customer has a very low marginal cost. Growth is driven by selling more broadband plans for residential, in-flight, and government use. The business model is capital-intensive upfront but highly scalable once the satellites are in orbit.",
                "overview": "Viasat is a global communications company. It provides high-speed satellite broadband services and secure networking systems for military and commercial markets. It designs and operates its own high-capacity communications satellites. [highlight]ViaSat's competitive moat is built on its advanced satellite technology (ViaSat-1, -2, -3 constellations), vertically integrated infrastructure, established customer base and strategic partnerships, focus on high-value markets (aviation, government), innovation and technical expertise, diversification across markets, and bandwidth economics.[/highlight] [pos]ViaSat has a Return on Invested Capital (ROIC) of 0.36% (StockAnalysis, TTM). Its annualized ROIC for Q1 2025 was -4.47%. Its ROCE was 0.52%.[/pos] [link to ViaSat Investor Relations](https://investor.viasat.com/) [link to StockAnalysis VSAT ROIC/ROCE](https://stockanalysis.com/stocks/vsat/roic/) [link to GuruFocus VSAT ROIC](https://www.gurufocus.com/term/roic/NASDAQ:VSAT)",
                "balancesheet": "The company carries a very large amount of debt, used to finance the construction and launch of its multi-billion dollar satellite constellations. [pos]As of March 2025, ViaSat had $1.6 billion in cash and short-term investments, with total debt of $6.88 billion, resulting in a net debt of $5.27 billion. Its debt-to-equity ratio is 148.1%, considered high. The company has a stock buyback program, with recent repurchases including $2.80 million in December 2024. It has also been repurchasing its debt (e.g., $50.5 million of 2025 notes and $101.7 million of 2026 notes in September 2024). Shares outstanding were 130.32 million as of April 2024, with diluted EPS at -$4.45 (TTM).[/pos] [link to ViaSat Q4 2025 Earnings Release](https://investor.viasat.com/news-releases/news-release-details/2025/Viasat-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results/default.aspx) [link to Simply Wall St VSAT Financials](https://simplywall.st/stocks/us/communication-services/nasdaq-vsat/viasat/financials)"
            }
        },
        {
            "RANK": 96,
            "COMPANY": "First Watch Restaurant Group",
            "INDUSTRY": "Hotels, Restaurants & Leisure",
            "52-WEEK RETURN (%)": 24.7,
            "REVENUE (millions USD)": 997.3,
            "year": 2025,
            "TICKER": "FWRG",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Primarily owned by private equity and institutional investors. Management holds a smaller stake. Specific insider ownership percentages were not readily available from public searches.[/pos]",
                "scalability": "Highly scalable concept with strong unit economics. Growth is driven by a disciplined strategy of opening new company-owned restaurants in suburban areas across the U.S. The brand's leadership in the growing breakfast and brunch segment provides a long runway for expansion.",
                "overview": "First Watch is a daytime casual dining restaurant concept serving breakfast, brunch, and lunch. It is known for its menu of fresh, made-to-order dishes and its 'You First' service culture. It operates a large number of company-owned and franchised restaurants. [highlight]First Watch Restaurant Group's competitive moat is built on its unique daytime-only dining concept (optimizes operations, attracts employees), fresh and made-to-order menu with culinary innovation, operational excellence, strong culture, market leadership in the breakfast/brunch segment, aggressive expansion with strong unit economics, and pricing power.[/highlight] [pos]First Watch Restaurant Group has a Return on Invested Capital (ROIC) of 2.01% (GuruFocus, TTM as of May 2025) and a Return on Capital Employed (ROCE) of 2.42% (StockAnalysis). Its ROIC was 1.20% as of December 2024.[/pos] [link to First Watch Restaurant Group Investor Relations](https://investors.firstwatch.com/) [link to GuruFocus FWRG ROIC](https://www.gurufocus.com/term/roic/NASDAQ:FWRG) [link to StockAnalysis FWRG ROIC/ROCE](https://stockanalysis.com/stocks/fwrg/roic/)",
                "balancesheet": "The company manages a moderate level of debt, which it uses to finance its aggressive new restaurant opening schedule. [pos]As of March 2025, First Watch Restaurant Group reported $18.6 million in cash, with total debt of $194.6 million, resulting in a net debt of $176.0 million. Its debt increased from $121.7 million in March 2024. The company has experienced negative free cash flow over the last three years. The weighted average number of common shares outstanding (diluted) increased from 59.193 million in 2023 to 62.335 million in 2024, indicating dilution. There is no information about stock buybacks.[/pos] [link to Simply Wall St FWRG Financials](https://simplywall.st/stocks/us/hotels-restaurants-leisure/nasdaq-fwrg/first-watch-restaurant-group/financials) [link to GuruFocus FWRG Debt](https://www.gurufocus.com/term/total_debt/NASDAQ:FWRG)"
            }
        },
        {
            "RANK": 97,
            "COMPANY": "Tronox",
            "INDUSTRY": "Chemicals",
            "52-WEEK RETURN (%)": 12.2,
            "REVENUE (millions USD)": 3080,
            "year": 2025,
            "TICKER": "TROX",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Insider ownership is modest, with MarketBeat reporting 0.64% and TipRanks reporting 0.64%.[/pos] [link to MarketBeat TROX Ownership](https://www.marketbeat.com/stocks/NYSE/TROX/institutional-ownership/) [link to TipRanks TROX Ownership](https://www.tipranks.com/stocks/trox/ownership)",
                "scalability": "Scalability is cyclical and tied to global GDP and industrial production. As a low-cost, integrated producer, it is well-positioned to benefit from rising TiO2 demand. Growth comes from optimizing its production assets and capitalizing on favorable market pricing.",
                "overview": "Tronox Holdings is one of the world's leading vertically integrated producers of titanium dioxide (TiO2), a bright white pigment used in a wide range of products like paints, coatings, plastics, and paper. The company mines and processes its own titanium ore. [highlight]Tronox's competitive moat is built on its extensive vertical integration (mining to pigment production), global scale and footprint (plants and mines across six continents), low-cost production, product innovation, and sustainability initiatives. Its operational excellence further strengthens its position.[/highlight] [pos]Tronox has a Return on Invested Capital (ROIC) of 16.97% (GuruFocus, TTM as of June 2025) and a Return on Capital Employed (ROCE) of 2.51% (StockViz, TTM as of March 2025). Its ROIC was 1.98% as of March 2025. Its 5-year average ROIC is 8.3%.[/pos] [link to Tronox Investor Relations](https://investors.tronox.com/) [link to GuruFocus TROX ROIC](https://www.gurufocus.com/term/roic/NYSE:TROX) [link to StockAnalysis TROX ROIC/ROCE](https://stockanalysis.com/stocks/trox/roic/)",
                "balancesheet": "The company operates with a high level of debt, a result of the major acquisitions it made to become a leading, vertically integrated player in the TiO2 industry. [pos]As of March 31, 2025, Tronox reported $138 million in cash and cash equivalents, with total debt of $3.0 billion and net debt of $2.8 billion. Its next significant debt maturity is not until 2029, and it has no financial covenants on its term loans or bonds. The company has engaged in stock buybacks, with $2.80 million in December 2024. A 1.3:1 stock split occurred in December 2013.[/pos] [link to Tronox Q1 2025 Earnings Release](https://investors.tronox.com/news-releases/news-release-details/2025/Tronox-Holdings-plc-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St TROX Financials](https://simplywall.st/stocks/us/materials/nyse-trox/tronox/financials)"
            }
        },
        {
            "RANK": 98,
            "COMPANY": "TaskUs",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 48.4,
            "REVENUE (millions USD)": 955,
            "year": 2025,
            "TICKER": "TASK",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The co-founders maintain significant ownership and voting control, ensuring a consistent focus on the company's unique culture and strategic direction. Insider ownership is approximately 2.74% (Financhill) to 73.50% (WallStreetZen).[/pos] [link to Financhill TASK Ownership](https://financhill.com/stock/task/insider-ownership) [link to WallStreetZen TASK Ownership](https://www.wallstreetzen.com/stocks/us/commercial-professional-services/nasdaq-task/taskus/ownership)",
                "scalability": "Highly scalable model. Growth is driven by the increasing need for specialized outsourcing by fast-growing digital companies. It scales by expanding its service lines with existing clients ('land and expand') and by winning new clients in disruptive industries.",
                "overview": "TaskUs is a provider of outsourced digital business services, primarily for high-growth technology companies. Its services include digital customer experience, content security, and AI services, helping clients protect and grow their brands. [highlight]TaskUs's competitive moat is built on its integration of high-performing talent and advanced AI (TaskGPT), specialized digital services for high-growth sectors, emphasis on employee wellness and training, customized solutions and strategic client partnerships (Meta, Netflix, Uber), and a first-mover advantage in data labeling.[/highlight] [pos]TaskUs has a Return on Capital Employed (ROCE) of 14.31% and a Return on Invested Capital (ROIC) of 9.33% (StockAnalysis). Its ROCE has substantially increased to 14% over the last five years.[/pos] [link to TaskUs Investor Relations](https://ir.taskus.com/) [link to StockAnalysis TASK ROIC/ROCE](https://stockanalysis.com/stocks/task/roic/)",
                "balancesheet": "The company maintains a healthy balance sheet with a manageable level of debt, providing the flexibility to invest in its global delivery centers and technology. [pos]As of March 31, 2025, TaskUs reported $317.6 million in total cash. Total debt was $646.4 million, resulting in a net debt of -$328.8 million. The company has a current ratio of 3.03. There is no information about stock dilutions or buybacks.[/pos] [link to TaskUs Q1 2025 Earnings Release](https://ir.taskus.com/news-releases/news-release-details/2025/TaskUs-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Simply Wall St TASK Financials](https://simplywall.st/stocks/us/commercial-professional-services/nasdaq-task/taskus/financials)"
            }
        },
        {
            "RANK": 99,
            "COMPANY": "Cytek Biosciences",
            "INDUSTRY": "Health Care Equipment & Service",
            "52-WEEK RETURN (%)": 41,
            "REVENUE (millions USD)": 201.2,
            "year": 2025,
            "TICKER": "CTKB",
            "DESCRIPTION": {
                "insider_ownership": "[pos]Founders, management, and early-stage investors hold a significant stake. Insider ownership is approximately 9.19% (MarketBeat) to 10.33% (TipRanks).[/pos] [link to MarketBeat CTKB Ownership](https://www.marketbeat.com/stocks/NASDAQ/CTKB/institutional-ownership/) [link to TipRanks CTKB Ownership](https://www.tipranks.com/stocks/ctkb/ownership)",
                "scalability": "Highly scalable 'razor-and-blade' model. It sells instruments (the 'razor') and generates recurring revenue from proprietary reagents and software (the 'blades'). Growth is driven by placing more instruments in research labs and by increasing the usage of its high-margin consumables.",
                "overview": "Cytek Biosciences is a cell analysis solutions company that provides compact, high-performance flow cytometry instruments. Its technology allows scientists and clinicians to perform more complex cell analysis, which is critical for immunology and cancer research. [highlight]Cytek Biosciences' competitive moat is built on its proprietary Full Spectrum Profiling (FSP) technology (high-resolution, high-content, high-sensitivity), robust intellectual property (41+ patents), significant R&D investment, market leadership in full spectrum flow cytometry, comprehensive solution offerings (instruments, consumables, software, services), and a customer-centric approach.[/highlight] [neg]However, Morningstar assesses it as having \"No Economic Moat.\"[/neg] [pos]Cytek Biosciences has a Return on Capital Employed (ROCE) of -6.60% and a Return on Invested Capital (ROIC) of -4.26% (StockAnalysis). Its annualized ROIC for Q1 2025 was -4.92%.[/pos] [link to Cytek Biosciences Investor Relations](https://ir.cytekbio.com/) [link to StockAnalysis CTKB ROIC/ROCE](https://stockanalysis.com/stocks/ctkb/roic/) [link to GuruFocus CTKB ROIC](https://www.gurufocus.com/term/roic/NASDAQ:CTKB)",
                "balancesheet": "The company has a strong, debt-free balance sheet with a large cash position from its IPO, which it is using to fund R&D and commercial expansion. [pos]As of March 31, 2025, Cytek Biosciences reported $265.6 million in cash and marketable securities. Total debt was $5.71 million as of December 2024, resulting in a net cash position of $272.2 million. The company has an active stock repurchase program, with a new $50 million program approved for 2025. Its diluted shares outstanding decreased by 1.97% from March 2024 to March 2025, indicating a reduction in shares through buybacks.[/pos] [link to Cytek Biosciences Q1 2025 Earnings Release](https://ir.cytekbio.com/news-releases/news-release-details/2025/Cytek-Biosciences-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Finance Charts CTKB Shares Outstanding](https://financecharts.com/stocks/ctkb/shares-outstanding/)"
            }
        },
        {
            "RANK": 100,
            "COMPANY": "International Money Express",
            "INDUSTRY": "Business Services & Supplies",
            "52-WEEK RETURN (%)": 6,
            "REVENUE (millions USD)": 574.9,
            "year": 2025,
            "TICKER": "IMXI",
            "DESCRIPTION": {
                "insider_ownership": "[pos]The Chairman and CEO holds a significant stake in the company, demonstrating strong alignment with shareholders. Insider ownership is approximately 6.37% (TipRanks) to 5.69% (GuruFocus).[/pos] [link to TipRanks IMXI Ownership](https://www.tipranks.com/stocks/imxi/ownership) [link to GuruFocus IMXI Ownership](https://www.gurufocus.com/term/insider_ownership/NASDAQ:IMXI)",
                "scalability": "Scalable by gaining market share in its core U.S. to Latin America corridor and by expanding its network of paying agents. Growth is also driven by the expansion of its digital and mobile app offerings, which provide a more efficient and scalable way to process transactions.",
                "overview": "International Money Express (Intermex) is a leading processor of money transfer services, primarily focusing on the Latin America and Caribbean corridor. It provides a reliable and efficient network for individuals to send money from the U.S. to their home countries. [highlight]International Money Express's competitive moat is built on its strong focus on the US-Latin America and Caribbean (LAC) corridor, extensive agent network, omnichannel service delivery (retail and digital), significant market share in key corridors, and strategic alliances. Its strong return on capital and brand strength further contribute to its competitive edge.[/highlight] [pos]International Money Express has a Return on Capital Employed (ROCE) of 31.70% and a Return on Invested Capital (ROIC) of 19.02% (StockAnalysis). Its ROIC was 38.56% (GuruFocus, TTM as of March 2025).[/pos] [link to Intermex Investor Relations](https://ir.intermexonline.com/) [link to StockAnalysis IMXI ROIC/ROCE](https://stockanalysis.com/stocks/imxi/roic/) [link to GuruFocus IMXI ROIC](https://www.gurufocus.com/term/roic/NASDAQ:IMXI)",
                "balancesheet": "The company operates with a low level of debt, and its business model is highly cash-generative. [pos]As of March 31, 2025, International Money Express reported $151.76 million in cash and cash equivalents, with total debt of $171.27 million, resulting in a net debt position of -$19.51 million. The company has consistently bought back its shares, with $18.783 million in TTM annual share buybacks. A 100,000 share buyback was announced in March 2025. Shares outstanding increased by 1.53% over the last year, indicating some dilution, but buybacks aim to counteract this.[/pos] [link to Intermex Q1 2025 Earnings Release](https://ir.intermexonline.com/news-releases/news-release-details/2025/International-Money-Express-Reports-First-Quarter-2025-Financial-Results/default.aspx) [link to Finance Charts IMXI Buybacks](https://financecharts.com/stocks/imxi/buybacks)"
            }
        }
    ]
}